id	sid	tid	token	lemma	pos
ajlm-2140	1	1	abstract	abstract	ADJ
ajlm-2140	1	2	introduction	introduction	NOUN
ajlm-2140	1	3	methods	method	NOUN
ajlm-2140	1	4	results	result	VERB
ajlm-2140	1	5	discussion	discussion	NOUN
ajlm-2140	1	6	acknowledgements	acknowledgement	NOUN
ajlm-2140	1	7	references	reference	NOUN
ajlm-2140	1	8	about	about	ADP
ajlm-2140	1	9	the	the	DET
ajlm-2140	1	10	author(s	author(s	NOUN
ajlm-2140	1	11	)	)	PUNCT
ajlm-2140	1	12	jasmine	jasmine	NOUN
ajlm-2140	1	13	ramiah	ramiah	NOUN
ajlm-2140	1	14	department	department	PROPN
ajlm-2140	1	15	of	of	ADP
ajlm-2140	1	16	haematology	haematology	PROPN
ajlm-2140	1	17	,	,	PUNCT
ajlm-2140	1	18	national	national	PROPN
ajlm-2140	1	19	health	health	PROPN
ajlm-2140	1	20	laboratory	laboratory	PROPN
ajlm-2140	1	21	services	service	NOUN
ajlm-2140	1	22	,	,	PUNCT
ajlm-2140	1	23	inkosi	inkosi	PROPN
ajlm-2140	1	24	albert	albert	PROPN
ajlm-2140	1	25	luthuli	luthuli	PROPN
ajlm-2140	1	26	central	central	PROPN
ajlm-2140	1	27	hospital	hospital	NOUN
ajlm-2140	1	28	,	,	PUNCT
ajlm-2140	1	29	durban	durban	PROPN
ajlm-2140	1	30	,	,	PUNCT
ajlm-2140	1	31	south	south	PROPN
ajlm-2140	1	32	africa	africa	PROPN
ajlm-2140	1	33	department	department	PROPN
ajlm-2140	1	34	of	of	ADP
ajlm-2140	1	35	haematology	haematology	PROPN
ajlm-2140	1	36	,	,	PUNCT
ajlm-2140	1	37	school	school	NOUN
ajlm-2140	1	38	of	of	ADP
ajlm-2140	1	39	laboratory	laboratory	NOUN
ajlm-2140	1	40	medicine	medicine	NOUN
ajlm-2140	1	41	,	,	PUNCT
ajlm-2140	1	42	university	university	NOUN
ajlm-2140	1	43	of	of	ADP
ajlm-2140	1	44	kwazulu	kwazulu	PROPN
ajlm-2140	1	45	-	-	PUNCT
ajlm-2140	1	46	natal	natal	ADJ
ajlm-2140	1	47	,	,	PUNCT
ajlm-2140	1	48	durban	durban	PROPN
ajlm-2140	1	49	,	,	PUNCT
ajlm-2140	1	50	south	south	PROPN
ajlm-2140	1	51	africa	africa	PROPN
ajlm-2140	1	52	dashini	dashini	PROPN
ajlm-2140	1	53	pillay	pillay	PROPN
ajlm-2140	1	54	department	department	PROPN
ajlm-2140	1	55	of	of	ADP
ajlm-2140	1	56	haematology	haematology	PROPN
ajlm-2140	1	57	,	,	PUNCT
ajlm-2140	1	58	national	national	PROPN
ajlm-2140	1	59	health	health	PROPN
ajlm-2140	1	60	laboratory	laboratory	PROPN
ajlm-2140	1	61	services	service	NOUN
ajlm-2140	1	62	,	,	PUNCT
ajlm-2140	1	63	inkosi	inkosi	PROPN
ajlm-2140	1	64	albert	albert	PROPN
ajlm-2140	1	65	luthuli	luthuli	PROPN
ajlm-2140	1	66	central	central	PROPN
ajlm-2140	1	67	hospital	hospital	NOUN
ajlm-2140	1	68	,	,	PUNCT
ajlm-2140	1	69	durban	durban	PROPN
ajlm-2140	1	70	,	,	PUNCT
ajlm-2140	1	71	south	south	PROPN
ajlm-2140	1	72	africa	africa	PROPN
ajlm-2140	1	73	department	department	PROPN
ajlm-2140	1	74	of	of	ADP
ajlm-2140	1	75	haematology	haematology	PROPN
ajlm-2140	1	76	,	,	PUNCT
ajlm-2140	1	77	school	school	NOUN
ajlm-2140	1	78	of	of	ADP
ajlm-2140	1	79	laboratory	laboratory	NOUN
ajlm-2140	1	80	medicine	medicine	NOUN
ajlm-2140	1	81	,	,	PUNCT
ajlm-2140	1	82	university	university	NOUN
ajlm-2140	1	83	of	of	ADP
ajlm-2140	1	84	kwazulu	kwazulu	PROPN
ajlm-2140	1	85	-	-	PUNCT
ajlm-2140	1	86	natal	natal	ADJ
ajlm-2140	1	87	,	,	PUNCT
ajlm-2140	1	88	durban	durban	PROPN
ajlm-2140	1	89	,	,	PUNCT
ajlm-2140	1	90	south	south	PROPN
ajlm-2140	1	91	africa	africa	PROPN
ajlm-2140	1	92	nadine	nadine	PROPN
ajlm-2140	1	93	rapiti	rapiti	PROPN
ajlm-2140	1	94	department	department	PROPN
ajlm-2140	1	95	of	of	ADP
ajlm-2140	1	96	haematology	haematology	PROPN
ajlm-2140	1	97	,	,	PUNCT
ajlm-2140	1	98	national	national	PROPN
ajlm-2140	1	99	health	health	PROPN
ajlm-2140	1	100	laboratory	laboratory	PROPN
ajlm-2140	1	101	services	service	NOUN
ajlm-2140	1	102	,	,	PUNCT
ajlm-2140	1	103	inkosi	inkosi	PROPN
ajlm-2140	1	104	albert	albert	PROPN
ajlm-2140	1	105	luthuli	luthuli	PROPN
ajlm-2140	1	106	central	central	PROPN
ajlm-2140	1	107	hospital	hospital	NOUN
ajlm-2140	1	108	,	,	PUNCT
ajlm-2140	1	109	durban	durban	PROPN
ajlm-2140	1	110	,	,	PUNCT
ajlm-2140	1	111	south	south	PROPN
ajlm-2140	1	112	africa	africa	PROPN
ajlm-2140	1	113	department	department	PROPN
ajlm-2140	1	114	of	of	ADP
ajlm-2140	1	115	haematology	haematology	PROPN
ajlm-2140	1	116	,	,	PUNCT
ajlm-2140	1	117	school	school	NOUN
ajlm-2140	1	118	of	of	ADP
ajlm-2140	1	119	laboratory	laboratory	NOUN
ajlm-2140	1	120	medicine	medicine	NOUN
ajlm-2140	1	121	,	,	PUNCT
ajlm-2140	1	122	university	university	NOUN
ajlm-2140	1	123	of	of	ADP
ajlm-2140	1	124	kwazulu	kwazulu	PROPN
ajlm-2140	1	125	-	-	PUNCT
ajlm-2140	1	126	natal	natal	ADJ
ajlm-2140	1	127	,	,	PUNCT
ajlm-2140	1	128	durban	durban	PROPN
ajlm-2140	1	129	,	,	PUNCT
ajlm-2140	1	130	south	south	PROPN
ajlm-2140	1	131	africa	africa	PROPN
ajlm-2140	1	132	citation	citation	PROPN
ajlm-2140	1	133	ramiah	ramiah	PROPN
ajlm-2140	1	134	j	j	PROPN
ajlm-2140	1	135	,	,	PUNCT
ajlm-2140	1	136	pillay	pillay	PROPN
ajlm-2140	1	137	d	d	PROPN
ajlm-2140	1	138	,	,	PUNCT
ajlm-2140	1	139	rapiti	rapiti	PROPN
ajlm-2140	1	140	n.	n.	PROPN
ajlm-2140	1	141	performance	performance	NOUN
ajlm-2140	1	142	of	of	ADP
ajlm-2140	1	143	the	the	DET
ajlm-2140	1	144	automated	automate	VERB
ajlm-2140	1	145	sysmex	sysmex	NOUN
ajlm-2140	1	146	xn-3000	xn-3000	PROPN
ajlm-2140	1	147	analyser	analyser	NOUN
ajlm-2140	1	148	for	for	ADP
ajlm-2140	1	149	detecting	detect	VERB
ajlm-2140	1	150	white	white	ADJ
ajlm-2140	1	151	blood	blood	NOUN
ajlm-2140	1	152	cell	cell	NOUN
ajlm-2140	1	153	abnormalities	abnormality	NOUN
ajlm-2140	1	154	in	in	ADP
ajlm-2140	1	155	south	south	PROPN
ajlm-2140	1	156	africa	africa	PROPN
ajlm-2140	1	157	.	.	PUNCT
ajlm-2140	2	1	afr	afr	PROPN
ajlm-2140	2	2	j	j	PROPN
ajlm-2140	2	3	lab	lab	PROPN
ajlm-2140	2	4	med	med	PROPN
ajlm-2140	2	5	.	.	PUNCT
ajlm-2140	3	1	2023;12(1	2023;12(1	NUM
ajlm-2140	3	2	)	)	PUNCT
ajlm-2140	3	3	,	,	PUNCT
ajlm-2140	4	1	a2140	a2140	PROPN
ajlm-2140	4	2	.	.	PUNCT
ajlm-2140	4	3	https://doi.org/10.4102/ajlm.v12i1.2140	https://doi.org/10.4102/ajlm.v12i1.2140	ADJ
ajlm-2140	4	4	original	original	ADJ
ajlm-2140	4	5	research	research	NOUN
ajlm-2140	4	6	performance	performance	NOUN
ajlm-2140	4	7	of	of	ADP
ajlm-2140	4	8	the	the	DET
ajlm-2140	4	9	automated	automate	VERB
ajlm-2140	4	10	sysmex	sysmex	NOUN
ajlm-2140	4	11	xn-3000	xn-3000	PROPN
ajlm-2140	4	12	analyser	analyser	NOUN
ajlm-2140	4	13	for	for	ADP
ajlm-2140	4	14	detecting	detect	VERB
ajlm-2140	4	15	white	white	ADJ
ajlm-2140	4	16	blood	blood	NOUN
ajlm-2140	4	17	cell	cell	NOUN
ajlm-2140	4	18	abnormalities	abnormality	NOUN
ajlm-2140	4	19	in	in	ADP
ajlm-2140	4	20	south	south	PROPN
ajlm-2140	4	21	africa	africa	PROPN
ajlm-2140	4	22	jasmine	jasmine	PROPN
ajlm-2140	4	23	ramiah	ramiah	PROPN
ajlm-2140	4	24	,	,	PUNCT
ajlm-2140	4	25	dashini	dashini	PROPN
ajlm-2140	4	26	pillay	pillay	PROPN
ajlm-2140	4	27	,	,	PUNCT
ajlm-2140	4	28	nadine	nadine	PROPN
ajlm-2140	4	29	rapiti	rapiti	PROPN
ajlm-2140	4	30	received	receive	VERB
ajlm-2140	4	31	:	:	PUNCT
ajlm-2140	4	32	07	07	NUM
ajlm-2140	4	33	dec	dec	PROPN
ajlm-2140	4	34	.	.	PROPN
ajlm-2140	4	35	2022	2022	NUM
ajlm-2140	4	36	;	;	PUNCT
ajlm-2140	4	37	accepted	accept	VERB
ajlm-2140	4	38	:	:	PUNCT
ajlm-2140	4	39	11	11	NUM
ajlm-2140	4	40	may	may	PROPN
ajlm-2140	4	41	2023	2023	NUM
ajlm-2140	4	42	;	;	PUNCT
ajlm-2140	4	43	published	publish	VERB
ajlm-2140	4	44	:	:	PUNCT
ajlm-2140	4	45	19	19	NUM
ajlm-2140	4	46	july	july	PROPN
ajlm-2140	4	47	2023	2023	NUM
ajlm-2140	4	48	copyright	copyright	NOUN
ajlm-2140	4	49	:	:	PUNCT
ajlm-2140	4	50	©	©	PROPN
ajlm-2140	4	51	2023	2023	NUM
ajlm-2140	4	52	.	.	PUNCT
ajlm-2140	5	1	the	the	DET
ajlm-2140	5	2	author(s	author(s	NOUN
ajlm-2140	5	3	)	)	PUNCT
ajlm-2140	5	4	.	.	PUNCT
ajlm-2140	6	1	licensee	licensee	NOUN
ajlm-2140	6	2	:	:	PUNCT
ajlm-2140	6	3	aosis	aosis	NOUN
ajlm-2140	6	4	.	.	PUNCT
ajlm-2140	7	1	this	this	PRON
ajlm-2140	7	2	is	be	AUX
ajlm-2140	7	3	an	an	DET
ajlm-2140	7	4	open	open	ADJ
ajlm-2140	7	5	access	access	NOUN
ajlm-2140	7	6	article	article	NOUN
ajlm-2140	7	7	distributed	distribute	VERB
ajlm-2140	7	8	under	under	ADP
ajlm-2140	7	9	the	the	DET
ajlm-2140	7	10	terms	term	NOUN
ajlm-2140	7	11	of	of	ADP
ajlm-2140	7	12	the	the	DET
ajlm-2140	7	13	creative	creative	ADJ
ajlm-2140	7	14	commons	common	NOUN
ajlm-2140	7	15	attribution	attribution	NOUN
ajlm-2140	7	16	license	license	NOUN
ajlm-2140	7	17	,	,	PUNCT
ajlm-2140	7	18	which	which	PRON
ajlm-2140	7	19	permits	permit	VERB
ajlm-2140	7	20	unrestricted	unrestricted	ADJ
ajlm-2140	7	21	use	use	NOUN
ajlm-2140	7	22	,	,	PUNCT
ajlm-2140	7	23	distribution	distribution	NOUN
ajlm-2140	7	24	,	,	PUNCT
ajlm-2140	7	25	and	and	CCONJ
ajlm-2140	7	26	reproduction	reproduction	NOUN
ajlm-2140	7	27	in	in	ADP
ajlm-2140	7	28	any	any	DET
ajlm-2140	7	29	medium	medium	NOUN
ajlm-2140	7	30	,	,	PUNCT
ajlm-2140	7	31	provided	provide	VERB
ajlm-2140	7	32	the	the	DET
ajlm-2140	7	33	original	original	ADJ
ajlm-2140	7	34	work	work	NOUN
ajlm-2140	7	35	is	be	AUX
ajlm-2140	7	36	properly	properly	ADV
ajlm-2140	7	37	cited	cite	VERB
ajlm-2140	7	38	.	.	PUNCT
ajlm-2140	8	1	abstract	abstract	ADJ
ajlm-2140	8	2	background	background	NOUN
ajlm-2140	8	3	:	:	PUNCT
ajlm-2140	8	4	automated	automate	VERB
ajlm-2140	8	5	haematology	haematology	NOUN
ajlm-2140	8	6	analysers	analyser	NOUN
ajlm-2140	8	7	such	such	ADJ
ajlm-2140	8	8	as	as	ADP
ajlm-2140	8	9	the	the	DET
ajlm-2140	8	10	sysmex	sysmex	NOUN
ajlm-2140	8	11	xn-3000	xn-3000	NOUN
ajlm-2140	8	12	(	(	PUNCT
ajlm-2140	8	13	sysmex	sysmex	NOUN
ajlm-2140	8	14	corporation	corporation	NOUN
ajlm-2140	8	15	,	,	PUNCT
ajlm-2140	8	16	kobe	kobe	PROPN
ajlm-2140	8	17	,	,	PUNCT
ajlm-2140	8	18	japan	japan	PROPN
ajlm-2140	8	19	)	)	PUNCT
ajlm-2140	8	20	utilise	utilise	VERB
ajlm-2140	8	21	white	white	ADJ
ajlm-2140	8	22	blood	blood	NOUN
ajlm-2140	8	23	cell	cell	NOUN
ajlm-2140	8	24	(	(	PUNCT
ajlm-2140	8	25	wbc	wbc	PROPN
ajlm-2140	8	26	)	)	PUNCT
ajlm-2140	8	27	flags	flag	NOUN
ajlm-2140	8	28	to	to	PART
ajlm-2140	8	29	identify	identify	VERB
ajlm-2140	8	30	quantitative	quantitative	ADJ
ajlm-2140	8	31	and	and	CCONJ
ajlm-2140	8	32	qualitative	qualitative	ADJ
ajlm-2140	8	33	abnormalities	abnormality	NOUN
ajlm-2140	8	34	.	.	PUNCT
ajlm-2140	9	1	owing	owe	VERB
ajlm-2140	9	2	to	to	ADP
ajlm-2140	9	3	clinical	clinical	ADJ
ajlm-2140	9	4	and	and	CCONJ
ajlm-2140	9	5	biological	biological	ADJ
ajlm-2140	9	6	factors	factor	NOUN
ajlm-2140	9	7	,	,	PUNCT
ajlm-2140	9	8	the	the	DET
ajlm-2140	9	9	sensitivity	sensitivity	NOUN
ajlm-2140	9	10	and	and	CCONJ
ajlm-2140	9	11	specificity	specificity	NOUN
ajlm-2140	9	12	of	of	ADP
ajlm-2140	9	13	the	the	DET
ajlm-2140	9	14	flags	flag	NOUN
ajlm-2140	9	15	vary	vary	VERB
ajlm-2140	9	16	when	when	SCONJ
ajlm-2140	9	17	compared	compare	VERB
ajlm-2140	9	18	to	to	ADP
ajlm-2140	9	19	microscopy	microscopy	VERB
ajlm-2140	9	20	,	,	PUNCT
ajlm-2140	9	21	the	the	DET
ajlm-2140	9	22	gold	gold	NOUN
ajlm-2140	9	23	-	-	PUNCT
ajlm-2140	9	24	standard	standard	NOUN
ajlm-2140	9	25	method	method	NOUN
ajlm-2140	9	26	for	for	ADP
ajlm-2140	9	27	assessing	assess	VERB
ajlm-2140	9	28	peripheral	peripheral	ADJ
ajlm-2140	9	29	blood	blood	NOUN
ajlm-2140	9	30	smear	smear	NOUN
ajlm-2140	9	31	(	(	PUNCT
ajlm-2140	9	32	pbs	pbs	PROPN
ajlm-2140	9	33	)	)	PUNCT
ajlm-2140	9	34	morphology	morphology	NOUN
ajlm-2140	9	35	.	.	PUNCT
ajlm-2140	10	1	objective	objective	NOUN
ajlm-2140	10	2	:	:	PUNCT
ajlm-2140	10	3	this	this	DET
ajlm-2140	10	4	study	study	NOUN
ajlm-2140	10	5	assessed	assess	VERB
ajlm-2140	10	6	the	the	DET
ajlm-2140	10	7	performance	performance	NOUN
ajlm-2140	10	8	of	of	ADP
ajlm-2140	10	9	the	the	DET
ajlm-2140	10	10	sysmex	sysmex	NOUN
ajlm-2140	10	11	xn-3000	xn-3000	PROPN
ajlm-2140	10	12	haematology	haematology	PROPN
ajlm-2140	10	13	analyser	analyser	NOUN
ajlm-2140	10	14	in	in	ADP
ajlm-2140	10	15	comparison	comparison	NOUN
ajlm-2140	10	16	to	to	ADP
ajlm-2140	10	17	pbs	pbs	PROPN
ajlm-2140	10	18	microscopy	microscopy	NOUN
ajlm-2140	10	19	for	for	ADP
ajlm-2140	10	20	the	the	DET
ajlm-2140	10	21	detection	detection	NOUN
ajlm-2140	10	22	of	of	ADP
ajlm-2140	10	23	wbc	wbc	ADJ
ajlm-2140	10	24	abnormalities	abnormality	NOUN
ajlm-2140	10	25	.	.	PUNCT
ajlm-2140	11	1	methods	method	NOUN
ajlm-2140	11	2	:	:	PUNCT
ajlm-2140	11	3	we	we	PRON
ajlm-2140	11	4	collected	collect	VERB
ajlm-2140	11	5	250	250	NUM
ajlm-2140	11	6	random	random	ADJ
ajlm-2140	11	7	full	full	ADJ
ajlm-2140	11	8	blood	blood	NOUN
ajlm-2140	11	9	count	count	NOUN
ajlm-2140	11	10	samples	sample	NOUN
ajlm-2140	11	11	from	from	ADP
ajlm-2140	11	12	the	the	DET
ajlm-2140	11	13	haematology	haematology	NOUN
ajlm-2140	11	14	laboratory	laboratory	NOUN
ajlm-2140	11	15	at	at	ADP
ajlm-2140	11	16	inkosi	inkosi	PROPN
ajlm-2140	11	17	albert	albert	PROPN
ajlm-2140	11	18	luthuli	luthuli	PROPN
ajlm-2140	11	19	central	central	PROPN
ajlm-2140	11	20	hospital	hospital	NOUN
ajlm-2140	11	21	,	,	PUNCT
ajlm-2140	11	22	durban	durban	PROPN
ajlm-2140	11	23	,	,	PUNCT
ajlm-2140	11	24	kwazulu	kwazulu	NOUN
ajlm-2140	11	25	-	-	PUNCT
ajlm-2140	11	26	natal	natal	ADJ
ajlm-2140	11	27	,	,	PUNCT
ajlm-2140	11	28	south	south	PROPN
ajlm-2140	11	29	africa	africa	PROPN
ajlm-2140	11	30	,	,	PUNCT
ajlm-2140	11	31	from	from	ADP
ajlm-2140	11	32	march	march	PROPN
ajlm-2140	11	33	2022	2022	NUM
ajlm-2140	11	34	to	to	ADP
ajlm-2140	11	35	april	april	PROPN
ajlm-2140	11	36	2022	2022	NUM
ajlm-2140	11	37	.	.	PUNCT
ajlm-2140	12	1	the	the	DET
ajlm-2140	12	2	performance	performance	NOUN
ajlm-2140	12	3	of	of	ADP
ajlm-2140	12	4	the	the	DET
ajlm-2140	12	5	automated	automate	VERB
ajlm-2140	12	6	wbc	wbc	PROPN
ajlm-2140	12	7	flags	flag	NOUN
ajlm-2140	12	8	of	of	ADP
ajlm-2140	12	9	the	the	DET
ajlm-2140	12	10	sysmex	sysmex	NOUN
ajlm-2140	12	11	xn-3000	xn-3000	PROPN
ajlm-2140	12	12	was	be	AUX
ajlm-2140	12	13	assessed	assess	VERB
ajlm-2140	12	14	in	in	ADP
ajlm-2140	12	15	comparison	comparison	NOUN
ajlm-2140	12	16	to	to	ADP
ajlm-2140	12	17	pbs	pbs	PROPN
ajlm-2140	12	18	microscopy	microscopy	PROPN
ajlm-2140	12	19	,	,	PUNCT
ajlm-2140	12	20	and	and	CCONJ
ajlm-2140	12	21	the	the	DET
ajlm-2140	12	22	impact	impact	NOUN
ajlm-2140	12	23	of	of	ADP
ajlm-2140	12	24	established	establish	VERB
ajlm-2140	12	25	clinical	clinical	ADJ
ajlm-2140	12	26	variables	variable	NOUN
ajlm-2140	12	27	on	on	ADP
ajlm-2140	12	28	the	the	DET
ajlm-2140	12	29	performance	performance	NOUN
ajlm-2140	12	30	of	of	ADP
ajlm-2140	12	31	the	the	DET
ajlm-2140	12	32	flags	flag	NOUN
ajlm-2140	12	33	was	be	AUX
ajlm-2140	12	34	determined	determine	VERB
ajlm-2140	12	35	.	.	PUNCT
ajlm-2140	13	1	results	result	NOUN
ajlm-2140	13	2	:	:	PUNCT
ajlm-2140	13	3	the	the	DET
ajlm-2140	13	4	sensitivity	sensitivity	NOUN
ajlm-2140	13	5	of	of	ADP
ajlm-2140	13	6	the	the	DET
ajlm-2140	13	7	‘	'	PUNCT
ajlm-2140	13	8	blast	blast	NOUN
ajlm-2140	13	9	’	'	PUNCT
ajlm-2140	13	10	flag	flag	NOUN
ajlm-2140	13	11	was	be	AUX
ajlm-2140	13	12	96.3	96.3	NUM
ajlm-2140	13	13	%	%	NOUN
ajlm-2140	13	14	,	,	PUNCT
ajlm-2140	13	15	and	and	CCONJ
ajlm-2140	13	16	the	the	DET
ajlm-2140	13	17	specificity	specificity	NOUN
ajlm-2140	13	18	was	be	AUX
ajlm-2140	13	19	84.9	84.9	NUM
ajlm-2140	13	20	%	%	NOUN
ajlm-2140	13	21	.	.	PUNCT
ajlm-2140	14	1	the	the	DET
ajlm-2140	14	2	efficiency	efficiency	NOUN
ajlm-2140	14	3	of	of	ADP
ajlm-2140	14	4	the	the	DET
ajlm-2140	14	5	flag	flag	NOUN
ajlm-2140	14	6	was	be	AUX
ajlm-2140	14	7	adversely	adversely	ADV
ajlm-2140	14	8	impacted	impact	VERB
ajlm-2140	14	9	by	by	ADP
ajlm-2140	14	10	low	low	ADJ
ajlm-2140	14	11	white	white	ADJ
ajlm-2140	14	12	cell	cell	NOUN
ajlm-2140	14	13	counts	count	NOUN
ajlm-2140	14	14	(	(	PUNCT
ajlm-2140	14	15	<	<	X
ajlm-2140	14	16	1.5	1.5	NUM
ajlm-2140	14	17	×	×	NOUN
ajlm-2140	14	18	109	109	NUM
ajlm-2140	14	19	/	/	SYM
ajlm-2140	14	20	l	l	NOUN
ajlm-2140	14	21	;	;	PUNCT
ajlm-2140	14	22	p	p	X
ajlm-2140	14	23	<	<	X
ajlm-2140	14	24	0.001	0.001	NUM
ajlm-2140	14	25	)	)	PUNCT
ajlm-2140	14	26	,	,	PUNCT
ajlm-2140	14	27	chemotherapy	chemotherapy	NOUN
ajlm-2140	14	28	(	(	PUNCT
ajlm-2140	14	29	p	p	NOUN
ajlm-2140	14	30	=	=	NOUN
ajlm-2140	14	31	0.002	0.002	NUM
ajlm-2140	14	32	)	)	PUNCT
ajlm-2140	14	33	,	,	PUNCT
ajlm-2140	14	34	malignancy	malignancy	NOUN
ajlm-2140	14	35	(	(	PUNCT
ajlm-2140	14	36	p	p	X
ajlm-2140	14	37	=	=	NOUN
ajlm-2140	14	38	0.02	0.02	NUM
ajlm-2140	14	39	)	)	PUNCT
ajlm-2140	14	40	,	,	PUNCT
ajlm-2140	14	41	and	and	CCONJ
ajlm-2140	14	42	infection	infection	NOUN
ajlm-2140	14	43	(	(	PUNCT
ajlm-2140	14	44	p	p	NOUN
ajlm-2140	14	45	=	=	NOUN
ajlm-2140	14	46	0.02	0.02	NUM
ajlm-2140	14	47	)	)	PUNCT
ajlm-2140	14	48	.	.	PUNCT
ajlm-2140	15	1	the	the	DET
ajlm-2140	15	2	‘	'	PUNCT
ajlm-2140	15	3	abnormal	abnormal	ADJ
ajlm-2140	15	4	lymphocyte	lymphocyte	NOUN
ajlm-2140	15	5	’	'	PUNCT
ajlm-2140	15	6	flag	flag	NOUN
ajlm-2140	15	7	demonstrated	demonstrate	VERB
ajlm-2140	15	8	a	a	DET
ajlm-2140	15	9	sensitivity	sensitivity	NOUN
ajlm-2140	15	10	of	of	ADP
ajlm-2140	15	11	90	90	NUM
ajlm-2140	15	12	%	%	NOUN
ajlm-2140	15	13	and	and	CCONJ
ajlm-2140	15	14	a	a	DET
ajlm-2140	15	15	specificity	specificity	NOUN
ajlm-2140	15	16	of	of	ADP
ajlm-2140	15	17	96.2	96.2	NUM
ajlm-2140	15	18	%	%	NOUN
ajlm-2140	15	19	,	,	PUNCT
ajlm-2140	15	20	and	and	CCONJ
ajlm-2140	15	21	its	its	PRON
ajlm-2140	15	22	performance	performance	NOUN
ajlm-2140	15	23	was	be	AUX
ajlm-2140	15	24	adversely	adversely	ADV
ajlm-2140	15	25	impacted	impact	VERB
ajlm-2140	15	26	by	by	ADP
ajlm-2140	15	27	chemotherapy	chemotherapy	NOUN
ajlm-2140	15	28	exposure	exposure	NOUN
ajlm-2140	15	29	(	(	PUNCT
ajlm-2140	15	30	p	p	X
ajlm-2140	15	31	=	=	NOUN
ajlm-2140	15	32	0.03	0.03	NUM
ajlm-2140	15	33	)	)	PUNCT
ajlm-2140	15	34	.	.	PUNCT
ajlm-2140	16	1	three	three	NUM
ajlm-2140	16	2	cases	case	NOUN
ajlm-2140	16	3	(	(	PUNCT
ajlm-2140	16	4	1.2	1.2	NUM
ajlm-2140	16	5	%	%	NOUN
ajlm-2140	16	6	)	)	PUNCT
ajlm-2140	16	7	erroneously	erroneously	ADV
ajlm-2140	16	8	flagged	flag	VERB
ajlm-2140	16	9	as	as	ADP
ajlm-2140	16	10	‘	'	PUNCT
ajlm-2140	16	11	monocytosis	monocytosis	NOUN
ajlm-2140	16	12	’	'	PUNCT
ajlm-2140	16	13	demonstrated	demonstrate	VERB
ajlm-2140	16	14	blasts	blast	NOUN
ajlm-2140	16	15	on	on	ADP
ajlm-2140	16	16	microscopy	microscopy	NOUN
ajlm-2140	16	17	.	.	PUNCT
ajlm-2140	17	1	conclusion	conclusion	NOUN
ajlm-2140	17	2	:	:	PUNCT
ajlm-2140	17	3	in	in	ADP
ajlm-2140	17	4	our	our	PRON
ajlm-2140	17	5	setting	setting	NOUN
ajlm-2140	17	6	,	,	PUNCT
ajlm-2140	17	7	pbs	pbs	PROPN
ajlm-2140	17	8	microscopy	microscopy	PROPN
ajlm-2140	17	9	remains	remain	VERB
ajlm-2140	17	10	necessary	necessary	ADJ
ajlm-2140	17	11	to	to	PART
ajlm-2140	17	12	confirm	confirm	VERB
ajlm-2140	17	13	blasts	blast	NOUN
ajlm-2140	17	14	,	,	PUNCT
ajlm-2140	17	15	abnormal	abnormal	ADJ
ajlm-2140	17	16	lymphocytes	lymphocyte	NOUN
ajlm-2140	17	17	,	,	PUNCT
ajlm-2140	17	18	and	and	CCONJ
ajlm-2140	17	19	monocytosis	monocytosis	NOUN
ajlm-2140	17	20	in	in	ADP
ajlm-2140	17	21	patients	patient	NOUN
ajlm-2140	17	22	with	with	ADP
ajlm-2140	17	23	malignancy	malignancy	NOUN
ajlm-2140	17	24	,	,	PUNCT
ajlm-2140	17	25	current	current	ADJ
ajlm-2140	17	26	chemotherapy	chemotherapy	NOUN
ajlm-2140	17	27	exposure	exposure	NOUN
ajlm-2140	17	28	,	,	PUNCT
ajlm-2140	17	29	low	low	ADJ
ajlm-2140	17	30	white	white	ADJ
ajlm-2140	17	31	cell	cell	NOUN
ajlm-2140	17	32	counts	count	NOUN
ajlm-2140	17	33	,	,	PUNCT
ajlm-2140	17	34	and	and	CCONJ
ajlm-2140	17	35	infection	infection	NOUN
ajlm-2140	17	36	.	.	PUNCT
ajlm-2140	18	1	what	what	PRON
ajlm-2140	18	2	this	this	DET
ajlm-2140	18	3	study	study	NOUN
ajlm-2140	18	4	adds	add	VERB
ajlm-2140	18	5	:	:	PUNCT
ajlm-2140	18	6	this	this	DET
ajlm-2140	18	7	study	study	NOUN
ajlm-2140	18	8	adds	add	VERB
ajlm-2140	18	9	evidence	evidence	NOUN
ajlm-2140	18	10	that	that	SCONJ
ajlm-2140	18	11	pbs	pbs	PROPN
ajlm-2140	18	12	morphology	morphology	NOUN
ajlm-2140	18	13	remains	remain	VERB
ajlm-2140	18	14	the	the	DET
ajlm-2140	18	15	gold	gold	ADJ
ajlm-2140	18	16	standard	standard	NOUN
ajlm-2140	18	17	for	for	ADP
ajlm-2140	18	18	confirming	confirm	VERB
ajlm-2140	18	19	wbc	wbc	ADJ
ajlm-2140	18	20	abnormalities	abnormality	NOUN
ajlm-2140	18	21	in	in	ADP
ajlm-2140	18	22	patients	patient	NOUN
ajlm-2140	18	23	with	with	ADP
ajlm-2140	18	24	a	a	DET
ajlm-2140	18	25	history	history	NOUN
ajlm-2140	18	26	of	of	ADP
ajlm-2140	18	27	malignancy	malignancy	NOUN
ajlm-2140	18	28	,	,	PUNCT
ajlm-2140	18	29	chemotherapy	chemotherapy	NOUN
ajlm-2140	18	30	,	,	PUNCT
ajlm-2140	18	31	and	and	CCONJ
ajlm-2140	18	32	leucopenia	leucopenia	NOUN
ajlm-2140	18	33	.	.	PUNCT
ajlm-2140	19	1	keywords	keyword	NOUN
ajlm-2140	19	2	:	:	PUNCT
ajlm-2140	19	3	sysmex	sysmex	NOUN
ajlm-2140	19	4	analyser	analyser	NOUN
ajlm-2140	19	5	;	;	PUNCT
ajlm-2140	19	6	xn	xn	X
ajlm-2140	19	7	-	-	PUNCT
ajlm-2140	19	8	series	series	NOUN
ajlm-2140	19	9	;	;	PUNCT
ajlm-2140	19	10	automated	automated	ADJ
ajlm-2140	19	11	analysers	analyser	NOUN
ajlm-2140	19	12	;	;	PUNCT
ajlm-2140	19	13	fbc	fbc	PROPN
ajlm-2140	19	14	;	;	PUNCT
ajlm-2140	19	15	flagging	flagging	ADJ
ajlm-2140	19	16	;	;	PUNCT
ajlm-2140	19	17	white	white	ADJ
ajlm-2140	19	18	blood	blood	NOUN
ajlm-2140	19	19	cell	cell	NOUN
ajlm-2140	19	20	flags	flag	NOUN
ajlm-2140	19	21	;	;	PUNCT
ajlm-2140	19	22	clinical	clinical	ADJ
ajlm-2140	19	23	and	and	CCONJ
ajlm-2140	19	24	laboratory	laboratory	NOUN
ajlm-2140	19	25	standards	standard	NOUN
ajlm-2140	19	26	institute	institute	PROPN
ajlm-2140	19	27	guidelines	guideline	NOUN
ajlm-2140	19	28	.	.	PUNCT
ajlm-2140	20	1	introduction	introduction	NOUN
ajlm-2140	20	2	the	the	DET
ajlm-2140	20	3	microscopic	microscopic	ADJ
ajlm-2140	20	4	assessment	assessment	NOUN
ajlm-2140	20	5	of	of	ADP
ajlm-2140	20	6	a	a	DET
ajlm-2140	20	7	well	well	ADV
ajlm-2140	20	8	-	-	PUNCT
ajlm-2140	20	9	prepared	prepare	VERB
ajlm-2140	20	10	and	and	CCONJ
ajlm-2140	20	11	well	well	ADV
ajlm-2140	20	12	-	-	PUNCT
ajlm-2140	20	13	stained	stain	VERB
ajlm-2140	20	14	peripheral	peripheral	ADJ
ajlm-2140	20	15	blood	blood	NOUN
ajlm-2140	20	16	smear	smear	NOUN
ajlm-2140	20	17	(	(	PUNCT
ajlm-2140	20	18	pbs	pbs	PROPN
ajlm-2140	20	19	)	)	PUNCT
ajlm-2140	20	20	is	be	AUX
ajlm-2140	20	21	the	the	DET
ajlm-2140	20	22	gold	gold	ADJ
ajlm-2140	20	23	standard	standard	NOUN
ajlm-2140	20	24	for	for	ADP
ajlm-2140	20	25	identifying	identify	VERB
ajlm-2140	20	26	white	white	ADJ
ajlm-2140	20	27	blood	blood	NOUN
ajlm-2140	20	28	cell	cell	NOUN
ajlm-2140	20	29	(	(	PUNCT
ajlm-2140	20	30	wbc	wbc	PROPN
ajlm-2140	20	31	)	)	PUNCT
ajlm-2140	20	32	abnormalities.1	abnormalities.1	ADP
ajlm-2140	20	33	this	this	DET
ajlm-2140	20	34	manual	manual	ADJ
ajlm-2140	20	35	pbs	pbs	PROPN
ajlm-2140	20	36	assessment	assessment	NOUN
ajlm-2140	20	37	requires	require	VERB
ajlm-2140	20	38	skilled	skilled	ADJ
ajlm-2140	20	39	and	and	CCONJ
ajlm-2140	20	40	trained	train	VERB
ajlm-2140	20	41	morphologists.2	morphologists.2	NOUN
ajlm-2140	20	42	automated	automate	VERB
ajlm-2140	20	43	full	full	ADJ
ajlm-2140	20	44	blood	blood	NOUN
ajlm-2140	20	45	count	count	NOUN
ajlm-2140	20	46	(	(	PUNCT
ajlm-2140	20	47	fbc	fbc	PROPN
ajlm-2140	20	48	)	)	PUNCT
ajlm-2140	20	49	haematology	haematology	NOUN
ajlm-2140	20	50	analysers	analyser	NOUN
ajlm-2140	20	51	can	can	AUX
ajlm-2140	20	52	flag	flag	VERB
ajlm-2140	20	53	suspected	suspect	VERB
ajlm-2140	20	54	quantitative	quantitative	ADJ
ajlm-2140	20	55	and	and	CCONJ
ajlm-2140	20	56	qualitative	qualitative	ADJ
ajlm-2140	20	57	abnormalities,1	abnormalities,1	NOUN
ajlm-2140	20	58	and	and	CCONJ
ajlm-2140	20	59	the	the	DET
ajlm-2140	20	60	wbc	wbc	PROPN
ajlm-2140	20	61	flags	flag	NOUN
ajlm-2140	20	62	can	can	AUX
ajlm-2140	20	63	potentially	potentially	ADV
ajlm-2140	20	64	alert	alert	VERB
ajlm-2140	20	65	the	the	DET
ajlm-2140	20	66	laboratory	laboratory	NOUN
ajlm-2140	20	67	technical	technical	ADJ
ajlm-2140	20	68	staff	staff	NOUN
ajlm-2140	20	69	to	to	ADP
ajlm-2140	20	70	abnormal	abnormal	ADJ
ajlm-2140	20	71	blood	blood	NOUN
ajlm-2140	20	72	samples	sample	NOUN
ajlm-2140	20	73	prior	prior	ADV
ajlm-2140	20	74	to	to	ADP
ajlm-2140	20	75	the	the	DET
ajlm-2140	20	76	review	review	NOUN
ajlm-2140	20	77	of	of	ADP
ajlm-2140	20	78	the	the	DET
ajlm-2140	20	79	pbs	pbs	PROPN
ajlm-2140	20	80	,	,	PUNCT
ajlm-2140	20	81	thus	thus	ADV
ajlm-2140	20	82	improving	improve	VERB
ajlm-2140	20	83	workflow	workflow	NOUN
ajlm-2140	20	84	,	,	PUNCT
ajlm-2140	20	85	particularly	particularly	ADV
ajlm-2140	20	86	in	in	ADP
ajlm-2140	20	87	resource	resource	NOUN
ajlm-2140	20	88	-	-	PUNCT
ajlm-2140	20	89	constrained	constrain	VERB
ajlm-2140	20	90	settings	setting	NOUN
ajlm-2140	20	91	.	.	PUNCT
ajlm-2140	21	1	globally	globally	ADV
ajlm-2140	21	2	,	,	PUNCT
ajlm-2140	21	3	restricted	restrict	VERB
ajlm-2140	21	4	laboratory	laboratory	NOUN
ajlm-2140	21	5	budgets	budget	NOUN
ajlm-2140	21	6	result	result	VERB
ajlm-2140	21	7	in	in	ADP
ajlm-2140	21	8	a	a	DET
ajlm-2140	21	9	reduction	reduction	NOUN
ajlm-2140	21	10	in	in	ADP
ajlm-2140	21	11	the	the	DET
ajlm-2140	21	12	number	number	NOUN
ajlm-2140	21	13	of	of	ADP
ajlm-2140	21	14	experienced	experienced	ADJ
ajlm-2140	21	15	morphologists.3	morphologists.3	NOUN
ajlm-2140	21	16	a	a	DET
ajlm-2140	21	17	laboratory	laboratory	NOUN
ajlm-2140	21	18	system	system	NOUN
ajlm-2140	21	19	with	with	ADP
ajlm-2140	21	20	automated	automate	VERB
ajlm-2140	21	21	technology	technology	NOUN
ajlm-2140	21	22	that	that	PRON
ajlm-2140	21	23	can	can	AUX
ajlm-2140	21	24	prioritise	prioritise	VERB
ajlm-2140	21	25	a	a	DET
ajlm-2140	21	26	blood	blood	NOUN
ajlm-2140	21	27	sample	sample	NOUN
ajlm-2140	21	28	with	with	ADP
ajlm-2140	21	29	abnormal	abnormal	ADJ
ajlm-2140	21	30	wbc	wbc	PROPN
ajlm-2140	21	31	features	feature	NOUN
ajlm-2140	21	32	is	be	AUX
ajlm-2140	21	33	thus	thus	ADV
ajlm-2140	21	34	advantageous	advantageous	ADJ
ajlm-2140	21	35	.	.	PUNCT
ajlm-2140	22	1	however	however	ADV
ajlm-2140	22	2	,	,	PUNCT
ajlm-2140	22	3	there	there	PRON
ajlm-2140	22	4	are	be	VERB
ajlm-2140	22	5	limitations	limitation	NOUN
ajlm-2140	22	6	in	in	ADP
ajlm-2140	22	7	the	the	DET
ajlm-2140	22	8	specificity	specificity	NOUN
ajlm-2140	22	9	and	and	CCONJ
ajlm-2140	22	10	sensitivity	sensitivity	NOUN
ajlm-2140	22	11	of	of	ADP
ajlm-2140	22	12	these	these	DET
ajlm-2140	22	13	flags.4	flags.4	VERB
ajlm-2140	22	14	the	the	DET
ajlm-2140	22	15	sysmex	sysmex	NOUN
ajlm-2140	22	16	xn-3000	xn-3000	PROPN
ajlm-2140	22	17	automated	automated	PROPN
ajlm-2140	22	18	fbc	fbc	PROPN
ajlm-2140	22	19	analyser	analyser	NOUN
ajlm-2140	22	20	(	(	PUNCT
ajlm-2140	22	21	sysmex	sysmex	NOUN
ajlm-2140	22	22	corporation	corporation	NOUN
ajlm-2140	22	23	,	,	PUNCT
ajlm-2140	22	24	kobe	kobe	PROPN
ajlm-2140	22	25	,	,	PUNCT
ajlm-2140	22	26	japan	japan	PROPN
ajlm-2140	22	27	)	)	PUNCT
ajlm-2140	22	28	has	have	VERB
ajlm-2140	22	29	white	white	ADJ
ajlm-2140	22	30	cell	cell	NOUN
ajlm-2140	22	31	differential	differential	NOUN
ajlm-2140	22	32	,	,	PUNCT
ajlm-2140	22	33	white	white	ADJ
ajlm-2140	22	34	cell	cell	NOUN
ajlm-2140	22	35	nucleated	nucleated	ADJ
ajlm-2140	22	36	,	,	PUNCT
ajlm-2140	22	37	and	and	CCONJ
ajlm-2140	22	38	white	white	ADJ
ajlm-2140	22	39	cell	cell	NOUN
ajlm-2140	22	40	precursor	precursor	NOUN
ajlm-2140	22	41	(	(	PUNCT
ajlm-2140	22	42	wpc	wpc	ADJ
ajlm-2140	22	43	)	)	PUNCT
ajlm-2140	22	44	channels	channel	NOUN
ajlm-2140	22	45	,	,	PUNCT
ajlm-2140	22	46	with	with	SCONJ
ajlm-2140	22	47	the	the	DET
ajlm-2140	22	48	wpc	wpc	ADJ
ajlm-2140	22	49	channel	channel	NOUN
ajlm-2140	22	50	demonstrated	demonstrate	VERB
ajlm-2140	22	51	to	to	PART
ajlm-2140	22	52	possess	possess	VERB
ajlm-2140	22	53	an	an	DET
ajlm-2140	22	54	improved	improved	ADJ
ajlm-2140	22	55	sensitivity	sensitivity	NOUN
ajlm-2140	22	56	for	for	ADP
ajlm-2140	22	57	detecting	detect	VERB
ajlm-2140	22	58	blasts.5	blasts.5	PROPN
ajlm-2140	22	59	the	the	DET
ajlm-2140	22	60	national	national	PROPN
ajlm-2140	22	61	health	health	PROPN
ajlm-2140	22	62	laboratory	laboratory	PROPN
ajlm-2140	22	63	services	services	PROPN
ajlm-2140	22	64	haematology	haematology	NOUN
ajlm-2140	22	65	laboratory	laboratory	NOUN
ajlm-2140	22	66	at	at	ADP
ajlm-2140	22	67	inkosi	inkosi	PROPN
ajlm-2140	22	68	albert	albert	PROPN
ajlm-2140	22	69	luthuli	luthuli	PROPN
ajlm-2140	22	70	central	central	PROPN
ajlm-2140	22	71	hospital	hospital	NOUN
ajlm-2140	22	72	,	,	PUNCT
ajlm-2140	22	73	located	locate	VERB
ajlm-2140	22	74	in	in	ADP
ajlm-2140	22	75	durban	durban	PROPN
ajlm-2140	22	76	,	,	PUNCT
ajlm-2140	22	77	kwazulu	kwazulu	NOUN
ajlm-2140	22	78	-	-	PUNCT
ajlm-2140	22	79	natal	natal	ADJ
ajlm-2140	22	80	,	,	PUNCT
ajlm-2140	22	81	south	south	PROPN
ajlm-2140	22	82	africa	africa	PROPN
ajlm-2140	22	83	,	,	PUNCT
ajlm-2140	22	84	processes	process	VERB
ajlm-2140	22	85	approximately	approximately	ADV
ajlm-2140	22	86	9000	9000	NUM
ajlm-2140	22	87	fbc	fbc	NOUN
ajlm-2140	22	88	samples	sample	NOUN
ajlm-2140	22	89	and	and	CCONJ
ajlm-2140	22	90	300–600	300–600	NUM
ajlm-2140	22	91	pbs	pbs	NOUN
ajlm-2140	22	92	samples	sample	NOUN
ajlm-2140	22	93	monthly	monthly	ADV
ajlm-2140	22	94	.	.	PUNCT
ajlm-2140	23	1	the	the	DET
ajlm-2140	23	2	inkosi	inkosi	PROPN
ajlm-2140	23	3	albert	albert	PROPN
ajlm-2140	23	4	luthuli	luthuli	PROPN
ajlm-2140	23	5	central	central	PROPN
ajlm-2140	23	6	hospital	hospital	NOUN
ajlm-2140	23	7	is	be	AUX
ajlm-2140	23	8	a	a	DET
ajlm-2140	23	9	referral	referral	ADJ
ajlm-2140	23	10	hospital	hospital	NOUN
ajlm-2140	23	11	that	that	PRON
ajlm-2140	23	12	provides	provide	VERB
ajlm-2140	23	13	medical	medical	ADJ
ajlm-2140	23	14	care	care	NOUN
ajlm-2140	23	15	to	to	ADP
ajlm-2140	23	16	patients	patient	NOUN
ajlm-2140	23	17	with	with	ADP
ajlm-2140	23	18	benign	benign	ADJ
ajlm-2140	23	19	and	and	CCONJ
ajlm-2140	23	20	malignant	malignant	ADJ
ajlm-2140	23	21	haematological	haematological	ADJ
ajlm-2140	23	22	conditions.6	conditions.6	PROPN
ajlm-2140	23	23	the	the	DET
ajlm-2140	23	24	purpose	purpose	NOUN
ajlm-2140	23	25	of	of	ADP
ajlm-2140	23	26	this	this	DET
ajlm-2140	23	27	study	study	NOUN
ajlm-2140	23	28	was	be	AUX
ajlm-2140	23	29	to	to	PART
ajlm-2140	23	30	assess	assess	VERB
ajlm-2140	23	31	the	the	DET
ajlm-2140	23	32	performance	performance	NOUN
ajlm-2140	23	33	of	of	ADP
ajlm-2140	23	34	the	the	DET
ajlm-2140	23	35	wbc	wbc	PROPN
ajlm-2140	23	36	flags	flag	NOUN
ajlm-2140	23	37	of	of	ADP
ajlm-2140	23	38	the	the	DET
ajlm-2140	23	39	sysmex	sysmex	NOUN
ajlm-2140	23	40	xn-3000	xn-3000	PROPN
ajlm-2140	23	41	analyser	analyser	PROPN
ajlm-2140	23	42	(	(	PUNCT
ajlm-2140	23	43	sysmex	sysmex	NOUN
ajlm-2140	23	44	corporation	corporation	NOUN
ajlm-2140	23	45	,	,	PUNCT
ajlm-2140	23	46	kobe	kobe	PROPN
ajlm-2140	23	47	,	,	PUNCT
ajlm-2140	23	48	japan	japan	PROPN
ajlm-2140	23	49	)	)	PUNCT
ajlm-2140	23	50	for	for	ADP
ajlm-2140	23	51	the	the	DET
ajlm-2140	23	52	detection	detection	NOUN
ajlm-2140	23	53	of	of	ADP
ajlm-2140	23	54	wbc	wbc	ADJ
ajlm-2140	23	55	abnormalities	abnormality	NOUN
ajlm-2140	23	56	in	in	ADP
ajlm-2140	23	57	comparison	comparison	NOUN
ajlm-2140	23	58	to	to	ADP
ajlm-2140	23	59	pbs	pbs	PROPN
ajlm-2140	23	60	microscopy	microscopy	PROPN
ajlm-2140	23	61	,	,	PUNCT
ajlm-2140	23	62	which	which	PRON
ajlm-2140	23	63	is	be	AUX
ajlm-2140	23	64	used	use	VERB
ajlm-2140	23	65	as	as	ADP
ajlm-2140	23	66	the	the	DET
ajlm-2140	23	67	gold	gold	NOUN
ajlm-2140	23	68	-	-	PUNCT
ajlm-2140	23	69	standard	standard	NOUN
ajlm-2140	23	70	method	method	NOUN
ajlm-2140	23	71	in	in	ADP
ajlm-2140	23	72	our	our	PRON
ajlm-2140	23	73	setting	setting	NOUN
ajlm-2140	23	74	.	.	PUNCT
ajlm-2140	24	1	we	we	PRON
ajlm-2140	24	2	also	also	ADV
ajlm-2140	24	3	aimed	aim	VERB
ajlm-2140	24	4	to	to	PART
ajlm-2140	24	5	identify	identify	VERB
ajlm-2140	24	6	the	the	DET
ajlm-2140	24	7	clinical	clinical	ADJ
ajlm-2140	24	8	variables	variable	NOUN
ajlm-2140	24	9	in	in	ADP
ajlm-2140	24	10	our	our	PRON
ajlm-2140	24	11	hospital	hospital	NOUN
ajlm-2140	24	12	setting	setting	NOUN
ajlm-2140	24	13	that	that	PRON
ajlm-2140	24	14	may	may	AUX
ajlm-2140	24	15	be	be	AUX
ajlm-2140	24	16	associated	associate	VERB
ajlm-2140	24	17	with	with	ADP
ajlm-2140	24	18	false	false	ADJ
ajlm-2140	24	19	-	-	PUNCT
ajlm-2140	24	20	positive	positive	ADJ
ajlm-2140	24	21	(	(	PUNCT
ajlm-2140	24	22	fp	fp	NOUN
ajlm-2140	24	23	)	)	PUNCT
ajlm-2140	24	24	and	and	CCONJ
ajlm-2140	24	25	false	false	ADJ
ajlm-2140	24	26	-	-	PUNCT
ajlm-2140	24	27	negative	negative	ADJ
ajlm-2140	24	28	(	(	PUNCT
ajlm-2140	24	29	fn	fn	NOUN
ajlm-2140	24	30	)	)	PUNCT
ajlm-2140	24	31	wbc	wbc	PROPN
ajlm-2140	24	32	flags.2	flags.2	PROPN
ajlm-2140	24	33	methods	method	NOUN
ajlm-2140	24	34	ethical	ethical	ADJ
ajlm-2140	24	35	considerations	consideration	NOUN
ajlm-2140	24	36	the	the	DET
ajlm-2140	24	37	study	study	NOUN
ajlm-2140	24	38	was	be	AUX
ajlm-2140	24	39	approved	approve	VERB
ajlm-2140	24	40	by	by	ADP
ajlm-2140	24	41	the	the	DET
ajlm-2140	24	42	university	university	PROPN
ajlm-2140	24	43	of	of	ADP
ajlm-2140	24	44	kwazulu	kwazulu	PROPN
ajlm-2140	24	45	-	-	PUNCT
ajlm-2140	24	46	natal	natal	ADJ
ajlm-2140	24	47	biomedical	biomedical	ADJ
ajlm-2140	24	48	research	research	NOUN
ajlm-2140	24	49	ethics	ethic	NOUN
ajlm-2140	24	50	committee	committee	PROPN
ajlm-2140	24	51	(	(	PUNCT
ajlm-2140	24	52	ethical	ethical	ADJ
ajlm-2140	24	53	clearance	clearance	NOUN
ajlm-2140	24	54	number	number	NOUN
ajlm-2140	24	55	:	:	PUNCT
ajlm-2140	24	56	brec/00003769/2022	brec/00003769/2022	NUM
ajlm-2140	24	57	)	)	PUNCT
ajlm-2140	24	58	.	.	PUNCT
ajlm-2140	25	1	informed	informed	ADJ
ajlm-2140	25	2	consent	consent	NOUN
ajlm-2140	25	3	was	be	AUX
ajlm-2140	25	4	not	not	PART
ajlm-2140	25	5	required	require	VERB
ajlm-2140	25	6	by	by	ADP
ajlm-2140	25	7	the	the	DET
ajlm-2140	25	8	ethics	ethic	NOUN
ajlm-2140	25	9	approval	approval	PROPN
ajlm-2140	25	10	committee	committee	NOUN
ajlm-2140	25	11	as	as	SCONJ
ajlm-2140	25	12	these	these	DET
ajlm-2140	25	13	samples	sample	NOUN
ajlm-2140	25	14	were	be	AUX
ajlm-2140	25	15	routinely	routinely	ADV
ajlm-2140	25	16	performed	perform	VERB
ajlm-2140	25	17	by	by	ADP
ajlm-2140	25	18	the	the	DET
ajlm-2140	25	19	clinician	clinician	NOUN
ajlm-2140	25	20	.	.	PUNCT
ajlm-2140	26	1	the	the	DET
ajlm-2140	26	2	clinician	clinician	NOUN
ajlm-2140	26	3	had	have	AUX
ajlm-2140	26	4	obtained	obtain	VERB
ajlm-2140	26	5	consent	consent	NOUN
ajlm-2140	26	6	for	for	ADP
ajlm-2140	26	7	all	all	DET
ajlm-2140	26	8	laboratory	laboratory	NOUN
ajlm-2140	26	9	procedures	procedure	NOUN
ajlm-2140	26	10	prior	prior	ADV
ajlm-2140	26	11	to	to	ADP
ajlm-2140	26	12	admission	admission	NOUN
ajlm-2140	26	13	of	of	ADP
ajlm-2140	26	14	the	the	DET
ajlm-2140	26	15	patients	patient	NOUN
ajlm-2140	26	16	and	and	CCONJ
ajlm-2140	26	17	the	the	DET
ajlm-2140	26	18	laboratory	laboratory	NOUN
ajlm-2140	26	19	had	have	AUX
ajlm-2140	26	20	waived	waive	VERB
ajlm-2140	26	21	need	need	NOUN
ajlm-2140	26	22	for	for	ADP
ajlm-2140	26	23	consent	consent	NOUN
ajlm-2140	26	24	as	as	SCONJ
ajlm-2140	26	25	no	no	DET
ajlm-2140	26	26	additional	additional	ADJ
ajlm-2140	26	27	tests	test	NOUN
ajlm-2140	26	28	were	be	AUX
ajlm-2140	26	29	performed	perform	VERB
ajlm-2140	26	30	.	.	PUNCT
ajlm-2140	27	1	full	full	ADJ
ajlm-2140	27	2	brec	brec	NOUN
ajlm-2140	27	3	ethics	ethic	NOUN
ajlm-2140	27	4	approval	approval	NOUN
ajlm-2140	27	5	was	be	AUX
ajlm-2140	27	6	obtained	obtain	VERB
ajlm-2140	27	7	for	for	ADP
ajlm-2140	27	8	this	this	DET
ajlm-2140	27	9	study	study	NOUN
ajlm-2140	27	10	.	.	PUNCT
ajlm-2140	28	1	informed	informed	ADJ
ajlm-2140	28	2	consent	consent	NOUN
ajlm-2140	28	3	was	be	AUX
ajlm-2140	28	4	not	not	PART
ajlm-2140	28	5	obtained	obtain	VERB
ajlm-2140	28	6	as	as	SCONJ
ajlm-2140	28	7	these	these	DET
ajlm-2140	28	8	samples	sample	NOUN
ajlm-2140	28	9	were	be	AUX
ajlm-2140	28	10	submitted	submit	VERB
ajlm-2140	28	11	to	to	ADP
ajlm-2140	28	12	the	the	DET
ajlm-2140	28	13	laboratory	laboratory	NOUN
ajlm-2140	28	14	for	for	ADP
ajlm-2140	28	15	routine	routine	ADJ
ajlm-2140	28	16	fbc	fbc	PROPN
ajlm-2140	28	17	analysis	analysis	NOUN
ajlm-2140	28	18	and	and	CCONJ
ajlm-2140	28	19	pbs	pbs	PROPN
ajlm-2140	28	20	microscopy	microscopy	NOUN
ajlm-2140	28	21	by	by	ADP
ajlm-2140	28	22	the	the	DET
ajlm-2140	28	23	treating	treat	VERB
ajlm-2140	28	24	clinician	clinician	NOUN
ajlm-2140	28	25	.	.	PUNCT
ajlm-2140	29	1	patient	patient	ADJ
ajlm-2140	29	2	confidentiality	confidentiality	NOUN
ajlm-2140	29	3	was	be	AUX
ajlm-2140	29	4	maintained	maintain	VERB
ajlm-2140	29	5	during	during	ADP
ajlm-2140	29	6	the	the	DET
ajlm-2140	29	7	study	study	NOUN
ajlm-2140	29	8	by	by	ADP
ajlm-2140	29	9	the	the	DET
ajlm-2140	29	10	allocation	allocation	NOUN
ajlm-2140	29	11	of	of	ADP
ajlm-2140	29	12	unique	unique	ADJ
ajlm-2140	29	13	and	and	CCONJ
ajlm-2140	29	14	anonymised	anonymise	VERB
ajlm-2140	29	15	study	study	NOUN
ajlm-2140	29	16	codes	code	NOUN
ajlm-2140	29	17	.	.	PUNCT
ajlm-2140	30	1	the	the	DET
ajlm-2140	30	2	research	research	NOUN
ajlm-2140	30	3	data	datum	NOUN
ajlm-2140	30	4	were	be	AUX
ajlm-2140	30	5	stored	store	VERB
ajlm-2140	30	6	electronically	electronically	ADV
ajlm-2140	30	7	on	on	ADP
ajlm-2140	30	8	password	password	NOUN
ajlm-2140	30	9	-	-	PUNCT
ajlm-2140	30	10	protected	protect	VERB
ajlm-2140	30	11	devices	device	NOUN
ajlm-2140	30	12	accessible	accessible	ADJ
ajlm-2140	30	13	only	only	ADV
ajlm-2140	30	14	by	by	ADP
ajlm-2140	30	15	the	the	DET
ajlm-2140	30	16	researchers	researcher	NOUN
ajlm-2140	30	17	.	.	PUNCT
ajlm-2140	31	1	study	study	NOUN
ajlm-2140	31	2	design	design	NOUN
ajlm-2140	31	3	this	this	PRON
ajlm-2140	31	4	was	be	AUX
ajlm-2140	31	5	a	a	DET
ajlm-2140	31	6	laboratory	laboratory	NOUN
ajlm-2140	31	7	-	-	PUNCT
ajlm-2140	31	8	based	base	VERB
ajlm-2140	31	9	prospective	prospective	ADJ
ajlm-2140	31	10	study	study	NOUN
ajlm-2140	31	11	conducted	conduct	VERB
ajlm-2140	31	12	in	in	ADP
ajlm-2140	31	13	the	the	DET
ajlm-2140	31	14	national	national	PROPN
ajlm-2140	31	15	health	health	PROPN
ajlm-2140	31	16	laboratory	laboratory	PROPN
ajlm-2140	31	17	services	services	PROPN
ajlm-2140	31	18	,	,	PUNCT
ajlm-2140	31	19	durban	durban	PROPN
ajlm-2140	31	20	,	,	PUNCT
ajlm-2140	31	21	kwazulu	kwazulu	NOUN
ajlm-2140	31	22	-	-	PUNCT
ajlm-2140	31	23	natal	natal	ADJ
ajlm-2140	31	24	,	,	PUNCT
ajlm-2140	31	25	south	south	PROPN
ajlm-2140	31	26	africa	africa	PROPN
ajlm-2140	31	27	.	.	PUNCT
ajlm-2140	32	1	the	the	DET
ajlm-2140	32	2	study	study	NOUN
ajlm-2140	32	3	comprised	comprise	VERB
ajlm-2140	32	4	250	250	NUM
ajlm-2140	32	5	blood	blood	NOUN
ajlm-2140	32	6	samples	sample	NOUN
ajlm-2140	32	7	,	,	PUNCT
ajlm-2140	32	8	which	which	PRON
ajlm-2140	32	9	were	be	AUX
ajlm-2140	32	10	representative	representative	ADJ
ajlm-2140	32	11	of	of	ADP
ajlm-2140	32	12	the	the	DET
ajlm-2140	32	13	normal	normal	ADJ
ajlm-2140	32	14	and	and	CCONJ
ajlm-2140	32	15	abnormal	abnormal	ADJ
ajlm-2140	32	16	adult	adult	NOUN
ajlm-2140	32	17	patient	patient	NOUN
ajlm-2140	32	18	population	population	NOUN
ajlm-2140	32	19	(	(	PUNCT
ajlm-2140	32	20	>	>	X
ajlm-2140	32	21	12	12	NUM
ajlm-2140	32	22	years	year	NOUN
ajlm-2140	32	23	of	of	ADP
ajlm-2140	32	24	age	age	NOUN
ajlm-2140	32	25	)	)	PUNCT
ajlm-2140	32	26	sent	send	VERB
ajlm-2140	32	27	to	to	ADP
ajlm-2140	32	28	the	the	DET
ajlm-2140	32	29	laboratory	laboratory	NOUN
ajlm-2140	32	30	for	for	ADP
ajlm-2140	32	31	routine	routine	ADJ
ajlm-2140	32	32	fbc	fbc	PROPN
ajlm-2140	32	33	analysis	analysis	NOUN
ajlm-2140	32	34	in	in	ADP
ajlm-2140	32	35	dipotassium	dipotassium	NOUN
ajlm-2140	32	36	ethylene	ethylene	NOUN
ajlm-2140	32	37	diamine	diamine	NOUN
ajlm-2140	32	38	tetra	tetra	NOUN
ajlm-2140	32	39	-	-	PUNCT
ajlm-2140	32	40	acetate	acetate	NOUN
ajlm-2140	32	41	tubes	tube	NOUN
ajlm-2140	32	42	(	(	PUNCT
ajlm-2140	32	43	becton	becton	PROPN
ajlm-2140	32	44	dickinson	dickinson	PROPN
ajlm-2140	32	45	,	,	PUNCT
ajlm-2140	32	46	berlin	berlin	PROPN
ajlm-2140	32	47	,	,	PUNCT
ajlm-2140	32	48	germany	germany	PROPN
ajlm-2140	32	49	)	)	PUNCT
ajlm-2140	32	50	.	.	PUNCT
ajlm-2140	33	1	the	the	DET
ajlm-2140	33	2	sample	sample	NOUN
ajlm-2140	33	3	size	size	NOUN
ajlm-2140	33	4	was	be	AUX
ajlm-2140	33	5	calculated	calculate	VERB
ajlm-2140	33	6	using	use	VERB
ajlm-2140	33	7	stata	stata	PROPN
ajlm-2140	33	8	®	®	NOUN
ajlm-2140	33	9	v15.1	v15.1	ADV
ajlm-2140	33	10	statistical	statistical	ADJ
ajlm-2140	33	11	software	software	NOUN
ajlm-2140	33	12	(	(	PUNCT
ajlm-2140	33	13	statacorp	statacorp	PROPN
ajlm-2140	33	14	llc	llc	PROPN
ajlm-2140	33	15	,	,	PUNCT
ajlm-2140	33	16	college	college	NOUN
ajlm-2140	33	17	station	station	NOUN
ajlm-2140	33	18	,	,	PUNCT
ajlm-2140	33	19	texas	texas	PROPN
ajlm-2140	33	20	,	,	PUNCT
ajlm-2140	33	21	united	united	PROPN
ajlm-2140	33	22	states	states	PROPN
ajlm-2140	33	23	)	)	PUNCT
ajlm-2140	33	24	in	in	ADP
ajlm-2140	33	25	consultation	consultation	NOUN
ajlm-2140	33	26	with	with	ADP
ajlm-2140	33	27	a	a	DET
ajlm-2140	33	28	statistician	statistician	NOUN
ajlm-2140	33	29	who	who	PRON
ajlm-2140	33	30	audited	audit	VERB
ajlm-2140	33	31	the	the	DET
ajlm-2140	33	32	number	number	NOUN
ajlm-2140	33	33	of	of	ADP
ajlm-2140	33	34	monthly	monthly	ADJ
ajlm-2140	33	35	fbc	fbc	PROPN
ajlm-2140	33	36	requests	request	NOUN
ajlm-2140	33	37	.	.	PUNCT
ajlm-2140	34	1	the	the	DET
ajlm-2140	34	2	samples	sample	NOUN
ajlm-2140	34	3	were	be	AUX
ajlm-2140	34	4	collected	collect	VERB
ajlm-2140	34	5	from	from	ADP
ajlm-2140	34	6	march	march	PROPN
ajlm-2140	34	7	2022	2022	NUM
ajlm-2140	34	8	to	to	ADP
ajlm-2140	34	9	april	april	PROPN
ajlm-2140	34	10	2022	2022	NUM
ajlm-2140	34	11	.	.	PUNCT
ajlm-2140	35	1	the	the	DET
ajlm-2140	35	2	results	result	NOUN
ajlm-2140	35	3	were	be	AUX
ajlm-2140	35	4	quality	quality	NOUN
ajlm-2140	35	5	assured	assure	VERB
ajlm-2140	35	6	by	by	ADP
ajlm-2140	35	7	assessing	assess	VERB
ajlm-2140	35	8	the	the	DET
ajlm-2140	35	9	instrument	instrument	NOUN
ajlm-2140	35	10	’s	’s	PART
ajlm-2140	35	11	daily	daily	ADJ
ajlm-2140	35	12	internal	internal	ADJ
ajlm-2140	35	13	quality	quality	NOUN
ajlm-2140	35	14	controls	control	NOUN
ajlm-2140	35	15	and	and	CCONJ
ajlm-2140	35	16	external	external	ADJ
ajlm-2140	35	17	quality	quality	NOUN
ajlm-2140	35	18	assurance	assurance	NOUN
ajlm-2140	35	19	,	,	PUNCT
ajlm-2140	35	20	according	accord	VERB
ajlm-2140	35	21	to	to	ADP
ajlm-2140	35	22	the	the	DET
ajlm-2140	35	23	department	department	NOUN
ajlm-2140	35	24	’s	’s	PART
ajlm-2140	35	25	standard	standard	ADJ
ajlm-2140	35	26	operating	operate	VERB
ajlm-2140	35	27	procedure.6	procedure.6	NOUN
ajlm-2140	35	28	automated	automate	VERB
ajlm-2140	35	29	white	white	ADJ
ajlm-2140	35	30	blood	blood	NOUN
ajlm-2140	35	31	cell	cell	NOUN
ajlm-2140	35	32	analysis	analysis	NOUN
ajlm-2140	35	33	the	the	DET
ajlm-2140	35	34	anticoagulated	anticoagulate	VERB
ajlm-2140	35	35	samples	sample	NOUN
ajlm-2140	35	36	were	be	AUX
ajlm-2140	35	37	drawn	draw	VERB
ajlm-2140	35	38	and	and	CCONJ
ajlm-2140	35	39	analysed	analyse	VERB
ajlm-2140	35	40	within	within	ADP
ajlm-2140	35	41	24	24	NUM
ajlm-2140	35	42	h	h	NOUN
ajlm-2140	35	43	of	of	ADP
ajlm-2140	35	44	sampling	sample	VERB
ajlm-2140	35	45	on	on	ADP
ajlm-2140	35	46	the	the	DET
ajlm-2140	35	47	sysmex	sysmex	NOUN
ajlm-2140	35	48	xn-3000	xn-3000	PROPN
ajlm-2140	35	49	analyser	analyser	PROPN
ajlm-2140	35	50	(	(	PUNCT
ajlm-2140	35	51	sysmex	sysmex	NOUN
ajlm-2140	35	52	corporation	corporation	NOUN
ajlm-2140	35	53	,	,	PUNCT
ajlm-2140	35	54	kobe	kobe	PROPN
ajlm-2140	35	55	,	,	PUNCT
ajlm-2140	35	56	japan	japan	PROPN
ajlm-2140	35	57	)	)	PUNCT
ajlm-2140	35	58	for	for	ADP
ajlm-2140	35	59	fbc	fbc	PROPN
ajlm-2140	35	60	and	and	CCONJ
ajlm-2140	35	61	wbc	wbc	PROPN
ajlm-2140	35	62	differential	differential	ADJ
ajlm-2140	35	63	count	count	NOUN
ajlm-2140	35	64	analysis	analysis	NOUN
ajlm-2140	35	65	.	.	PUNCT
ajlm-2140	36	1	if	if	SCONJ
ajlm-2140	36	2	the	the	DET
ajlm-2140	36	3	sample	sample	NOUN
ajlm-2140	36	4	demonstrated	demonstrate	VERB
ajlm-2140	36	5	‘	'	PUNCT
ajlm-2140	36	6	blast	blast	NOUN
ajlm-2140	36	7	’	'	PUNCT
ajlm-2140	36	8	,	,	PUNCT
ajlm-2140	36	9	‘	'	PUNCT
ajlm-2140	36	10	atypical	atypical	ADJ
ajlm-2140	36	11	lymphocytes	lymphocyte	NOUN
ajlm-2140	36	12	’	'	PUNCT
ajlm-2140	36	13	,	,	PUNCT
ajlm-2140	36	14	or	or	CCONJ
ajlm-2140	36	15	‘	'	PUNCT
ajlm-2140	36	16	abnormal	abnormal	ADJ
ajlm-2140	36	17	lymphocytes	lymphocyte	NOUN
ajlm-2140	36	18	’	'	PUNCT
ajlm-2140	36	19	,	,	PUNCT
ajlm-2140	36	20	the	the	DET
ajlm-2140	36	21	wpc	wpc	ADJ
ajlm-2140	36	22	channel	channel	NOUN
ajlm-2140	36	23	was	be	AUX
ajlm-2140	36	24	reflexed	reflexe	VERB
ajlm-2140	36	25	and	and	CCONJ
ajlm-2140	36	26	run	run	VERB
ajlm-2140	36	27	according	accord	VERB
ajlm-2140	36	28	to	to	ADP
ajlm-2140	36	29	the	the	DET
ajlm-2140	36	30	routine	routine	ADJ
ajlm-2140	36	31	procedure.5	procedure.5	VERB
ajlm-2140	36	32	samples	sample	NOUN
ajlm-2140	36	33	that	that	PRON
ajlm-2140	36	34	were	be	AUX
ajlm-2140	36	35	clotted	clot	VERB
ajlm-2140	36	36	or	or	CCONJ
ajlm-2140	36	37	haemolysed	haemolyse	VERB
ajlm-2140	36	38	,	,	PUNCT
ajlm-2140	36	39	had	have	VERB
ajlm-2140	36	40	insufficient	insufficient	ADJ
ajlm-2140	36	41	volume	volume	NOUN
ajlm-2140	36	42	,	,	PUNCT
ajlm-2140	36	43	were	be	AUX
ajlm-2140	36	44	older	old	ADJ
ajlm-2140	36	45	than	than	ADP
ajlm-2140	36	46	24	24	NUM
ajlm-2140	36	47	h	h	NOUN
ajlm-2140	36	48	,	,	PUNCT
ajlm-2140	36	49	or	or	CCONJ
ajlm-2140	36	50	were	be	AUX
ajlm-2140	36	51	collected	collect	VERB
ajlm-2140	36	52	in	in	ADP
ajlm-2140	36	53	an	an	DET
ajlm-2140	36	54	incorrect	incorrect	ADJ
ajlm-2140	36	55	tube	tube	NOUN
ajlm-2140	36	56	or	or	CCONJ
ajlm-2140	36	57	erroneously	erroneously	ADV
ajlm-2140	36	58	labelled	label	VERB
ajlm-2140	36	59	were	be	AUX
ajlm-2140	36	60	excluded	exclude	VERB
ajlm-2140	36	61	from	from	ADP
ajlm-2140	36	62	the	the	DET
ajlm-2140	36	63	study	study	NOUN
ajlm-2140	36	64	.	.	PUNCT
ajlm-2140	37	1	the	the	DET
ajlm-2140	37	2	sysmex	sysmex	NOUN
ajlm-2140	37	3	xn-3000	xn-3000	PROPN
ajlm-2140	37	4	analyser	analyser	PROPN
ajlm-2140	37	5	uses	use	VERB
ajlm-2140	37	6	the	the	DET
ajlm-2140	37	7	principles	principle	NOUN
ajlm-2140	37	8	of	of	ADP
ajlm-2140	37	9	fluorescent	fluorescent	ADJ
ajlm-2140	37	10	flow	flow	NOUN
ajlm-2140	37	11	cytometry	cytometry	NOUN
ajlm-2140	37	12	to	to	PART
ajlm-2140	37	13	identify	identify	VERB
ajlm-2140	37	14	wbc	wbc	PROPN
ajlm-2140	37	15	sub	sub	NOUN
ajlm-2140	37	16	-	-	NOUN
ajlm-2140	37	17	populations	population	NOUN
ajlm-2140	37	18	based	base	VERB
ajlm-2140	37	19	on	on	ADP
ajlm-2140	37	20	the	the	DET
ajlm-2140	37	21	intensity	intensity	NOUN
ajlm-2140	37	22	of	of	ADP
ajlm-2140	37	23	the	the	DET
ajlm-2140	37	24	side	side	NOUN
ajlm-2140	37	25	-	-	PUNCT
ajlm-2140	37	26	fluorescent	fluorescent	ADJ
ajlm-2140	37	27	light	light	NOUN
ajlm-2140	37	28	and	and	CCONJ
ajlm-2140	37	29	side	side	NOUN
ajlm-2140	37	30	-	-	PUNCT
ajlm-2140	37	31	scattered	scatter	VERB
ajlm-2140	37	32	light.5,7	light.5,7	NOUN
ajlm-2140	37	33	the	the	DET
ajlm-2140	37	34	initial	initial	ADJ
ajlm-2140	37	35	reflex	reflex	NOUN
ajlm-2140	37	36	or	or	CCONJ
ajlm-2140	37	37	warning	warning	NOUN
ajlm-2140	37	38	is	be	AUX
ajlm-2140	37	39	identified	identify	VERB
ajlm-2140	37	40	by	by	ADP
ajlm-2140	37	41	the	the	DET
ajlm-2140	37	42	white	white	PROPN
ajlm-2140	37	43	cell	cell	NOUN
ajlm-2140	37	44	differential	differential	NOUN
ajlm-2140	37	45	,	,	PUNCT
ajlm-2140	37	46	which	which	PRON
ajlm-2140	37	47	generates	generate	VERB
ajlm-2140	37	48	an	an	DET
ajlm-2140	37	49	internal	internal	ADJ
ajlm-2140	37	50	protocol	protocol	NOUN
ajlm-2140	37	51	message	message	NOUN
ajlm-2140	37	52	or	or	CCONJ
ajlm-2140	37	53	flag	flag	NOUN
ajlm-2140	37	54	.	.	PUNCT
ajlm-2140	38	1	this	this	DET
ajlm-2140	38	2	flag	flag	NOUN
ajlm-2140	38	3	is	be	AUX
ajlm-2140	38	4	further	far	ADV
ajlm-2140	38	5	confirmed	confirm	VERB
ajlm-2140	38	6	or	or	CCONJ
ajlm-2140	38	7	removed	remove	VERB
ajlm-2140	38	8	by	by	ADP
ajlm-2140	38	9	the	the	DET
ajlm-2140	38	10	more	more	ADV
ajlm-2140	38	11	sensitive	sensitive	ADJ
ajlm-2140	38	12	wpc	wpc	X
ajlm-2140	38	13	channel.5,8	channel.5,8	PROPN
ajlm-2140	38	14	peripheral	peripheral	ADJ
ajlm-2140	38	15	blood	blood	NOUN
ajlm-2140	38	16	smear	smear	NOUN
ajlm-2140	38	17	analysis	analysis	NOUN
ajlm-2140	38	18	a	a	DET
ajlm-2140	38	19	pbs	pbs	NOUN
ajlm-2140	38	20	was	be	AUX
ajlm-2140	38	21	prepared	prepare	VERB
ajlm-2140	38	22	from	from	ADP
ajlm-2140	38	23	each	each	DET
ajlm-2140	38	24	blood	blood	NOUN
ajlm-2140	38	25	sample	sample	NOUN
ajlm-2140	38	26	and	and	CCONJ
ajlm-2140	38	27	stained	stain	VERB
ajlm-2140	38	28	according	accord	VERB
ajlm-2140	38	29	to	to	ADP
ajlm-2140	38	30	the	the	DET
ajlm-2140	38	31	may	may	PROPN
ajlm-2140	38	32	-	-	PUNCT
ajlm-2140	38	33	grunwald	grunwald	PROPN
ajlm-2140	38	34	giemsa	giemsa	NOUN
ajlm-2140	38	35	technique	technique	NOUN
ajlm-2140	38	36	using	use	VERB
ajlm-2140	38	37	the	the	DET
ajlm-2140	38	38	automated	automate	VERB
ajlm-2140	38	39	slide	slide	NOUN
ajlm-2140	38	40	stainer	stainer	NOUN
ajlm-2140	38	41	(	(	PUNCT
ajlm-2140	38	42	sysmex	sysmex	NOUN
ajlm-2140	38	43	p10	p10	NOUN
ajlm-2140	38	44	slide	slide	NOUN
ajlm-2140	38	45	maker	maker	NOUN
ajlm-2140	38	46	and	and	CCONJ
ajlm-2140	38	47	stainer	stainer	NOUN
ajlm-2140	38	48	,	,	PUNCT
ajlm-2140	38	49	sysmex	sysmex	NOUN
ajlm-2140	38	50	corporation	corporation	NOUN
ajlm-2140	38	51	,	,	PUNCT
ajlm-2140	38	52	kobe	kobe	PROPN
ajlm-2140	38	53	,	,	PUNCT
ajlm-2140	38	54	japan	japan	PROPN
ajlm-2140	38	55	)	)	PUNCT
ajlm-2140	38	56	according	accord	VERB
ajlm-2140	38	57	to	to	ADP
ajlm-2140	38	58	the	the	DET
ajlm-2140	38	59	clinical	clinical	ADJ
ajlm-2140	38	60	and	and	CCONJ
ajlm-2140	38	61	laboratory	laboratory	NOUN
ajlm-2140	38	62	standards	standard	NOUN
ajlm-2140	38	63	institute	institute	VERB
ajlm-2140	38	64	recommendations.9	recommendations.9	PROPN
ajlm-2140	38	65	each	each	DET
ajlm-2140	38	66	pbs	pbs	PROPN
ajlm-2140	38	67	was	be	AUX
ajlm-2140	38	68	microscopically	microscopically	ADV
ajlm-2140	38	69	assessed	assess	VERB
ajlm-2140	38	70	(	(	PUNCT
ajlm-2140	38	71	olympus	olympus	PROPN
ajlm-2140	38	72	cx23	cx23	PROPN
ajlm-2140	38	73	,	,	PUNCT
ajlm-2140	38	74	evident	evident	ADJ
ajlm-2140	38	75	corporation	corporation	NOUN
ajlm-2140	38	76	,	,	PUNCT
ajlm-2140	38	77	tokyo	tokyo	PROPN
ajlm-2140	38	78	,	,	PUNCT
ajlm-2140	38	79	japan	japan	PROPN
ajlm-2140	38	80	)	)	PUNCT
ajlm-2140	38	81	at	at	ADP
ajlm-2140	38	82	10×	10×	NUM
ajlm-2140	38	83	and	and	CCONJ
ajlm-2140	38	84	50×	50×	NUM
ajlm-2140	38	85	magnification	magnification	NOUN
ajlm-2140	38	86	with	with	ADP
ajlm-2140	38	87	oil	oil	NOUN
ajlm-2140	38	88	by	by	ADP
ajlm-2140	38	89	the	the	DET
ajlm-2140	38	90	principal	principal	ADJ
ajlm-2140	38	91	investigator	investigator	NOUN
ajlm-2140	38	92	and	and	CCONJ
ajlm-2140	38	93	a	a	DET
ajlm-2140	38	94	trained	train	VERB
ajlm-2140	38	95	haematology	haematology	NOUN
ajlm-2140	38	96	laboratory	laboratory	NOUN
ajlm-2140	38	97	technologist	technologist	NOUN
ajlm-2140	38	98	.	.	PUNCT
ajlm-2140	39	1	a	a	DET
ajlm-2140	39	2	100	100	NUM
ajlm-2140	39	3	wbc	wbc	PROPN
ajlm-2140	39	4	differential	differential	ADJ
ajlm-2140	39	5	count	count	NOUN
ajlm-2140	39	6	was	be	AUX
ajlm-2140	39	7	performed	perform	VERB
ajlm-2140	39	8	for	for	ADP
ajlm-2140	39	9	each	each	DET
ajlm-2140	39	10	sample	sample	NOUN
ajlm-2140	39	11	.	.	PUNCT
ajlm-2140	40	1	the	the	DET
ajlm-2140	40	2	machine	machine	NOUN
ajlm-2140	40	3	differential	differential	NOUN
ajlm-2140	40	4	and	and	CCONJ
ajlm-2140	40	5	manual	manual	ADJ
ajlm-2140	40	6	differential	differential	NOUN
ajlm-2140	40	7	counts	count	NOUN
ajlm-2140	40	8	were	be	AUX
ajlm-2140	40	9	entered	enter	VERB
ajlm-2140	40	10	into	into	ADP
ajlm-2140	40	11	microsoft	microsoft	PROPN
ajlm-2140	40	12	®	®	NOUN
ajlm-2140	40	13	excel	excel	VERB
ajlm-2140	40	14	2016	2016	NUM
ajlm-2140	40	15	spreadsheets	spreadsheet	NOUN
ajlm-2140	40	16	(	(	PUNCT
ajlm-2140	40	17	microsoft	microsoft	PROPN
ajlm-2140	40	18	®	®	PROPN
ajlm-2140	40	19	,	,	PUNCT
ajlm-2140	40	20	redmond	redmond	PROPN
ajlm-2140	40	21	,	,	PUNCT
ajlm-2140	40	22	washington	washington	PROPN
ajlm-2140	40	23	,	,	PUNCT
ajlm-2140	40	24	united	united	PROPN
ajlm-2140	40	25	states	states	PROPN
ajlm-2140	40	26	)	)	PUNCT
ajlm-2140	40	27	.	.	PUNCT
ajlm-2140	41	1	clinical	clinical	ADJ
ajlm-2140	41	2	information	information	NOUN
ajlm-2140	41	3	we	we	PRON
ajlm-2140	41	4	collected	collect	VERB
ajlm-2140	41	5	the	the	DET
ajlm-2140	41	6	following	follow	VERB
ajlm-2140	41	7	clinical	clinical	ADJ
ajlm-2140	41	8	information	information	NOUN
ajlm-2140	41	9	from	from	ADP
ajlm-2140	41	10	the	the	DET
ajlm-2140	41	11	hospital	hospital	NOUN
ajlm-2140	41	12	and	and	CCONJ
ajlm-2140	41	13	laboratory	laboratory	NOUN
ajlm-2140	41	14	information	information	NOUN
ajlm-2140	41	15	systems	system	NOUN
ajlm-2140	41	16	:	:	PUNCT
ajlm-2140	41	17	age	age	NOUN
ajlm-2140	41	18	,	,	PUNCT
ajlm-2140	41	19	sex	sex	NOUN
ajlm-2140	41	20	,	,	PUNCT
ajlm-2140	41	21	white	white	ADJ
ajlm-2140	41	22	cell	cell	NOUN
ajlm-2140	41	23	count	count	NOUN
ajlm-2140	41	24	(	(	PUNCT
ajlm-2140	41	25	wcc	wcc	PROPN
ajlm-2140	41	26	)	)	PUNCT
ajlm-2140	41	27	,	,	PUNCT
ajlm-2140	41	28	presence	presence	NOUN
ajlm-2140	41	29	of	of	ADP
ajlm-2140	41	30	an	an	DET
ajlm-2140	41	31	infection	infection	NOUN
ajlm-2140	41	32	,	,	PUNCT
ajlm-2140	41	33	coronavirus	coronavirus	NOUN
ajlm-2140	41	34	disease	disease	NOUN
ajlm-2140	41	35	2019	2019	NUM
ajlm-2140	41	36	active	active	ADJ
ajlm-2140	41	37	infection	infection	NOUN
ajlm-2140	41	38	or	or	CCONJ
ajlm-2140	41	39	previous	previous	ADJ
ajlm-2140	41	40	coronavirus	coronavirus	NOUN
ajlm-2140	41	41	disease	disease	NOUN
ajlm-2140	41	42	2019	2019	NUM
ajlm-2140	41	43	infection	infection	NOUN
ajlm-2140	41	44	,	,	PUNCT
ajlm-2140	41	45	clinical	clinical	ADJ
ajlm-2140	41	46	diagnosis	diagnosis	NOUN
ajlm-2140	41	47	,	,	PUNCT
ajlm-2140	41	48	transplant	transplant	NOUN
ajlm-2140	41	49	status	status	NOUN
ajlm-2140	41	50	,	,	PUNCT
ajlm-2140	41	51	current	current	ADJ
ajlm-2140	41	52	chemotherapy	chemotherapy	NOUN
ajlm-2140	41	53	exposure	exposure	NOUN
ajlm-2140	41	54	,	,	PUNCT
ajlm-2140	41	55	and	and	CCONJ
ajlm-2140	41	56	hiv	hiv	PROPN
ajlm-2140	41	57	status	status	NOUN
ajlm-2140	41	58	.	.	PUNCT
ajlm-2140	42	1	infection	infection	NOUN
ajlm-2140	42	2	,	,	PUNCT
ajlm-2140	42	3	as	as	SCONJ
ajlm-2140	42	4	recorded	record	VERB
ajlm-2140	42	5	in	in	ADP
ajlm-2140	42	6	the	the	DET
ajlm-2140	42	7	clinical	clinical	ADJ
ajlm-2140	42	8	information	information	NOUN
ajlm-2140	42	9	,	,	PUNCT
ajlm-2140	42	10	was	be	AUX
ajlm-2140	42	11	determined	determine	VERB
ajlm-2140	42	12	by	by	ADP
ajlm-2140	42	13	a	a	DET
ajlm-2140	42	14	temperature	temperature	NOUN
ajlm-2140	42	15	of	of	ADP
ajlm-2140	42	16	≥	≥	NOUN
ajlm-2140	42	17	38	38	NUM
ajlm-2140	42	18	°	°	NOUN
ajlm-2140	42	19	c	c	NOUN
ajlm-2140	42	20	or	or	CCONJ
ajlm-2140	42	21	culture	culture	NOUN
ajlm-2140	42	22	of	of	ADP
ajlm-2140	42	23	an	an	DET
ajlm-2140	42	24	organism	organism	NOUN
ajlm-2140	42	25	(	(	PUNCT
ajlm-2140	42	26	bacterial	bacterial	ADJ
ajlm-2140	42	27	,	,	PUNCT
ajlm-2140	42	28	viral	viral	ADJ
ajlm-2140	42	29	,	,	PUNCT
ajlm-2140	42	30	etc	etc	X
ajlm-2140	42	31	.	.	X
ajlm-2140	42	32	)	)	PUNCT
ajlm-2140	42	33	from	from	ADP
ajlm-2140	42	34	any	any	DET
ajlm-2140	42	35	clinical	clinical	ADJ
ajlm-2140	42	36	site	site	NOUN
ajlm-2140	42	37	,	,	PUNCT
ajlm-2140	42	38	or	or	CCONJ
ajlm-2140	42	39	a	a	DET
ajlm-2140	42	40	clinical	clinical	ADJ
ajlm-2140	42	41	site	site	NOUN
ajlm-2140	42	42	of	of	ADP
ajlm-2140	42	43	infection.10	infection.10	NOUN
ajlm-2140	42	44	the	the	DET
ajlm-2140	42	45	reference	reference	NOUN
ajlm-2140	42	46	range	range	NOUN
ajlm-2140	42	47	for	for	ADP
ajlm-2140	42	48	wcc	wcc	PROPN
ajlm-2140	42	49	in	in	ADP
ajlm-2140	42	50	our	our	PRON
ajlm-2140	42	51	setting	set	VERB
ajlm-2140	42	52	ranges	range	NOUN
ajlm-2140	42	53	from	from	ADP
ajlm-2140	42	54	3.92	3.92	NUM
ajlm-2140	42	55	to	to	ADP
ajlm-2140	42	56	10.40	10.40	NUM
ajlm-2140	42	57	×	×	NOUN
ajlm-2140	42	58	109	109	NUM
ajlm-2140	42	59	/	/	SYM
ajlm-2140	42	60	l	l	NOUN
ajlm-2140	42	61	for	for	ADP
ajlm-2140	42	62	male	male	ADJ
ajlm-2140	42	63	patients	patient	NOUN
ajlm-2140	42	64	and	and	CCONJ
ajlm-2140	42	65	from	from	ADP
ajlm-2140	42	66	3.90	3.90	NUM
ajlm-2140	42	67	to	to	ADP
ajlm-2140	42	68	12.60	12.60	NUM
ajlm-2140	42	69	×	×	NOUN
ajlm-2140	42	70	109	109	NUM
ajlm-2140	42	71	/	/	SYM
ajlm-2140	42	72	l	l	NOUN
ajlm-2140	42	73	for	for	ADP
ajlm-2140	42	74	female	female	ADJ
ajlm-2140	42	75	patients	patient	NOUN
ajlm-2140	42	76	.	.	PUNCT
ajlm-2140	43	1	in	in	ADP
ajlm-2140	43	2	our	our	PRON
ajlm-2140	43	3	study	study	NOUN
ajlm-2140	43	4	,	,	PUNCT
ajlm-2140	43	5	a	a	DET
ajlm-2140	43	6	low	low	ADJ
ajlm-2140	43	7	wcc	wcc	PROPN
ajlm-2140	43	8	was	be	AUX
ajlm-2140	43	9	defined	define	VERB
ajlm-2140	43	10	as	as	ADP
ajlm-2140	43	11	a	a	DET
ajlm-2140	43	12	count	count	NOUN
ajlm-2140	43	13	less	less	ADJ
ajlm-2140	43	14	than	than	ADP
ajlm-2140	43	15	1.5	1.5	NUM
ajlm-2140	43	16	×	×	NOUN
ajlm-2140	43	17	109	109	NUM
ajlm-2140	43	18	/	/	SYM
ajlm-2140	43	19	l.6	l.6	PROPN
ajlm-2140	43	20	data	data	VERB
ajlm-2140	43	21	analysis	analysis	NOUN
ajlm-2140	43	22	statistical	statistical	ADJ
ajlm-2140	43	23	data	datum	NOUN
ajlm-2140	43	24	were	be	AUX
ajlm-2140	43	25	captured	capture	VERB
ajlm-2140	43	26	using	use	VERB
ajlm-2140	43	27	microsoft	microsoft	PROPN
ajlm-2140	43	28	®	®	PROPN
ajlm-2140	43	29	excel	excel	VERB
ajlm-2140	43	30	2016	2016	NUM
ajlm-2140	43	31	(	(	PUNCT
ajlm-2140	43	32	microsoft	microsoft	PROPN
ajlm-2140	43	33	®	®	PROPN
ajlm-2140	43	34	,	,	PUNCT
ajlm-2140	43	35	redmond	redmond	PROPN
ajlm-2140	43	36	,	,	PUNCT
ajlm-2140	43	37	washington	washington	PROPN
ajlm-2140	43	38	,	,	PUNCT
ajlm-2140	43	39	united	united	PROPN
ajlm-2140	43	40	states	states	PROPN
ajlm-2140	43	41	)	)	PUNCT
ajlm-2140	43	42	and	and	CCONJ
ajlm-2140	43	43	analysed	analyse	VERB
ajlm-2140	43	44	using	use	VERB
ajlm-2140	43	45	r	r	NOUN
ajlm-2140	43	46	statistical	statistical	ADJ
ajlm-2140	43	47	computing	computing	NOUN
ajlm-2140	43	48	software	software	NOUN
ajlm-2140	43	49	of	of	ADP
ajlm-2140	43	50	the	the	DET
ajlm-2140	43	51	r	r	NOUN
ajlm-2140	43	52	core	core	NOUN
ajlm-2140	43	53	team	team	NOUN
ajlm-2140	43	54	,	,	PUNCT
ajlm-2140	43	55	2020	2020	NUM
ajlm-2140	43	56	,	,	PUNCT
ajlm-2140	43	57	version	version	NOUN
ajlm-2140	43	58	3.63	3.63	NUM
ajlm-2140	43	59	(	(	PUNCT
ajlm-2140	43	60	microsoft	microsoft	PROPN
ajlm-2140	43	61	,	,	PUNCT
ajlm-2140	43	62	windows	window	VERB
ajlm-2140	44	1	[	[	X
ajlm-2140	44	2	32/64	32/64	NUM
ajlm-2140	44	3	bit	bit	NOUN
ajlm-2140	44	4	]	]	X
ajlm-2140	44	5	,	,	PUNCT
ajlm-2140	44	6	redmond	redmond	PROPN
ajlm-2140	44	7	,	,	PUNCT
ajlm-2140	44	8	washington	washington	PROPN
ajlm-2140	44	9	,	,	PUNCT
ajlm-2140	44	10	united	united	PROPN
ajlm-2140	44	11	states	states	PROPN
ajlm-2140	44	12	)	)	PUNCT
ajlm-2140	44	13	.	.	PUNCT
ajlm-2140	45	1	all	all	DET
ajlm-2140	45	2	the	the	DET
ajlm-2140	45	3	numeric	numeric	ADJ
ajlm-2140	45	4	variables	variable	NOUN
ajlm-2140	45	5	were	be	AUX
ajlm-2140	45	6	skewed	skew	VERB
ajlm-2140	45	7	,	,	PUNCT
ajlm-2140	45	8	and	and	CCONJ
ajlm-2140	45	9	the	the	DET
ajlm-2140	45	10	descriptive	descriptive	ADJ
ajlm-2140	45	11	statistics	statistic	NOUN
ajlm-2140	45	12	were	be	AUX
ajlm-2140	45	13	consequently	consequently	ADV
ajlm-2140	45	14	presented	present	VERB
ajlm-2140	45	15	as	as	ADP
ajlm-2140	45	16	medians	median	NOUN
ajlm-2140	45	17	with	with	ADP
ajlm-2140	45	18	lower	low	ADJ
ajlm-2140	45	19	and	and	CCONJ
ajlm-2140	45	20	upper	upper	ADJ
ajlm-2140	45	21	quartiles	quartile	NOUN
ajlm-2140	45	22	.	.	PUNCT
ajlm-2140	46	1	the	the	DET
ajlm-2140	46	2	categorical	categorical	ADJ
ajlm-2140	46	3	variables	variable	NOUN
ajlm-2140	46	4	were	be	AUX
ajlm-2140	46	5	presented	present	VERB
ajlm-2140	46	6	as	as	ADP
ajlm-2140	46	7	counts	count	NOUN
ajlm-2140	46	8	and	and	CCONJ
ajlm-2140	46	9	percentage	percentage	NOUN
ajlm-2140	46	10	frequencies	frequency	NOUN
ajlm-2140	46	11	.	.	PUNCT
ajlm-2140	47	1	the	the	DET
ajlm-2140	47	2	association	association	NOUN
ajlm-2140	47	3	between	between	ADP
ajlm-2140	47	4	the	the	DET
ajlm-2140	47	5	numeric	numeric	ADJ
ajlm-2140	47	6	variables	variable	NOUN
ajlm-2140	47	7	was	be	AUX
ajlm-2140	47	8	determined	determine	VERB
ajlm-2140	47	9	using	use	VERB
ajlm-2140	47	10	pearson	pearson	PROPN
ajlm-2140	47	11	’s	’s	PART
ajlm-2140	47	12	correlation	correlation	NOUN
ajlm-2140	47	13	test	test	NOUN
ajlm-2140	47	14	.	.	PUNCT
ajlm-2140	48	1	all	all	DET
ajlm-2140	48	2	the	the	DET
ajlm-2140	48	3	statistical	statistical	ADJ
ajlm-2140	48	4	tests	test	NOUN
ajlm-2140	48	5	were	be	AUX
ajlm-2140	48	6	conducted	conduct	VERB
ajlm-2140	48	7	at	at	ADP
ajlm-2140	48	8	a	a	DET
ajlm-2140	48	9	5	5	NUM
ajlm-2140	48	10	%	%	NOUN
ajlm-2140	48	11	level	level	NOUN
ajlm-2140	48	12	of	of	ADP
ajlm-2140	48	13	significance	significance	NOUN
ajlm-2140	48	14	.	.	PUNCT
ajlm-2140	49	1	a	a	DET
ajlm-2140	49	2	p	p	NOUN
ajlm-2140	49	3	-	-	PUNCT
ajlm-2140	49	4	value	value	NOUN
ajlm-2140	49	5	of	of	ADP
ajlm-2140	49	6	<	<	X
ajlm-2140	49	7	0.05	0.05	NUM
ajlm-2140	49	8	was	be	AUX
ajlm-2140	49	9	considered	consider	VERB
ajlm-2140	49	10	significant	significant	ADJ
ajlm-2140	49	11	for	for	ADP
ajlm-2140	49	12	this	this	DET
ajlm-2140	49	13	study	study	NOUN
ajlm-2140	49	14	.	.	PUNCT
ajlm-2140	50	1	sensitivity	sensitivity	NOUN
ajlm-2140	50	2	and	and	CCONJ
ajlm-2140	50	3	specificity	specificity	NOUN
ajlm-2140	50	4	analyses	analysis	NOUN
ajlm-2140	50	5	were	be	AUX
ajlm-2140	50	6	calculated	calculate	VERB
ajlm-2140	50	7	using	use	VERB
ajlm-2140	50	8	the	the	DET
ajlm-2140	50	9	‘	'	PUNCT
ajlm-2140	50	10	epi.tests	epi.test	NOUN
ajlm-2140	50	11	’	'	PUNCT
ajlm-2140	50	12	r	r	NOUN
ajlm-2140	50	13	function	function	NOUN
ajlm-2140	50	14	from	from	ADP
ajlm-2140	50	15	the	the	DET
ajlm-2140	50	16	epir	epir	ADJ
ajlm-2140	50	17	package	package	NOUN
ajlm-2140	50	18	(	(	PUNCT
ajlm-2140	50	19	https://cran.r-project.org/package=epir	https://cran.r-project.org/package=epir	PROPN
ajlm-2140	50	20	)	)	PUNCT
ajlm-2140	50	21	while	while	SCONJ
ajlm-2140	50	22	the	the	DET
ajlm-2140	50	23	mcnemar	mcnemar	NOUN
ajlm-2140	50	24	test	test	NOUN
ajlm-2140	50	25	was	be	AUX
ajlm-2140	50	26	performed	perform	VERB
ajlm-2140	50	27	using	use	VERB
ajlm-2140	50	28	the	the	DET
ajlm-2140	50	29	epi.kappa	epi.kappa	ADJ
ajlm-2140	50	30	function	function	NOUN
ajlm-2140	50	31	also	also	ADV
ajlm-2140	50	32	from	from	ADP
ajlm-2140	50	33	the	the	DET
ajlm-2140	50	34	epir	epir	ADJ
ajlm-2140	50	35	package	package	NOUN
ajlm-2140	50	36	.	.	PUNCT
ajlm-2140	51	1	a	a	DET
ajlm-2140	51	2	‘	'	PUNCT
ajlm-2140	51	3	true	true	ADJ
ajlm-2140	51	4	-	-	PUNCT
ajlm-2140	51	5	positive	positive	ADJ
ajlm-2140	51	6	’	'	PUNCT
ajlm-2140	51	7	(	(	PUNCT
ajlm-2140	51	8	tp	tp	NOUN
ajlm-2140	51	9	)	)	PUNCT
ajlm-2140	51	10	was	be	AUX
ajlm-2140	51	11	defined	define	VERB
ajlm-2140	51	12	as	as	ADP
ajlm-2140	51	13	a	a	DET
ajlm-2140	51	14	wbc	wbc	PROPN
ajlm-2140	51	15	abnormality	abnormality	NOUN
ajlm-2140	51	16	detected	detect	VERB
ajlm-2140	51	17	by	by	ADP
ajlm-2140	51	18	the	the	DET
ajlm-2140	51	19	analyser	analyser	NOUN
ajlm-2140	51	20	and	and	CCONJ
ajlm-2140	51	21	confirmed	confirm	VERB
ajlm-2140	51	22	by	by	ADP
ajlm-2140	51	23	pbs	pbs	PROPN
ajlm-2140	51	24	microscopy	microscopy	PROPN
ajlm-2140	51	25	.	.	PUNCT
ajlm-2140	52	1	a	a	DET
ajlm-2140	52	2	‘	'	PUNCT
ajlm-2140	52	3	false	false	ADJ
ajlm-2140	52	4	positive	positive	ADJ
ajlm-2140	52	5	’	'	PUNCT
ajlm-2140	52	6	(	(	PUNCT
ajlm-2140	52	7	fp	fp	X
ajlm-2140	52	8	)	)	PUNCT
ajlm-2140	52	9	was	be	AUX
ajlm-2140	52	10	defined	define	VERB
ajlm-2140	52	11	as	as	ADP
ajlm-2140	52	12	a	a	DET
ajlm-2140	52	13	wbc	wbc	PROPN
ajlm-2140	52	14	abnormality	abnormality	NOUN
ajlm-2140	52	15	detected	detect	VERB
ajlm-2140	52	16	by	by	ADP
ajlm-2140	52	17	the	the	DET
ajlm-2140	52	18	analyser	analyser	NOUN
ajlm-2140	52	19	but	but	CCONJ
ajlm-2140	52	20	not	not	PART
ajlm-2140	52	21	observed	observe	VERB
ajlm-2140	52	22	on	on	ADP
ajlm-2140	52	23	pbs	pbs	PROPN
ajlm-2140	52	24	microscopy	microscopy	PROPN
ajlm-2140	52	25	.	.	PUNCT
ajlm-2140	53	1	a	a	DET
ajlm-2140	53	2	‘	'	PUNCT
ajlm-2140	53	3	true	true	ADJ
ajlm-2140	53	4	-	-	PUNCT
ajlm-2140	53	5	negative	negative	ADJ
ajlm-2140	53	6	’	'	PUNCT
ajlm-2140	53	7	(	(	PUNCT
ajlm-2140	53	8	tn	tn	NOUN
ajlm-2140	53	9	)	)	PUNCT
ajlm-2140	53	10	was	be	AUX
ajlm-2140	53	11	defined	define	VERB
ajlm-2140	53	12	as	as	ADP
ajlm-2140	53	13	a	a	DET
ajlm-2140	53	14	wbc	wbc	NOUN
ajlm-2140	53	15	abnormality	abnormality	NOUN
ajlm-2140	53	16	not	not	PART
ajlm-2140	53	17	detected	detect	VERB
ajlm-2140	53	18	by	by	ADP
ajlm-2140	53	19	the	the	DET
ajlm-2140	53	20	analyser	analyser	NOUN
ajlm-2140	53	21	and	and	CCONJ
ajlm-2140	53	22	not	not	PART
ajlm-2140	53	23	observed	observe	VERB
ajlm-2140	53	24	on	on	ADP
ajlm-2140	53	25	pbs	pbs	PROPN
ajlm-2140	53	26	microscopy	microscopy	PROPN
ajlm-2140	53	27	.	.	PUNCT
ajlm-2140	54	1	a	a	DET
ajlm-2140	54	2	‘	'	PUNCT
ajlm-2140	54	3	false	false	ADJ
ajlm-2140	54	4	negative	negative	ADJ
ajlm-2140	54	5	’	'	PUNCT
ajlm-2140	54	6	(	(	PUNCT
ajlm-2140	54	7	fn	fn	NOUN
ajlm-2140	54	8	)	)	PUNCT
ajlm-2140	54	9	was	be	AUX
ajlm-2140	54	10	defined	define	VERB
ajlm-2140	54	11	as	as	ADP
ajlm-2140	54	12	a	a	DET
ajlm-2140	54	13	wbc	wbc	NOUN
ajlm-2140	54	14	abnormality	abnormality	NOUN
ajlm-2140	54	15	not	not	PART
ajlm-2140	54	16	detected	detect	VERB
ajlm-2140	54	17	by	by	ADP
ajlm-2140	54	18	the	the	DET
ajlm-2140	54	19	analyser	analyser	NOUN
ajlm-2140	54	20	but	but	CCONJ
ajlm-2140	54	21	observed	observe	VERB
ajlm-2140	54	22	on	on	ADP
ajlm-2140	54	23	pbs	pbs	PROPN
ajlm-2140	54	24	microscopy	microscopy	PROPN
ajlm-2140	54	25	.	.	PUNCT
ajlm-2140	55	1	the	the	DET
ajlm-2140	55	2	equations	equation	NOUN
ajlm-2140	55	3	used	use	VERB
ajlm-2140	55	4	for	for	ADP
ajlm-2140	55	5	the	the	DET
ajlm-2140	55	6	sensitivity	sensitivity	NOUN
ajlm-2140	55	7	,	,	PUNCT
ajlm-2140	55	8	specificity	specificity	NOUN
ajlm-2140	55	9	,	,	PUNCT
ajlm-2140	55	10	positive	positive	ADJ
ajlm-2140	55	11	predictive	predictive	ADJ
ajlm-2140	55	12	value	value	NOUN
ajlm-2140	55	13	(	(	PUNCT
ajlm-2140	55	14	ppv	ppv	NOUN
ajlm-2140	55	15	)	)	PUNCT
ajlm-2140	55	16	,	,	PUNCT
ajlm-2140	55	17	and	and	CCONJ
ajlm-2140	55	18	negative	negative	ADJ
ajlm-2140	55	19	predictive	predictive	ADJ
ajlm-2140	55	20	value	value	NOUN
ajlm-2140	55	21	(	(	PUNCT
ajlm-2140	55	22	npv	npv	NOUN
ajlm-2140	55	23	)	)	PUNCT
ajlm-2140	55	24	calculations	calculation	NOUN
ajlm-2140	55	25	using	use	VERB
ajlm-2140	55	26	the	the	DET
ajlm-2140	55	27	epir	epir	ADJ
ajlm-2140	55	28	package	package	NOUN
ajlm-2140	55	29	are	be	AUX
ajlm-2140	55	30	shown	show	VERB
ajlm-2140	55	31	below	below	ADP
ajlm-2140	55	32	:	:	PUNCT
ajlm-2140	55	33	the	the	DET
ajlm-2140	55	34	impact	impact	NOUN
ajlm-2140	55	35	of	of	ADP
ajlm-2140	55	36	the	the	DET
ajlm-2140	55	37	clinical	clinical	ADJ
ajlm-2140	55	38	variables	variable	NOUN
ajlm-2140	55	39	(	(	PUNCT
ajlm-2140	55	40	presence	presence	NOUN
ajlm-2140	55	41	of	of	ADP
ajlm-2140	55	42	infection	infection	NOUN
ajlm-2140	55	43	,	,	PUNCT
ajlm-2140	55	44	malignancy	malignancy	NOUN
ajlm-2140	55	45	,	,	PUNCT
ajlm-2140	55	46	current	current	ADJ
ajlm-2140	55	47	chemotherapy	chemotherapy	NOUN
ajlm-2140	55	48	usage	usage	NOUN
ajlm-2140	55	49	and	and	CCONJ
ajlm-2140	55	50	low	low	ADJ
ajlm-2140	55	51	wcc	wcc	PROPN
ajlm-2140	55	52	[	[	X
ajlm-2140	55	53	<	<	X
ajlm-2140	55	54	1.5	1.5	NUM
ajlm-2140	55	55	×	×	NOUN
ajlm-2140	55	56	109	109	NUM
ajlm-2140	55	57	/	/	SYM
ajlm-2140	55	58	l	l	NOUN
ajlm-2140	55	59	]	]	PUNCT
ajlm-2140	55	60	)	)	PUNCT
ajlm-2140	55	61	on	on	ADP
ajlm-2140	55	62	the	the	DET
ajlm-2140	55	63	wbc	wbc	PROPN
ajlm-2140	55	64	flags	flag	NOUN
ajlm-2140	55	65	was	be	AUX
ajlm-2140	55	66	assessed	assess	VERB
ajlm-2140	55	67	using	use	VERB
ajlm-2140	55	68	the	the	DET
ajlm-2140	55	69	mcnemar	mcnemar	NOUN
ajlm-2140	55	70	test	test	NOUN
ajlm-2140	55	71	when	when	SCONJ
ajlm-2140	55	72	the	the	DET
ajlm-2140	55	73	wbc	wbc	PROPN
ajlm-2140	55	74	flag	flag	NOUN
ajlm-2140	55	75	did	do	AUX
ajlm-2140	55	76	not	not	PART
ajlm-2140	55	77	correlate	correlate	VERB
ajlm-2140	55	78	(	(	PUNCT
ajlm-2140	55	79	fp	fp	INTJ
ajlm-2140	55	80	or	or	CCONJ
ajlm-2140	55	81	fn	fn	NOUN
ajlm-2140	55	82	)	)	PUNCT
ajlm-2140	55	83	with	with	ADP
ajlm-2140	55	84	the	the	DET
ajlm-2140	55	85	microscopy	microscopy	NOUN
ajlm-2140	55	86	results	result	NOUN
ajlm-2140	55	87	.	.	PUNCT
ajlm-2140	56	1	results	result	NOUN
ajlm-2140	56	2	study	study	VERB
ajlm-2140	56	3	population	population	NOUN
ajlm-2140	56	4	this	this	DET
ajlm-2140	56	5	study	study	NOUN
ajlm-2140	56	6	included	include	VERB
ajlm-2140	56	7	250	250	NUM
ajlm-2140	56	8	adult	adult	NOUN
ajlm-2140	56	9	patient	patient	NOUN
ajlm-2140	56	10	samples	sample	NOUN
ajlm-2140	56	11	(	(	PUNCT
ajlm-2140	56	12	table	table	NOUN
ajlm-2140	56	13	1	1	NUM
ajlm-2140	56	14	)	)	PUNCT
ajlm-2140	56	15	.	.	PUNCT
ajlm-2140	57	1	one	one	NUM
ajlm-2140	57	2	hundred	hundred	NUM
ajlm-2140	57	3	and	and	CCONJ
ajlm-2140	57	4	thirteen	thirteen	NUM
ajlm-2140	57	5	(	(	PUNCT
ajlm-2140	57	6	45.2	45.2	NUM
ajlm-2140	57	7	%	%	NOUN
ajlm-2140	57	8	)	)	PUNCT
ajlm-2140	57	9	of	of	ADP
ajlm-2140	57	10	the	the	DET
ajlm-2140	57	11	patients	patient	NOUN
ajlm-2140	57	12	were	be	AUX
ajlm-2140	57	13	men	man	NOUN
ajlm-2140	57	14	and	and	CCONJ
ajlm-2140	57	15	137	137	NUM
ajlm-2140	57	16	(	(	PUNCT
ajlm-2140	57	17	54.8	54.8	NUM
ajlm-2140	57	18	%	%	NOUN
ajlm-2140	57	19	)	)	PUNCT
ajlm-2140	57	20	were	be	AUX
ajlm-2140	57	21	women	woman	NOUN
ajlm-2140	57	22	.	.	PUNCT
ajlm-2140	58	1	one	one	NUM
ajlm-2140	58	2	hundred	hundred	NUM
ajlm-2140	58	3	and	and	CCONJ
ajlm-2140	58	4	forty	forty	NUM
ajlm-2140	58	5	-	-	PUNCT
ajlm-2140	58	6	five	five	NUM
ajlm-2140	58	7	samples	sample	NOUN
ajlm-2140	58	8	(	(	PUNCT
ajlm-2140	58	9	56	56	NUM
ajlm-2140	58	10	%	%	NOUN
ajlm-2140	58	11	)	)	PUNCT
ajlm-2140	58	12	were	be	AUX
ajlm-2140	58	13	from	from	ADP
ajlm-2140	58	14	the	the	DET
ajlm-2140	58	15	haematology	haematology	NOUN
ajlm-2140	58	16	or	or	CCONJ
ajlm-2140	58	17	oncology	oncology	NOUN
ajlm-2140	58	18	clinic	clinic	NOUN
ajlm-2140	58	19	or	or	CCONJ
ajlm-2140	58	20	ward	ward	NOUN
ajlm-2140	58	21	.	.	PUNCT
ajlm-2140	59	1	of	of	ADP
ajlm-2140	59	2	the	the	DET
ajlm-2140	59	3	total	total	ADJ
ajlm-2140	59	4	250	250	NUM
ajlm-2140	59	5	study	study	NOUN
ajlm-2140	59	6	samples	sample	NOUN
ajlm-2140	59	7	,	,	PUNCT
ajlm-2140	59	8	there	there	PRON
ajlm-2140	59	9	were	be	VERB
ajlm-2140	59	10	125	125	NUM
ajlm-2140	59	11	normal	normal	ADJ
ajlm-2140	59	12	(	(	PUNCT
ajlm-2140	59	13	no	no	DET
ajlm-2140	59	14	quantitative	quantitative	ADJ
ajlm-2140	59	15	or	or	CCONJ
ajlm-2140	59	16	qualitative	qualitative	ADJ
ajlm-2140	59	17	wbc	wbc	ADJ
ajlm-2140	59	18	abnormalities	abnormality	NOUN
ajlm-2140	59	19	present	present	ADJ
ajlm-2140	59	20	)	)	PUNCT
ajlm-2140	59	21	and	and	CCONJ
ajlm-2140	59	22	125	125	NUM
ajlm-2140	59	23	abnormal	abnormal	ADJ
ajlm-2140	59	24	(	(	PUNCT
ajlm-2140	59	25	flagged	flag	VERB
ajlm-2140	59	26	by	by	ADP
ajlm-2140	59	27	the	the	DET
ajlm-2140	59	28	analyser	analyser	NOUN
ajlm-2140	59	29	as	as	ADP
ajlm-2140	59	30	having	have	VERB
ajlm-2140	59	31	wbc	wbc	ADJ
ajlm-2140	59	32	abnormalities	abnormality	NOUN
ajlm-2140	59	33	)	)	PUNCT
ajlm-2140	59	34	samples	sample	NOUN
ajlm-2140	59	35	.	.	PUNCT
ajlm-2140	60	1	table	table	NOUN
ajlm-2140	60	2	1	1	NUM
ajlm-2140	60	3	:	:	PUNCT
ajlm-2140	60	4	 	 	SPACE
ajlm-2140	60	5	demographic	demographic	ADJ
ajlm-2140	60	6	characteristics	characteristic	NOUN
ajlm-2140	60	7	and	and	CCONJ
ajlm-2140	60	8	clinical	clinical	ADJ
ajlm-2140	60	9	information	information	NOUN
ajlm-2140	60	10	of	of	ADP
ajlm-2140	60	11	the	the	DET
ajlm-2140	60	12	study	study	NOUN
ajlm-2140	60	13	population	population	NOUN
ajlm-2140	60	14	,	,	PUNCT
ajlm-2140	60	15	inkosi	inkosi	PROPN
ajlm-2140	60	16	albert	albert	PROPN
ajlm-2140	60	17	luthuli	luthuli	PROPN
ajlm-2140	60	18	central	central	PROPN
ajlm-2140	60	19	hospital	hospital	NOUN
ajlm-2140	60	20	,	,	PUNCT
ajlm-2140	60	21	durban	durban	PROPN
ajlm-2140	60	22	,	,	PUNCT
ajlm-2140	60	23	kwazulu	kwazulu	NOUN
ajlm-2140	60	24	-	-	PUNCT
ajlm-2140	60	25	natal	natal	ADJ
ajlm-2140	60	26	,	,	PUNCT
ajlm-2140	60	27	south	south	PROPN
ajlm-2140	60	28	africa	africa	PROPN
ajlm-2140	60	29	,	,	PUNCT
ajlm-2140	60	30	march	march	PROPN
ajlm-2140	60	31	2022	2022	NUM
ajlm-2140	60	32	–	–	PUNCT
ajlm-2140	60	33	april	april	PROPN
ajlm-2140	60	34	2022	2022	NUM
ajlm-2140	60	35	.	.	PUNCT
ajlm-2140	61	1	clinical	clinical	ADJ
ajlm-2140	61	2	characteristics	characteristic	NOUN
ajlm-2140	61	3	of	of	ADP
ajlm-2140	61	4	the	the	DET
ajlm-2140	61	5	112	112	NUM
ajlm-2140	61	6	(	(	PUNCT
ajlm-2140	61	7	44.8	44.8	NUM
ajlm-2140	61	8	%	%	NOUN
ajlm-2140	61	9	)	)	PUNCT
ajlm-2140	61	10	patients	patient	NOUN
ajlm-2140	61	11	with	with	ADP
ajlm-2140	61	12	a	a	DET
ajlm-2140	61	13	haematological	haematological	ADJ
ajlm-2140	61	14	malignancy	malignancy	NOUN
ajlm-2140	61	15	,	,	PUNCT
ajlm-2140	61	16	51	51	NUM
ajlm-2140	61	17	(	(	PUNCT
ajlm-2140	61	18	20.4	20.4	NUM
ajlm-2140	61	19	%	%	NOUN
ajlm-2140	61	20	)	)	PUNCT
ajlm-2140	61	21	had	have	VERB
ajlm-2140	61	22	acute	acute	ADJ
ajlm-2140	61	23	myeloid	myeloid	ADJ
ajlm-2140	61	24	leukaemia	leukaemia	NOUN
ajlm-2140	61	25	,	,	PUNCT
ajlm-2140	61	26	36	36	NUM
ajlm-2140	61	27	(	(	PUNCT
ajlm-2140	61	28	14.4	14.4	NUM
ajlm-2140	61	29	%	%	NOUN
ajlm-2140	61	30	)	)	PUNCT
ajlm-2140	61	31	had	have	VERB
ajlm-2140	61	32	acute	acute	ADJ
ajlm-2140	61	33	lymphoblastic	lymphoblastic	ADJ
ajlm-2140	61	34	leukaemia	leukaemia	NOUN
ajlm-2140	61	35	or	or	CCONJ
ajlm-2140	61	36	lymphoma	lymphoma	NOUN
ajlm-2140	61	37	,	,	PUNCT
ajlm-2140	61	38	10	10	NUM
ajlm-2140	61	39	(	(	PUNCT
ajlm-2140	61	40	4	4	NUM
ajlm-2140	61	41	%	%	NOUN
ajlm-2140	61	42	)	)	PUNCT
ajlm-2140	61	43	had	have	VERB
ajlm-2140	61	44	a	a	DET
ajlm-2140	61	45	lymphoproliferative	lymphoproliferative	ADJ
ajlm-2140	61	46	disorder	disorder	NOUN
ajlm-2140	61	47	,	,	PUNCT
ajlm-2140	61	48	and	and	CCONJ
ajlm-2140	61	49	8	8	NUM
ajlm-2140	61	50	(	(	PUNCT
ajlm-2140	61	51	3.2	3.2	NUM
ajlm-2140	61	52	%	%	NOUN
ajlm-2140	61	53	)	)	PUNCT
ajlm-2140	61	54	had	have	VERB
ajlm-2140	61	55	a	a	DET
ajlm-2140	61	56	plasma	plasma	NOUN
ajlm-2140	61	57	cell	cell	NOUN
ajlm-2140	61	58	dyscrasia	dyscrasia	PROPN
ajlm-2140	61	59	.	.	PUNCT
ajlm-2140	62	1	one	one	NUM
ajlm-2140	62	2	hundred	hundred	NUM
ajlm-2140	62	3	and	and	CCONJ
ajlm-2140	62	4	three	three	NUM
ajlm-2140	62	5	(	(	PUNCT
ajlm-2140	62	6	41.2	41.2	NUM
ajlm-2140	62	7	%	%	NOUN
ajlm-2140	62	8	)	)	PUNCT
ajlm-2140	63	1	patients	patient	NOUN
ajlm-2140	63	2	were	be	AUX
ajlm-2140	63	3	on	on	ADP
ajlm-2140	63	4	chemotherapy	chemotherapy	NOUN
ajlm-2140	63	5	,	,	PUNCT
ajlm-2140	63	6	74	74	NUM
ajlm-2140	63	7	(	(	PUNCT
ajlm-2140	63	8	29.6	29.6	NUM
ajlm-2140	63	9	%	%	NOUN
ajlm-2140	63	10	)	)	PUNCT
ajlm-2140	63	11	had	have	AUX
ajlm-2140	63	12	an	an	DET
ajlm-2140	63	13	infection	infection	NOUN
ajlm-2140	63	14	,	,	PUNCT
ajlm-2140	63	15	and	and	CCONJ
ajlm-2140	63	16	8	8	NUM
ajlm-2140	63	17	(	(	PUNCT
ajlm-2140	63	18	3.2	3.2	NUM
ajlm-2140	63	19	%	%	NOUN
ajlm-2140	63	20	)	)	PUNCT
ajlm-2140	63	21	patients	patient	NOUN
ajlm-2140	63	22	had	have	AUX
ajlm-2140	63	23	received	receive	VERB
ajlm-2140	63	24	a	a	DET
ajlm-2140	63	25	haematopoietic	haematopoietic	ADJ
ajlm-2140	63	26	stem	stem	NOUN
ajlm-2140	63	27	cell	cell	NOUN
ajlm-2140	63	28	transplant	transplant	NOUN
ajlm-2140	63	29	.	.	PUNCT
ajlm-2140	64	1	twenty	twenty	NUM
ajlm-2140	64	2	-	-	PUNCT
ajlm-2140	64	3	two	two	NUM
ajlm-2140	64	4	(	(	PUNCT
ajlm-2140	64	5	8.8	8.8	NUM
ajlm-2140	64	6	%	%	NOUN
ajlm-2140	64	7	)	)	PUNCT
ajlm-2140	64	8	samples	sample	NOUN
ajlm-2140	64	9	were	be	AUX
ajlm-2140	64	10	from	from	ADP
ajlm-2140	64	11	patients	patient	NOUN
ajlm-2140	64	12	with	with	ADP
ajlm-2140	64	13	benign	benign	ADJ
ajlm-2140	64	14	haematological	haematological	ADJ
ajlm-2140	64	15	disorders	disorder	NOUN
ajlm-2140	64	16	such	such	ADJ
ajlm-2140	64	17	as	as	ADP
ajlm-2140	64	18	thalassaemia	thalassaemia	NOUN
ajlm-2140	64	19	major	major	ADJ
ajlm-2140	64	20	,	,	PUNCT
ajlm-2140	64	21	aplastic	aplastic	ADJ
ajlm-2140	64	22	anaemia	anaemia	NOUN
ajlm-2140	64	23	and	and	CCONJ
ajlm-2140	64	24	sickle	sickle	NOUN
ajlm-2140	64	25	cell	cell	NOUN
ajlm-2140	64	26	disease	disease	NOUN
ajlm-2140	64	27	.	.	PUNCT
ajlm-2140	65	1	among	among	ADP
ajlm-2140	65	2	the	the	DET
ajlm-2140	65	3	28	28	NUM
ajlm-2140	65	4	(	(	PUNCT
ajlm-2140	65	5	11.2	11.2	NUM
ajlm-2140	65	6	%	%	NOUN
ajlm-2140	65	7	)	)	PUNCT
ajlm-2140	65	8	hiv	hiv	PROPN
ajlm-2140	65	9	-	-	PUNCT
ajlm-2140	65	10	positive	positive	ADJ
ajlm-2140	65	11	patients	patient	NOUN
ajlm-2140	65	12	,	,	PUNCT
ajlm-2140	65	13	the	the	DET
ajlm-2140	65	14	cd4	cd4	PROPN
ajlm-2140	65	15	count	count	NOUN
ajlm-2140	65	16	ranged	range	VERB
ajlm-2140	65	17	from	from	ADP
ajlm-2140	65	18	35	35	NUM
ajlm-2140	65	19	×	×	NOUN
ajlm-2140	65	20	109	109	NUM
ajlm-2140	65	21	/	/	SYM
ajlm-2140	65	22	l	l	NOUN
ajlm-2140	65	23	to	to	ADP
ajlm-2140	65	24	1233	1233	NUM
ajlm-2140	65	25	×	×	NOUN
ajlm-2140	65	26	109	109	NUM
ajlm-2140	65	27	/	/	SYM
ajlm-2140	65	28	l	l	NOUN
ajlm-2140	65	29	,	,	PUNCT
ajlm-2140	65	30	and	and	CCONJ
ajlm-2140	65	31	viral	viral	ADJ
ajlm-2140	65	32	load	load	NOUN
ajlm-2140	65	33	ranged	range	VERB
ajlm-2140	65	34	from	from	ADP
ajlm-2140	65	35	0	0	NUM
ajlm-2140	65	36	copies	copy	NOUN
ajlm-2140	65	37	/	/	SYM
ajlm-2140	65	38	ml	ml	NOUN
ajlm-2140	65	39	to	to	PART
ajlm-2140	65	40	656	656	NUM
ajlm-2140	65	41	000	000	NUM
ajlm-2140	65	42	copies	copy	NOUN
ajlm-2140	65	43	/	/	SYM
ajlm-2140	65	44	ml	ml	NOUN
ajlm-2140	65	45	.	.	PUNCT
ajlm-2140	65	46	white	white	PROPN
ajlm-2140	65	47	cell	cell	NOUN
ajlm-2140	65	48	count	count	VERB
ajlm-2140	65	49	the	the	DET
ajlm-2140	65	50	wcc	wcc	PROPN
ajlm-2140	65	51	among	among	ADP
ajlm-2140	65	52	the	the	DET
ajlm-2140	65	53	study	study	NOUN
ajlm-2140	65	54	subjects	subject	NOUN
ajlm-2140	65	55	ranged	range	VERB
ajlm-2140	65	56	from	from	ADP
ajlm-2140	65	57	0.1	0.1	NUM
ajlm-2140	65	58	×	×	NOUN
ajlm-2140	65	59	109	109	NUM
ajlm-2140	65	60	/	/	SYM
ajlm-2140	65	61	l	l	NOUN
ajlm-2140	65	62	to	to	ADP
ajlm-2140	65	63	145.5	145.5	NUM
ajlm-2140	65	64	×	×	NOUN
ajlm-2140	65	65	109	109	NUM
ajlm-2140	65	66	/	/	SYM
ajlm-2140	65	67	l	l	NOUN
ajlm-2140	65	68	(	(	PUNCT
ajlm-2140	65	69	median	median	NOUN
ajlm-2140	65	70	:	:	PUNCT
ajlm-2140	65	71	5.24	5.24	NUM
ajlm-2140	65	72	×	×	NOUN
ajlm-2140	65	73	109	109	NUM
ajlm-2140	65	74	/	/	SYM
ajlm-2140	65	75	l	l	NOUN
ajlm-2140	65	76	;	;	PUNCT
ajlm-2140	65	77	interquartile	interquartile	ADJ
ajlm-2140	65	78	range	range	NOUN
ajlm-2140	65	79	:	:	PUNCT
ajlm-2140	65	80	2.43–8.67	2.43–8.67	NUM
ajlm-2140	65	81	×	×	NOUN
ajlm-2140	65	82	109	109	NUM
ajlm-2140	65	83	/	/	SYM
ajlm-2140	65	84	l	l	NOUN
ajlm-2140	65	85	)	)	PUNCT
ajlm-2140	65	86	.	.	PUNCT
ajlm-2140	66	1	thirty	thirty	NUM
ajlm-2140	66	2	-	-	PUNCT
ajlm-2140	66	3	seven	seven	NUM
ajlm-2140	66	4	samples	sample	NOUN
ajlm-2140	66	5	(	(	PUNCT
ajlm-2140	66	6	14.8	14.8	NUM
ajlm-2140	66	7	%	%	NOUN
ajlm-2140	66	8	)	)	PUNCT
ajlm-2140	66	9	demonstrated	demonstrate	VERB
ajlm-2140	66	10	a	a	DET
ajlm-2140	66	11	wcc	wcc	PROPN
ajlm-2140	66	12	≤	≤	NUM
ajlm-2140	66	13	1.5	1.5	NUM
ajlm-2140	66	14	×	×	NOUN
ajlm-2140	66	15	109	109	NUM
ajlm-2140	66	16	/	/	SYM
ajlm-2140	66	17	l	l	NOUN
ajlm-2140	66	18	,	,	PUNCT
ajlm-2140	66	19	169	169	NUM
ajlm-2140	66	20	(	(	PUNCT
ajlm-2140	66	21	67.6	67.6	NUM
ajlm-2140	66	22	%	%	NOUN
ajlm-2140	66	23	)	)	PUNCT
ajlm-2140	66	24	demonstrated	demonstrate	VERB
ajlm-2140	66	25	a	a	DET
ajlm-2140	66	26	wcc	wcc	NOUN
ajlm-2140	66	27	between	between	ADP
ajlm-2140	66	28	1.6–11.9	1.6–11.9	NUM
ajlm-2140	66	29	×	×	NOUN
ajlm-2140	66	30	109	109	NUM
ajlm-2140	66	31	/	/	SYM
ajlm-2140	66	32	l	l	NOUN
ajlm-2140	66	33	,	,	PUNCT
ajlm-2140	66	34	and	and	CCONJ
ajlm-2140	66	35	44	44	NUM
ajlm-2140	66	36	samples	sample	NOUN
ajlm-2140	66	37	(	(	PUNCT
ajlm-2140	66	38	17.6	17.6	NUM
ajlm-2140	66	39	%	%	NOUN
ajlm-2140	66	40	)	)	PUNCT
ajlm-2140	66	41	demonstrated	demonstrate	VERB
ajlm-2140	66	42	a	a	DET
ajlm-2140	66	43	wcc	wcc	NOUN
ajlm-2140	66	44	of	of	ADP
ajlm-2140	66	45	≥	≥	NOUN
ajlm-2140	66	46	12	12	NUM
ajlm-2140	66	47	×	×	NOUN
ajlm-2140	66	48	109	109	NUM
ajlm-2140	66	49	/	/	SYM
ajlm-2140	66	50	l.	l.	PROPN
ajlm-2140	66	51	the	the	DET
ajlm-2140	66	52	blast	blast	NOUN
ajlm-2140	66	53	percentage	percentage	NOUN
ajlm-2140	66	54	ranged	range	VERB
ajlm-2140	66	55	from	from	ADP
ajlm-2140	66	56	0	0	NUM
ajlm-2140	66	57	%	%	NOUN
ajlm-2140	66	58	to	to	PART
ajlm-2140	66	59	78	78	NUM
ajlm-2140	66	60	%	%	NOUN
ajlm-2140	66	61	.	.	PUNCT
ajlm-2140	67	1	there	there	PRON
ajlm-2140	67	2	were	be	VERB
ajlm-2140	67	3	agreements	agreement	NOUN
ajlm-2140	67	4	(	(	PUNCT
ajlm-2140	67	5	p	p	X
ajlm-2140	67	6	<	<	X
ajlm-2140	67	7	0.001	0.001	NUM
ajlm-2140	67	8	)	)	PUNCT
ajlm-2140	67	9	between	between	ADP
ajlm-2140	67	10	the	the	DET
ajlm-2140	67	11	pbs	pbs	PROPN
ajlm-2140	67	12	microscopy	microscopy	NOUN
ajlm-2140	67	13	and	and	CCONJ
ajlm-2140	67	14	the	the	DET
ajlm-2140	67	15	numerical	numerical	ADJ
ajlm-2140	67	16	wbc	wbc	PROPN
ajlm-2140	67	17	values	value	NOUN
ajlm-2140	67	18	noted	note	VERB
ajlm-2140	67	19	on	on	ADP
ajlm-2140	67	20	the	the	DET
ajlm-2140	67	21	sysmex	sysmex	NOUN
ajlm-2140	67	22	xn-3000	xn-3000	PROPN
ajlm-2140	67	23	analyser	analyser	NOUN
ajlm-2140	67	24	for	for	ADP
ajlm-2140	67	25	the	the	DET
ajlm-2140	67	26	median	median	ADJ
ajlm-2140	67	27	differential	differential	NOUN
ajlm-2140	67	28	counts	count	NOUN
ajlm-2140	67	29	of	of	ADP
ajlm-2140	67	30	neutrophils	neutrophil	NOUN
ajlm-2140	67	31	(	(	PUNCT
ajlm-2140	67	32	54	54	NUM
ajlm-2140	67	33	×	×	NOUN
ajlm-2140	67	34	109	109	NUM
ajlm-2140	67	35	/	/	SYM
ajlm-2140	67	36	l	l	NOUN
ajlm-2140	67	37	vs	vs	ADP
ajlm-2140	67	38	55.4	55.4	NUM
ajlm-2140	67	39	×	×	NOUN
ajlm-2140	67	40	109	109	NUM
ajlm-2140	67	41	/	/	SYM
ajlm-2140	67	42	l	l	NOUN
ajlm-2140	67	43	)	)	PUNCT
ajlm-2140	67	44	,	,	PUNCT
ajlm-2140	67	45	lymphocytes	lymphocyte	VERB
ajlm-2140	67	46	(	(	PUNCT
ajlm-2140	67	47	26	26	NUM
ajlm-2140	67	48	×	×	NOUN
ajlm-2140	67	49	109	109	NUM
ajlm-2140	67	50	/	/	SYM
ajlm-2140	67	51	l	l	NOUN
ajlm-2140	67	52	vs	vs	ADP
ajlm-2140	67	53	29.1	29.1	NUM
ajlm-2140	67	54	×	×	NOUN
ajlm-2140	67	55	109	109	NUM
ajlm-2140	67	56	/	/	SYM
ajlm-2140	67	57	l	l	NOUN
ajlm-2140	67	58	)	)	PUNCT
ajlm-2140	67	59	,	,	PUNCT
ajlm-2140	67	60	immature	immature	ADJ
ajlm-2140	67	61	granulocytes	granulocyte	NOUN
ajlm-2140	67	62	(	(	PUNCT
ajlm-2140	67	63	0	0	NUM
ajlm-2140	67	64	×	×	NOUN
ajlm-2140	67	65	109	109	NUM
ajlm-2140	67	66	/	/	SYM
ajlm-2140	67	67	l	l	NOUN
ajlm-2140	67	68	vs	vs	ADP
ajlm-2140	67	69	0.50	0.50	NUM
ajlm-2140	67	70	×	×	NOUN
ajlm-2140	67	71	109	109	NUM
ajlm-2140	67	72	/	/	SYM
ajlm-2140	67	73	l	l	NOUN
ajlm-2140	67	74	)	)	PUNCT
ajlm-2140	67	75	,	,	PUNCT
ajlm-2140	67	76	and	and	CCONJ
ajlm-2140	67	77	monocytes	monocyte	NOUN
ajlm-2140	67	78	(	(	PUNCT
ajlm-2140	67	79	7	7	NUM
ajlm-2140	67	80	×	×	NOUN
ajlm-2140	67	81	109	109	NUM
ajlm-2140	67	82	/	/	SYM
ajlm-2140	67	83	l	l	NOUN
ajlm-2140	67	84	vs	vs	ADP
ajlm-2140	67	85	7.55	7.55	NUM
ajlm-2140	67	86	×	×	NOUN
ajlm-2140	67	87	109	109	NUM
ajlm-2140	67	88	/	/	SYM
ajlm-2140	67	89	l	l	NOUN
ajlm-2140	67	90	)	)	PUNCT
ajlm-2140	67	91	(	(	PUNCT
ajlm-2140	67	92	table	table	NOUN
ajlm-2140	67	93	2	2	NUM
ajlm-2140	67	94	)	)	PUNCT
ajlm-2140	67	95	.	.	PUNCT
ajlm-2140	68	1	the	the	DET
ajlm-2140	68	2	basophils	basophils	PROPN
ajlm-2140	68	3	,	,	PUNCT
ajlm-2140	68	4	however	however	ADV
ajlm-2140	68	5	,	,	PUNCT
ajlm-2140	68	6	did	do	AUX
ajlm-2140	68	7	not	not	PART
ajlm-2140	68	8	demonstrate	demonstrate	VERB
ajlm-2140	68	9	an	an	DET
ajlm-2140	68	10	agreement	agreement	NOUN
ajlm-2140	68	11	as	as	SCONJ
ajlm-2140	68	12	the	the	DET
ajlm-2140	68	13	median	median	ADJ
ajlm-2140	68	14	count	count	NOUN
ajlm-2140	68	15	was	be	AUX
ajlm-2140	68	16	0	0	NUM
ajlm-2140	68	17	×	×	NOUN
ajlm-2140	68	18	109	109	NUM
ajlm-2140	68	19	/	/	SYM
ajlm-2140	68	20	l	l	NOUN
ajlm-2140	68	21	by	by	ADP
ajlm-2140	68	22	pbs	pbs	PROPN
ajlm-2140	68	23	and	and	CCONJ
ajlm-2140	68	24	0.40	0.40	NUM
ajlm-2140	68	25	×	×	NOUN
ajlm-2140	68	26	109	109	NUM
ajlm-2140	68	27	/	/	SYM
ajlm-2140	68	28	l	l	NOUN
ajlm-2140	68	29	by	by	ADP
ajlm-2140	68	30	the	the	DET
ajlm-2140	68	31	automated	automate	VERB
ajlm-2140	68	32	analyser	analyser	NOUN
ajlm-2140	68	33	(	(	PUNCT
ajlm-2140	68	34	p	p	X
ajlm-2140	68	35	=	=	NOUN
ajlm-2140	68	36	0.494	0.494	NUM
ajlm-2140	68	37	)	)	PUNCT
ajlm-2140	68	38	.	.	PUNCT
ajlm-2140	69	1	table	table	NOUN
ajlm-2140	69	2	2	2	NUM
ajlm-2140	69	3	:	:	PUNCT
ajlm-2140	69	4	 	 	SPACE
ajlm-2140	69	5	correlation	correlation	NOUN
ajlm-2140	69	6	between	between	ADP
ajlm-2140	69	7	white	white	ADJ
ajlm-2140	69	8	blood	blood	NOUN
ajlm-2140	69	9	cell	cell	NOUN
ajlm-2140	69	10	differential	differential	NOUN
ajlm-2140	69	11	count	count	NOUN
ajlm-2140	69	12	by	by	ADP
ajlm-2140	69	13	the	the	DET
ajlm-2140	69	14	sysmex	sysmex	NOUN
ajlm-2140	69	15	xn-3000	xn-3000	PROPN
ajlm-2140	69	16	analyser	analyser	PROPN
ajlm-2140	69	17	and	and	CCONJ
ajlm-2140	69	18	white	white	ADJ
ajlm-2140	69	19	blood	blood	NOUN
ajlm-2140	69	20	cell	cell	NOUN
ajlm-2140	69	21	differential	differential	NOUN
ajlm-2140	69	22	count	count	NOUN
ajlm-2140	69	23	by	by	ADP
ajlm-2140	69	24	microscopy	microscopy	NOUN
ajlm-2140	69	25	,	,	PUNCT
ajlm-2140	69	26	inkosi	inkosi	PROPN
ajlm-2140	69	27	albert	albert	PROPN
ajlm-2140	69	28	luthuli	luthuli	PROPN
ajlm-2140	69	29	central	central	PROPN
ajlm-2140	69	30	hospital	hospital	NOUN
ajlm-2140	69	31	,	,	PUNCT
ajlm-2140	69	32	durban	durban	PROPN
ajlm-2140	69	33	,	,	PUNCT
ajlm-2140	69	34	kwazulu	kwazulu	NOUN
ajlm-2140	69	35	-	-	PUNCT
ajlm-2140	69	36	natal	natal	ADJ
ajlm-2140	69	37	,	,	PUNCT
ajlm-2140	69	38	south	south	PROPN
ajlm-2140	69	39	africa	africa	PROPN
ajlm-2140	69	40	,	,	PUNCT
ajlm-2140	69	41	march	march	PROPN
ajlm-2140	69	42	2022	2022	NUM
ajlm-2140	69	43	–	–	PUNCT
ajlm-2140	69	44	april	april	PROPN
ajlm-2140	69	45	2022	2022	NUM
ajlm-2140	69	46	.	.	PUNCT
ajlm-2140	70	1	sixty	sixty	NUM
ajlm-2140	70	2	-	-	PUNCT
ajlm-2140	70	3	two	two	NUM
ajlm-2140	70	4	(	(	PUNCT
ajlm-2140	70	5	24.8	24.8	NUM
ajlm-2140	70	6	%	%	NOUN
ajlm-2140	70	7	)	)	PUNCT
ajlm-2140	70	8	samples	sample	NOUN
ajlm-2140	70	9	were	be	AUX
ajlm-2140	70	10	flagged	flag	VERB
ajlm-2140	70	11	for	for	ADP
ajlm-2140	70	12	‘	'	PUNCT
ajlm-2140	70	13	blast	blast	NOUN
ajlm-2140	70	14	’	'	PUNCT
ajlm-2140	70	15	by	by	ADP
ajlm-2140	70	16	the	the	DET
ajlm-2140	70	17	analyser	analyser	NOUN
ajlm-2140	70	18	,	,	PUNCT
ajlm-2140	70	19	47	47	NUM
ajlm-2140	70	20	(	(	PUNCT
ajlm-2140	70	21	18.8	18.8	NUM
ajlm-2140	70	22	%	%	NOUN
ajlm-2140	70	23	)	)	PUNCT
ajlm-2140	70	24	were	be	AUX
ajlm-2140	70	25	flagged	flag	VERB
ajlm-2140	70	26	for	for	ADP
ajlm-2140	70	27	‘	'	PUNCT
ajlm-2140	70	28	immature	immature	ADJ
ajlm-2140	70	29	granulocytes	granulocyte	NOUN
ajlm-2140	70	30	’	'	PUNCT
ajlm-2140	70	31	,	,	PUNCT
ajlm-2140	70	32	and	and	CCONJ
ajlm-2140	70	33	43	43	NUM
ajlm-2140	70	34	(	(	PUNCT
ajlm-2140	70	35	17.2	17.2	NUM
ajlm-2140	70	36	%	%	NOUN
ajlm-2140	70	37	)	)	PUNCT
ajlm-2140	70	38	were	be	AUX
ajlm-2140	70	39	flagged	flag	VERB
ajlm-2140	70	40	for	for	ADP
ajlm-2140	70	41	‘	'	PUNCT
ajlm-2140	70	42	abnormal	abnormal	ADJ
ajlm-2140	70	43	lymphocytes	lymphocyte	NOUN
ajlm-2140	70	44	’	'	PUNCT
ajlm-2140	70	45	.	.	PUNCT
ajlm-2140	71	1	the	the	DET
ajlm-2140	71	2	efficiencies	efficiency	NOUN
ajlm-2140	71	3	of	of	ADP
ajlm-2140	71	4	the	the	DET
ajlm-2140	71	5	‘	'	PUNCT
ajlm-2140	71	6	conspicuous	conspicuous	ADJ
ajlm-2140	71	7	eosinophil	eosinophil	ADJ
ajlm-2140	71	8	’	'	PUNCT
ajlm-2140	71	9	,	,	PUNCT
ajlm-2140	71	10	‘	'	PUNCT
ajlm-2140	71	11	lymphocytosis	lymphocytosis	NOUN
ajlm-2140	71	12	’	'	PUNCT
ajlm-2140	71	13	,	,	PUNCT
ajlm-2140	71	14	‘	'	PUNCT
ajlm-2140	71	15	atypical	atypical	ADJ
ajlm-2140	71	16	lymphocyte	lymphocyte	NOUN
ajlm-2140	71	17	’	'	PUNCT
ajlm-2140	71	18	,	,	PUNCT
ajlm-2140	71	19	and	and	CCONJ
ajlm-2140	71	20	‘	'	PUNCT
ajlm-2140	71	21	immature	immature	ADJ
ajlm-2140	71	22	granulocyte	granulocyte	ADJ
ajlm-2140	71	23	’	'	PUNCT
ajlm-2140	71	24	flags	flag	NOUN
ajlm-2140	71	25	were	be	AUX
ajlm-2140	71	26	not	not	PART
ajlm-2140	71	27	impacted	impact	VERB
ajlm-2140	71	28	by	by	ADP
ajlm-2140	71	29	the	the	DET
ajlm-2140	71	30	clinical	clinical	ADJ
ajlm-2140	71	31	parameters	parameter	NOUN
ajlm-2140	71	32	(	(	PUNCT
ajlm-2140	71	33	p	p	X
ajlm-2140	71	34	>	>	X
ajlm-2140	71	35	0.05	0.05	NUM
ajlm-2140	71	36	)	)	PUNCT
ajlm-2140	71	37	(	(	PUNCT
ajlm-2140	71	38	table	table	NOUN
ajlm-2140	71	39	3	3	NUM
ajlm-2140	71	40	)	)	PUNCT
ajlm-2140	71	41	.	.	PUNCT
ajlm-2140	72	1	table	table	NOUN
ajlm-2140	72	2	3	3	NUM
ajlm-2140	72	3	:	:	PUNCT
ajlm-2140	72	4	 	 	SPACE
ajlm-2140	72	5	performance	performance	NOUN
ajlm-2140	72	6	of	of	ADP
ajlm-2140	72	7	the	the	DET
ajlm-2140	72	8	sysmex	sysmex	NOUN
ajlm-2140	72	9	xn	xn	PROPN
ajlm-2140	72	10	3000	3000	NUM
ajlm-2140	72	11	analyser	analyser	NOUN
ajlm-2140	72	12	for	for	ADP
ajlm-2140	72	13	the	the	DET
ajlm-2140	72	14	detection	detection	NOUN
ajlm-2140	72	15	of	of	ADP
ajlm-2140	72	16	white	white	ADJ
ajlm-2140	72	17	blood	blood	NOUN
ajlm-2140	72	18	cell	cell	NOUN
ajlm-2140	72	19	abnormalities	abnormality	NOUN
ajlm-2140	72	20	and	and	CCONJ
ajlm-2140	72	21	the	the	DET
ajlm-2140	72	22	impact	impact	NOUN
ajlm-2140	72	23	of	of	ADP
ajlm-2140	72	24	clinical	clinical	ADJ
ajlm-2140	72	25	variables	variable	NOUN
ajlm-2140	72	26	on	on	ADP
ajlm-2140	72	27	the	the	DET
ajlm-2140	72	28	performance	performance	NOUN
ajlm-2140	72	29	of	of	ADP
ajlm-2140	72	30	wbc	wbc	PROPN
ajlm-2140	72	31	flags	flag	NOUN
ajlm-2140	72	32	,	,	PUNCT
ajlm-2140	72	33	inkosi	inkosi	PROPN
ajlm-2140	72	34	albert	albert	PROPN
ajlm-2140	72	35	luthuli	luthuli	PROPN
ajlm-2140	72	36	central	central	PROPN
ajlm-2140	72	37	hospital	hospital	NOUN
ajlm-2140	72	38	,	,	PUNCT
ajlm-2140	72	39	durban	durban	PROPN
ajlm-2140	72	40	,	,	PUNCT
ajlm-2140	72	41	kwazulu	kwazulu	NOUN
ajlm-2140	72	42	-	-	PUNCT
ajlm-2140	72	43	natal	natal	ADJ
ajlm-2140	72	44	,	,	PUNCT
ajlm-2140	72	45	south	south	PROPN
ajlm-2140	72	46	africa	africa	PROPN
ajlm-2140	72	47	,	,	PUNCT
ajlm-2140	72	48	march	march	PROPN
ajlm-2140	72	49	2022	2022	NUM
ajlm-2140	72	50	–	–	PUNCT
ajlm-2140	72	51	april	april	PROPN
ajlm-2140	72	52	2022	2022	NUM
ajlm-2140	72	53	.	.	PUNCT
ajlm-2140	73	1	the	the	DET
ajlm-2140	73	2	‘	'	PUNCT
ajlm-2140	73	3	abnormal	abnormal	ADJ
ajlm-2140	73	4	lymphocyte	lymphocyte	NOUN
ajlm-2140	73	5	’	'	PUNCT
ajlm-2140	73	6	wbc	wbc	ADJ
ajlm-2140	73	7	flag	flag	NOUN
ajlm-2140	73	8	generated	generate	VERB
ajlm-2140	73	9	by	by	ADP
ajlm-2140	73	10	the	the	DET
ajlm-2140	73	11	instrument	instrument	NOUN
ajlm-2140	73	12	demonstrated	demonstrate	VERB
ajlm-2140	73	13	a	a	DET
ajlm-2140	73	14	sensitivity	sensitivity	NOUN
ajlm-2140	73	15	of	of	ADP
ajlm-2140	73	16	90	90	NUM
ajlm-2140	73	17	%	%	NOUN
ajlm-2140	73	18	(	(	PUNCT
ajlm-2140	73	19	95	95	NUM
ajlm-2140	73	20	%	%	NOUN
ajlm-2140	73	21	confidence	confidence	NOUN
ajlm-2140	73	22	interval	interval	NOUN
ajlm-2140	74	1	[	[	X
ajlm-2140	74	2	ci	ci	X
ajlm-2140	74	3	]	]	X
ajlm-2140	74	4	:	:	PUNCT
ajlm-2140	74	5	76.3	76.3	NUM
ajlm-2140	74	6	%	%	NOUN
ajlm-2140	74	7	–	–	PUNCT
ajlm-2140	74	8	97.2	97.2	NUM
ajlm-2140	74	9	%	%	NOUN
ajlm-2140	74	10	)	)	PUNCT
ajlm-2140	74	11	,	,	PUNCT
ajlm-2140	74	12	a	a	DET
ajlm-2140	74	13	specificity	specificity	NOUN
ajlm-2140	74	14	of	of	ADP
ajlm-2140	74	15	96.2	96.2	NUM
ajlm-2140	74	16	%	%	NOUN
ajlm-2140	74	17	(	(	PUNCT
ajlm-2140	74	18	95	95	NUM
ajlm-2140	74	19	%	%	NOUN
ajlm-2140	74	20	ci	ci	NOUN
ajlm-2140	74	21	:	:	PUNCT
ajlm-2140	74	22	92.6	92.6	NUM
ajlm-2140	74	23	%	%	NOUN
ajlm-2140	74	24	–	–	PUNCT
ajlm-2140	74	25	98.3	98.3	NUM
ajlm-2140	74	26	%	%	NOUN
ajlm-2140	74	27	)	)	PUNCT
ajlm-2140	74	28	,	,	PUNCT
ajlm-2140	74	29	a	a	DET
ajlm-2140	74	30	ppv	ppv	NOUN
ajlm-2140	74	31	of	of	ADP
ajlm-2140	74	32	81.8	81.8	NUM
ajlm-2140	74	33	%	%	NOUN
ajlm-2140	74	34	,	,	PUNCT
ajlm-2140	74	35	and	and	CCONJ
ajlm-2140	74	36	an	an	DET
ajlm-2140	74	37	npv	npv	NOUN
ajlm-2140	74	38	of	of	ADP
ajlm-2140	74	39	98.1	98.1	NUM
ajlm-2140	74	40	%	%	NOUN
ajlm-2140	74	41	.	.	PUNCT
ajlm-2140	75	1	on	on	ADP
ajlm-2140	75	2	comparing	compare	VERB
ajlm-2140	75	3	the	the	DET
ajlm-2140	75	4	analyser	analyser	NOUN
ajlm-2140	75	5	results	result	NOUN
ajlm-2140	75	6	to	to	ADP
ajlm-2140	75	7	microscopy	microscopy	VERB
ajlm-2140	75	8	,	,	PUNCT
ajlm-2140	75	9	four	four	NUM
ajlm-2140	75	10	samples	sample	NOUN
ajlm-2140	75	11	(	(	PUNCT
ajlm-2140	75	12	1.6	1.6	NUM
ajlm-2140	75	13	%	%	NOUN
ajlm-2140	75	14	)	)	PUNCT
ajlm-2140	75	15	that	that	PRON
ajlm-2140	75	16	were	be	AUX
ajlm-2140	75	17	not	not	PART
ajlm-2140	75	18	flagged	flag	VERB
ajlm-2140	75	19	for	for	ADP
ajlm-2140	75	20	‘	'	PUNCT
ajlm-2140	75	21	abnormal	abnormal	ADJ
ajlm-2140	75	22	lymphocytes	lymphocyte	NOUN
ajlm-2140	75	23	’	'	PUNCT
ajlm-2140	75	24	by	by	ADP
ajlm-2140	75	25	the	the	DET
ajlm-2140	75	26	analyser	analyser	NOUN
ajlm-2140	75	27	were	be	AUX
ajlm-2140	75	28	determined	determine	VERB
ajlm-2140	75	29	to	to	PART
ajlm-2140	75	30	be	be	AUX
ajlm-2140	75	31	fn	fn	ADJ
ajlm-2140	75	32	,	,	PUNCT
ajlm-2140	75	33	and	and	CCONJ
ajlm-2140	75	34	eight	eight	NUM
ajlm-2140	75	35	(	(	PUNCT
ajlm-2140	75	36	3.2	3.2	NUM
ajlm-2140	75	37	%	%	NOUN
ajlm-2140	75	38	)	)	PUNCT
ajlm-2140	75	39	samples	sample	NOUN
ajlm-2140	75	40	were	be	AUX
ajlm-2140	75	41	fp	fp	NOUN
ajlm-2140	75	42	for	for	ADP
ajlm-2140	75	43	‘	'	PUNCT
ajlm-2140	75	44	abnormal	abnormal	ADJ
ajlm-2140	75	45	lymphocytes	lymphocyte	NOUN
ajlm-2140	75	46	’	'	PUNCT
ajlm-2140	75	47	.	.	PUNCT
ajlm-2140	76	1	the	the	DET
ajlm-2140	76	2	‘	'	PUNCT
ajlm-2140	76	3	blast	blast	NOUN
ajlm-2140	76	4	’	'	PUNCT
ajlm-2140	76	5	flag	flag	NOUN
ajlm-2140	76	6	generated	generate	VERB
ajlm-2140	76	7	by	by	ADP
ajlm-2140	76	8	the	the	DET
ajlm-2140	76	9	instrument	instrument	NOUN
ajlm-2140	76	10	demonstrated	demonstrate	VERB
ajlm-2140	76	11	a	a	DET
ajlm-2140	76	12	sensitivity	sensitivity	NOUN
ajlm-2140	76	13	of	of	ADP
ajlm-2140	76	14	96.3	96.3	NUM
ajlm-2140	76	15	%	%	NOUN
ajlm-2140	76	16	(	(	PUNCT
ajlm-2140	76	17	95	95	NUM
ajlm-2140	76	18	%	%	NOUN
ajlm-2140	76	19	ci	ci	NOUN
ajlm-2140	76	20	:	:	PUNCT
ajlm-2140	76	21	81	81	NUM
ajlm-2140	76	22	%	%	NOUN
ajlm-2140	76	23	–	–	PUNCT
ajlm-2140	76	24	99.9	99.9	NUM
ajlm-2140	76	25	%	%	NOUN
ajlm-2140	76	26	)	)	PUNCT
ajlm-2140	76	27	,	,	PUNCT
ajlm-2140	76	28	a	a	DET
ajlm-2140	76	29	specificity	specificity	NOUN
ajlm-2140	76	30	of	of	ADP
ajlm-2140	76	31	84.9	84.9	NUM
ajlm-2140	76	32	%	%	NOUN
ajlm-2140	76	33	(	(	PUNCT
ajlm-2140	76	34	95	95	NUM
ajlm-2140	76	35	%	%	NOUN
ajlm-2140	76	36	ci	ci	NOUN
ajlm-2140	76	37	:	:	PUNCT
ajlm-2140	76	38	79.5	79.5	NUM
ajlm-2140	76	39	%	%	NOUN
ajlm-2140	76	40	–	–	PUNCT
ajlm-2140	76	41	89.4	89.4	NUM
ajlm-2140	76	42	%	%	NOUN
ajlm-2140	76	43	)	)	PUNCT
ajlm-2140	76	44	,	,	PUNCT
ajlm-2140	76	45	a	a	DET
ajlm-2140	76	46	ppv	ppv	NOUN
ajlm-2140	76	47	of	of	ADP
ajlm-2140	76	48	44.1	44.1	NUM
ajlm-2140	76	49	%	%	NOUN
ajlm-2140	76	50	,	,	PUNCT
ajlm-2140	76	51	and	and	CCONJ
ajlm-2140	76	52	an	an	DET
ajlm-2140	76	53	npv	npv	NOUN
ajlm-2140	76	54	of	of	ADP
ajlm-2140	76	55	99.5	99.5	NUM
ajlm-2140	76	56	%	%	NOUN
ajlm-2140	76	57	.	.	PUNCT
ajlm-2140	77	1	one	one	NUM
ajlm-2140	77	2	(	(	PUNCT
ajlm-2140	77	3	0.4	0.4	NUM
ajlm-2140	77	4	%	%	NOUN
ajlm-2140	77	5	)	)	PUNCT
ajlm-2140	77	6	sample	sample	NOUN
ajlm-2140	77	7	was	be	AUX
ajlm-2140	77	8	fn	fn	NOUN
ajlm-2140	77	9	for	for	ADP
ajlm-2140	77	10	‘	'	PUNCT
ajlm-2140	77	11	blast	blast	NOUN
ajlm-2140	77	12	’	'	PUNCT
ajlm-2140	77	13	,	,	PUNCT
ajlm-2140	77	14	and	and	CCONJ
ajlm-2140	77	15	33	33	NUM
ajlm-2140	77	16	(	(	PUNCT
ajlm-2140	77	17	13.2	13.2	NUM
ajlm-2140	77	18	%	%	NOUN
ajlm-2140	77	19	)	)	PUNCT
ajlm-2140	77	20	were	be	AUX
ajlm-2140	77	21	fp	fp	NOUN
ajlm-2140	77	22	.	.	PUNCT
ajlm-2140	78	1	the	the	DET
ajlm-2140	78	2	blast	blast	NOUN
ajlm-2140	78	3	count	count	NOUN
ajlm-2140	78	4	ranged	range	VERB
ajlm-2140	78	5	from	from	ADP
ajlm-2140	78	6	0	0	NUM
ajlm-2140	78	7	%	%	NOUN
ajlm-2140	78	8	to	to	PART
ajlm-2140	78	9	78	78	NUM
ajlm-2140	78	10	%	%	NOUN
ajlm-2140	78	11	.	.	PUNCT
ajlm-2140	79	1	the	the	DET
ajlm-2140	79	2	accuracy	accuracy	NOUN
ajlm-2140	79	3	of	of	ADP
ajlm-2140	79	4	the	the	DET
ajlm-2140	79	5	‘	'	PUNCT
ajlm-2140	79	6	blast	blast	NOUN
ajlm-2140	79	7	’	'	PUNCT
ajlm-2140	79	8	flag	flag	NOUN
ajlm-2140	79	9	was	be	AUX
ajlm-2140	79	10	influenced	influence	VERB
ajlm-2140	79	11	by	by	ADP
ajlm-2140	79	12	a	a	DET
ajlm-2140	79	13	low	low	ADJ
ajlm-2140	79	14	wcc	wcc	NOUN
ajlm-2140	79	15	(	(	PUNCT
ajlm-2140	79	16	p	p	X
ajlm-2140	79	17	<	<	X
ajlm-2140	79	18	0.001	0.001	NUM
ajlm-2140	79	19	)	)	PUNCT
ajlm-2140	79	20	,	,	PUNCT
ajlm-2140	79	21	the	the	DET
ajlm-2140	79	22	presence	presence	NOUN
ajlm-2140	79	23	of	of	ADP
ajlm-2140	79	24	malignancy	malignancy	NOUN
ajlm-2140	79	25	(	(	PUNCT
ajlm-2140	79	26	p	p	X
ajlm-2140	79	27	=	=	NOUN
ajlm-2140	79	28	0.002	0.002	NUM
ajlm-2140	79	29	)	)	PUNCT
ajlm-2140	79	30	,	,	PUNCT
ajlm-2140	79	31	current	current	ADJ
ajlm-2140	79	32	chemotherapy	chemotherapy	NOUN
ajlm-2140	79	33	exposure	exposure	NOUN
ajlm-2140	79	34	(	(	PUNCT
ajlm-2140	79	35	p	p	NOUN
ajlm-2140	79	36	=	=	NOUN
ajlm-2140	79	37	0.02	0.02	NUM
ajlm-2140	79	38	)	)	PUNCT
ajlm-2140	79	39	,	,	PUNCT
ajlm-2140	79	40	and	and	CCONJ
ajlm-2140	79	41	infection	infection	NOUN
ajlm-2140	79	42	(	(	PUNCT
ajlm-2140	79	43	p	p	NOUN
ajlm-2140	79	44	=	=	NOUN
ajlm-2140	79	45	0.02	0.02	NUM
ajlm-2140	79	46	)	)	PUNCT
ajlm-2140	79	47	.	.	PUNCT
ajlm-2140	80	1	the	the	DET
ajlm-2140	80	2	monocytosis	monocytosis	ADJ
ajlm-2140	80	3	‘	'	PUNCT
ajlm-2140	80	4	flag	flag	NOUN
ajlm-2140	80	5	’	'	PUNCT
ajlm-2140	80	6	generated	generate	VERB
ajlm-2140	80	7	by	by	ADP
ajlm-2140	80	8	the	the	DET
ajlm-2140	80	9	instrument	instrument	NOUN
ajlm-2140	80	10	demonstrated	demonstrate	VERB
ajlm-2140	80	11	a	a	DET
ajlm-2140	80	12	sensitivity	sensitivity	NOUN
ajlm-2140	80	13	of	of	ADP
ajlm-2140	80	14	84.3	84.3	NUM
ajlm-2140	80	15	%	%	NOUN
ajlm-2140	80	16	(	(	PUNCT
ajlm-2140	80	17	95	95	NUM
ajlm-2140	80	18	%	%	NOUN
ajlm-2140	80	19	ci	ci	NOUN
ajlm-2140	80	20	:	:	PUNCT
ajlm-2140	80	21	60.4	60.4	NUM
ajlm-2140	80	22	%	%	NOUN
ajlm-2140	80	23	–	–	PUNCT
ajlm-2140	80	24	96.6	96.6	NUM
ajlm-2140	80	25	%	%	NOUN
ajlm-2140	80	26	)	)	PUNCT
ajlm-2140	80	27	,	,	PUNCT
ajlm-2140	80	28	a	a	DET
ajlm-2140	80	29	specificity	specificity	NOUN
ajlm-2140	80	30	of	of	ADP
ajlm-2140	80	31	97.0	97.0	NUM
ajlm-2140	80	32	%	%	NOUN
ajlm-2140	80	33	(	(	PUNCT
ajlm-2140	80	34	95	95	NUM
ajlm-2140	80	35	%	%	NOUN
ajlm-2140	80	36	ci	ci	NOUN
ajlm-2140	80	37	:	:	PUNCT
ajlm-2140	80	38	93.9	93.9	NUM
ajlm-2140	80	39	%	%	NOUN
ajlm-2140	80	40	–	–	PUNCT
ajlm-2140	80	41	98.8	98.8	NUM
ajlm-2140	80	42	%	%	NOUN
ajlm-2140	80	43	)	)	PUNCT
ajlm-2140	80	44	,	,	PUNCT
ajlm-2140	80	45	a	a	DET
ajlm-2140	80	46	ppv	ppv	NOUN
ajlm-2140	80	47	of	of	ADP
ajlm-2140	80	48	69.6	69.6	NUM
ajlm-2140	80	49	%	%	NOUN
ajlm-2140	80	50	,	,	PUNCT
ajlm-2140	80	51	and	and	CCONJ
ajlm-2140	80	52	an	an	DET
ajlm-2140	80	53	npv	npv	NOUN
ajlm-2140	80	54	of	of	ADP
ajlm-2140	80	55	98.7	98.7	NUM
ajlm-2140	80	56	%	%	NOUN
ajlm-2140	80	57	.	.	PUNCT
ajlm-2140	81	1	seven	seven	NUM
ajlm-2140	81	2	(	(	PUNCT
ajlm-2140	81	3	2.8	2.8	NUM
ajlm-2140	81	4	%	%	NOUN
ajlm-2140	81	5	)	)	PUNCT
ajlm-2140	81	6	samples	sample	NOUN
ajlm-2140	81	7	flagged	flag	VERB
ajlm-2140	81	8	for	for	ADP
ajlm-2140	81	9	monocytosis	monocytosis	NOUN
ajlm-2140	81	10	by	by	ADP
ajlm-2140	81	11	the	the	DET
ajlm-2140	81	12	automated	automate	VERB
ajlm-2140	81	13	analyser	analyser	NOUN
ajlm-2140	81	14	were	be	AUX
ajlm-2140	81	15	determined	determine	VERB
ajlm-2140	81	16	to	to	PART
ajlm-2140	81	17	be	be	AUX
ajlm-2140	81	18	fp	fp	NOUN
ajlm-2140	81	19	for	for	ADP
ajlm-2140	81	20	monocytosis	monocytosis	NOUN
ajlm-2140	81	21	and	and	CCONJ
ajlm-2140	81	22	three	three	NUM
ajlm-2140	81	23	(	(	PUNCT
ajlm-2140	81	24	1.2	1.2	NUM
ajlm-2140	81	25	%	%	NOUN
ajlm-2140	81	26	)	)	PUNCT
ajlm-2140	82	1	samples	sample	NOUN
ajlm-2140	82	2	not	not	PART
ajlm-2140	82	3	flagged	flag	VERB
ajlm-2140	82	4	by	by	ADP
ajlm-2140	82	5	the	the	DET
ajlm-2140	82	6	analyser	analyser	NOUN
ajlm-2140	82	7	were	be	AUX
ajlm-2140	82	8	determined	determine	VERB
ajlm-2140	82	9	to	to	PART
ajlm-2140	82	10	be	be	AUX
ajlm-2140	82	11	fn	fn	ADJ
ajlm-2140	82	12	.	.	PUNCT
ajlm-2140	83	1	these	these	DET
ajlm-2140	83	2	three	three	NUM
ajlm-2140	83	3	(	(	PUNCT
ajlm-2140	83	4	1.2	1.2	NUM
ajlm-2140	83	5	%	%	NOUN
ajlm-2140	83	6	)	)	PUNCT
ajlm-2140	83	7	samples	sample	NOUN
ajlm-2140	83	8	had	have	VERB
ajlm-2140	83	9	>	>	X
ajlm-2140	83	10	20	20	NUM
ajlm-2140	83	11	%	%	NOUN
ajlm-2140	83	12	blasts	blast	VERB
ajlm-2140	83	13	on	on	ADP
ajlm-2140	83	14	manual	manual	ADJ
ajlm-2140	83	15	microscopic	microscopic	ADJ
ajlm-2140	83	16	assessment	assessment	NOUN
ajlm-2140	83	17	of	of	ADP
ajlm-2140	83	18	the	the	DET
ajlm-2140	83	19	pbs	pbs	PROPN
ajlm-2140	83	20	.	.	PUNCT
ajlm-2140	84	1	the	the	DET
ajlm-2140	84	2	‘	'	PUNCT
ajlm-2140	84	3	left	left	ADJ
ajlm-2140	84	4	shift	shift	NOUN
ajlm-2140	84	5	’	'	PUNCT
ajlm-2140	84	6	flag	flag	NOUN
ajlm-2140	84	7	generated	generate	VERB
ajlm-2140	84	8	by	by	ADP
ajlm-2140	84	9	the	the	DET
ajlm-2140	84	10	instrument	instrument	NOUN
ajlm-2140	84	11	demonstrated	demonstrate	VERB
ajlm-2140	84	12	a	a	DET
ajlm-2140	84	13	sensitivity	sensitivity	NOUN
ajlm-2140	84	14	of	of	ADP
ajlm-2140	84	15	59.7	59.7	NUM
ajlm-2140	84	16	%	%	NOUN
ajlm-2140	84	17	(	(	PUNCT
ajlm-2140	84	18	95	95	NUM
ajlm-2140	84	19	%	%	NOUN
ajlm-2140	84	20	ci	ci	NOUN
ajlm-2140	84	21	:	:	PUNCT
ajlm-2140	84	22	47.5	47.5	NUM
ajlm-2140	84	23	%	%	NOUN
ajlm-2140	84	24	–	–	PUNCT
ajlm-2140	84	25	71.1	71.1	NUM
ajlm-2140	84	26	%	%	NOUN
ajlm-2140	84	27	)	)	PUNCT
ajlm-2140	84	28	,	,	PUNCT
ajlm-2140	84	29	specificity	specificity	NOUN
ajlm-2140	84	30	of	of	ADP
ajlm-2140	84	31	95.1	95.1	NUM
ajlm-2140	84	32	%	%	NOUN
ajlm-2140	84	33	(	(	PUNCT
ajlm-2140	84	34	95	95	NUM
ajlm-2140	84	35	%	%	NOUN
ajlm-2140	84	36	ci	ci	NOUN
ajlm-2140	84	37	:	:	PUNCT
ajlm-2140	84	38	96	96	NUM
ajlm-2140	84	39	%	%	NOUN
ajlm-2140	84	40	–	–	PUNCT
ajlm-2140	84	41	99.9	99.9	NUM
ajlm-2140	84	42	%	%	NOUN
ajlm-2140	84	43	)	)	PUNCT
ajlm-2140	84	44	,	,	PUNCT
ajlm-2140	84	45	a	a	DET
ajlm-2140	84	46	ppv	ppv	NOUN
ajlm-2140	84	47	of	of	ADP
ajlm-2140	84	48	95.6	95.6	NUM
ajlm-2140	84	49	%	%	NOUN
ajlm-2140	84	50	,	,	PUNCT
ajlm-2140	84	51	and	and	CCONJ
ajlm-2140	84	52	an	an	DET
ajlm-2140	84	53	npv	npv	NOUN
ajlm-2140	84	54	of	of	ADP
ajlm-2140	84	55	85.9	85.9	NUM
ajlm-2140	84	56	%	%	NOUN
ajlm-2140	84	57	.	.	PUNCT
ajlm-2140	85	1	twenty	twenty	NUM
ajlm-2140	85	2	-	-	PUNCT
ajlm-2140	85	3	nine	nine	NUM
ajlm-2140	85	4	(	(	PUNCT
ajlm-2140	85	5	11.6	11.6	NUM
ajlm-2140	85	6	%	%	NOUN
ajlm-2140	85	7	)	)	PUNCT
ajlm-2140	85	8	samples	sample	NOUN
ajlm-2140	85	9	were	be	AUX
ajlm-2140	85	10	determined	determine	VERB
ajlm-2140	85	11	to	to	PART
ajlm-2140	85	12	be	be	AUX
ajlm-2140	85	13	fn	fn	ADJ
ajlm-2140	85	14	and	and	CCONJ
ajlm-2140	85	15	two	two	NUM
ajlm-2140	85	16	(	(	PUNCT
ajlm-2140	85	17	0.8	0.8	NUM
ajlm-2140	85	18	%	%	NOUN
ajlm-2140	85	19	)	)	PUNCT
ajlm-2140	85	20	samples	sample	NOUN
ajlm-2140	85	21	were	be	AUX
ajlm-2140	85	22	fp	fp	NOUN
ajlm-2140	85	23	.	.	PUNCT
ajlm-2140	86	1	the	the	DET
ajlm-2140	86	2	accuracy	accuracy	NOUN
ajlm-2140	86	3	of	of	ADP
ajlm-2140	86	4	this	this	DET
ajlm-2140	86	5	flag	flag	NOUN
ajlm-2140	86	6	was	be	AUX
ajlm-2140	86	7	influenced	influence	VERB
ajlm-2140	86	8	by	by	ADP
ajlm-2140	86	9	current	current	ADJ
ajlm-2140	86	10	chemotherapy	chemotherapy	NOUN
ajlm-2140	86	11	exposure	exposure	NOUN
ajlm-2140	86	12	(	(	PUNCT
ajlm-2140	86	13	p	p	NOUN
ajlm-2140	86	14	=	=	NOUN
ajlm-2140	86	15	0.005	0.005	NUM
ajlm-2140	86	16	)	)	PUNCT
ajlm-2140	86	17	.	.	PUNCT
ajlm-2140	87	1	discussion	discussion	NOUN
ajlm-2140	87	2	we	we	PRON
ajlm-2140	87	3	evaluated	evaluate	VERB
ajlm-2140	87	4	the	the	DET
ajlm-2140	87	5	performance	performance	NOUN
ajlm-2140	87	6	of	of	ADP
ajlm-2140	87	7	the	the	DET
ajlm-2140	87	8	sysmex	sysmex	NOUN
ajlm-2140	87	9	xn-3000	xn-3000	PROPN
ajlm-2140	87	10	automated	automate	VERB
ajlm-2140	87	11	analyser	analyser	NOUN
ajlm-2140	87	12	for	for	ADP
ajlm-2140	87	13	the	the	DET
ajlm-2140	87	14	detection	detection	NOUN
ajlm-2140	87	15	of	of	ADP
ajlm-2140	87	16	wbc	wbc	ADJ
ajlm-2140	87	17	abnormalities	abnormality	NOUN
ajlm-2140	87	18	in	in	ADP
ajlm-2140	87	19	250	250	NUM
ajlm-2140	87	20	routine	routine	ADJ
ajlm-2140	87	21	adult	adult	NOUN
ajlm-2140	87	22	blood	blood	NOUN
ajlm-2140	87	23	samples	sample	NOUN
ajlm-2140	87	24	at	at	ADP
ajlm-2140	87	25	the	the	DET
ajlm-2140	87	26	national	national	PROPN
ajlm-2140	87	27	health	health	PROPN
ajlm-2140	87	28	laboratory	laboratory	PROPN
ajlm-2140	87	29	services	services	PROPN
ajlm-2140	87	30	laboratory	laboratory	NOUN
ajlm-2140	87	31	at	at	ADP
ajlm-2140	87	32	inkosi	inkosi	PROPN
ajlm-2140	87	33	albert	albert	PROPN
ajlm-2140	87	34	luthuli	luthuli	PROPN
ajlm-2140	87	35	central	central	PROPN
ajlm-2140	87	36	hospital	hospital	NOUN
ajlm-2140	87	37	,	,	PUNCT
ajlm-2140	87	38	durban	durban	PROPN
ajlm-2140	87	39	,	,	PUNCT
ajlm-2140	87	40	kwazulu	kwazulu	NOUN
ajlm-2140	87	41	-	-	PUNCT
ajlm-2140	87	42	natal	natal	ADJ
ajlm-2140	87	43	,	,	PUNCT
ajlm-2140	87	44	south	south	PROPN
ajlm-2140	87	45	africa	africa	PROPN
ajlm-2140	87	46	.	.	PUNCT
ajlm-2140	88	1	the	the	DET
ajlm-2140	88	2	majority	majority	NOUN
ajlm-2140	88	3	of	of	ADP
ajlm-2140	88	4	the	the	DET
ajlm-2140	88	5	samples	sample	NOUN
ajlm-2140	88	6	were	be	AUX
ajlm-2140	88	7	from	from	ADP
ajlm-2140	88	8	patients	patient	NOUN
ajlm-2140	88	9	diagnosed	diagnose	VERB
ajlm-2140	88	10	with	with	ADP
ajlm-2140	88	11	a	a	DET
ajlm-2140	88	12	malignancy	malignancy	NOUN
ajlm-2140	88	13	and	and	CCONJ
ajlm-2140	88	14	patients	patient	NOUN
ajlm-2140	88	15	receiving	receive	VERB
ajlm-2140	88	16	chemotherapy	chemotherapy	NOUN
ajlm-2140	88	17	,	,	PUNCT
ajlm-2140	88	18	which	which	PRON
ajlm-2140	88	19	was	be	AUX
ajlm-2140	88	20	expected	expect	VERB
ajlm-2140	88	21	as	as	SCONJ
ajlm-2140	88	22	this	this	PRON
ajlm-2140	88	23	is	be	AUX
ajlm-2140	88	24	a	a	DET
ajlm-2140	88	25	tertiary	tertiary	ADJ
ajlm-2140	88	26	referral	referral	ADJ
ajlm-2140	88	27	centre	centre	NOUN
ajlm-2140	88	28	for	for	ADP
ajlm-2140	88	29	haematological	haematological	ADJ
ajlm-2140	88	30	and	and	CCONJ
ajlm-2140	88	31	oncological	oncological	ADJ
ajlm-2140	88	32	disorders	disorder	NOUN
ajlm-2140	88	33	.	.	PUNCT
ajlm-2140	89	1	congruent	congruent	ADJ
ajlm-2140	89	2	with	with	ADP
ajlm-2140	89	3	reports	report	NOUN
ajlm-2140	89	4	in	in	ADP
ajlm-2140	89	5	the	the	DET
ajlm-2140	89	6	literature	literature	NOUN
ajlm-2140	89	7	,	,	PUNCT
ajlm-2140	89	8	the	the	DET
ajlm-2140	89	9	accuracy	accuracy	NOUN
ajlm-2140	89	10	of	of	ADP
ajlm-2140	89	11	the	the	DET
ajlm-2140	89	12	‘	'	PUNCT
ajlm-2140	89	13	blast	blast	NOUN
ajlm-2140	89	14	’	'	PUNCT
ajlm-2140	89	15	,	,	PUNCT
ajlm-2140	89	16	‘	'	PUNCT
ajlm-2140	89	17	abnormal	abnormal	ADJ
ajlm-2140	89	18	lymphocytes	lymphocyte	NOUN
ajlm-2140	89	19	’	'	PUNCT
ajlm-2140	89	20	,	,	PUNCT
ajlm-2140	89	21	‘	'	PUNCT
ajlm-2140	89	22	left	left	ADJ
ajlm-2140	89	23	shift	shift	NOUN
ajlm-2140	89	24	’	'	PUNCT
ajlm-2140	89	25	and	and	CCONJ
ajlm-2140	89	26	‘	'	PUNCT
ajlm-2140	89	27	monocytosis	monocytosis	NOUN
ajlm-2140	89	28	’	'	PUNCT
ajlm-2140	89	29	automated	automate	VERB
ajlm-2140	89	30	wbc	wbc	PROPN
ajlm-2140	89	31	flags	flag	NOUN
ajlm-2140	89	32	were	be	AUX
ajlm-2140	89	33	impacted	impact	VERB
ajlm-2140	89	34	by	by	ADP
ajlm-2140	89	35	clinical	clinical	ADJ
ajlm-2140	89	36	parameters	parameter	NOUN
ajlm-2140	89	37	such	such	ADJ
ajlm-2140	89	38	as	as	ADP
ajlm-2140	89	39	current	current	ADJ
ajlm-2140	89	40	infection	infection	NOUN
ajlm-2140	89	41	,	,	PUNCT
ajlm-2140	89	42	low	low	ADJ
ajlm-2140	89	43	wcc	wcc	PROPN
ajlm-2140	89	44	(	(	PUNCT
ajlm-2140	89	45	≤	≤	NUM
ajlm-2140	89	46	1.5	1.5	NUM
ajlm-2140	89	47	×	×	NOUN
ajlm-2140	89	48	109	109	NUM
ajlm-2140	89	49	/	/	SYM
ajlm-2140	89	50	l	l	NOUN
ajlm-2140	89	51	)	)	PUNCT
ajlm-2140	89	52	,	,	PUNCT
ajlm-2140	89	53	malignancy	malignancy	NOUN
ajlm-2140	89	54	,	,	PUNCT
ajlm-2140	89	55	and	and	CCONJ
ajlm-2140	89	56	current	current	ADJ
ajlm-2140	89	57	treatment	treatment	NOUN
ajlm-2140	89	58	with	with	ADP
ajlm-2140	89	59	chemotherapy.11	chemotherapy.11	ADJ
ajlm-2140	89	60	failure	failure	NOUN
ajlm-2140	89	61	to	to	PART
ajlm-2140	89	62	identify	identify	VERB
ajlm-2140	89	63	malignant	malignant	ADJ
ajlm-2140	89	64	conditions	condition	NOUN
ajlm-2140	89	65	portends	portend	VERB
ajlm-2140	89	66	significant	significant	ADJ
ajlm-2140	89	67	clinical	clinical	ADJ
ajlm-2140	89	68	implications	implication	NOUN
ajlm-2140	89	69	and	and	CCONJ
ajlm-2140	89	70	is	be	AUX
ajlm-2140	89	71	one	one	NUM
ajlm-2140	89	72	of	of	ADP
ajlm-2140	89	73	the	the	DET
ajlm-2140	89	74	greatest	great	ADJ
ajlm-2140	89	75	concerns	concern	NOUN
ajlm-2140	89	76	for	for	ADP
ajlm-2140	89	77	laboratories	laboratory	NOUN
ajlm-2140	89	78	.	.	PUNCT
ajlm-2140	90	1	therefore	therefore	ADV
ajlm-2140	90	2	,	,	PUNCT
ajlm-2140	90	3	in	in	ADP
ajlm-2140	90	4	these	these	DET
ajlm-2140	90	5	instances	instance	NOUN
ajlm-2140	90	6	,	,	PUNCT
ajlm-2140	90	7	laboratories	laboratory	NOUN
ajlm-2140	90	8	should	should	AUX
ajlm-2140	90	9	rely	rely	VERB
ajlm-2140	90	10	on	on	ADP
ajlm-2140	90	11	the	the	DET
ajlm-2140	90	12	confirmatory	confirmatory	NOUN
ajlm-2140	90	13	result	result	NOUN
ajlm-2140	90	14	of	of	ADP
ajlm-2140	90	15	a	a	DET
ajlm-2140	90	16	detailed	detailed	ADJ
ajlm-2140	90	17	microscopic	microscopic	ADJ
ajlm-2140	90	18	assessment	assessment	NOUN
ajlm-2140	90	19	,	,	PUNCT
ajlm-2140	90	20	which	which	PRON
ajlm-2140	90	21	is	be	AUX
ajlm-2140	90	22	the	the	DET
ajlm-2140	90	23	gold	gold	NOUN
ajlm-2140	90	24	standard.12	standard.12	NOUN
ajlm-2140	90	25	there	there	PRON
ajlm-2140	90	26	was	be	VERB
ajlm-2140	90	27	an	an	DET
ajlm-2140	90	28	agreement	agreement	NOUN
ajlm-2140	90	29	between	between	ADP
ajlm-2140	90	30	the	the	DET
ajlm-2140	90	31	sysmex	sysmex	NOUN
ajlm-2140	90	32	xn-3000	xn-3000	PROPN
ajlm-2140	90	33	analyser	analyser	PROPN
ajlm-2140	90	34	and	and	CCONJ
ajlm-2140	90	35	pbs	pbs	PROPN
ajlm-2140	90	36	microscopy	microscopy	NOUN
ajlm-2140	90	37	for	for	ADP
ajlm-2140	90	38	the	the	DET
ajlm-2140	90	39	differential	differential	ADJ
ajlm-2140	90	40	counts	count	NOUN
ajlm-2140	90	41	of	of	ADP
ajlm-2140	90	42	neutrophils	neutrophil	NOUN
ajlm-2140	90	43	,	,	PUNCT
ajlm-2140	90	44	lymphocytes	lymphocyte	NOUN
ajlm-2140	90	45	,	,	PUNCT
ajlm-2140	90	46	immature	immature	ADJ
ajlm-2140	90	47	granulocytes	granulocyte	NOUN
ajlm-2140	90	48	,	,	PUNCT
ajlm-2140	90	49	and	and	CCONJ
ajlm-2140	90	50	monocytes	monocyte	VERB
ajlm-2140	90	51	(	(	PUNCT
ajlm-2140	90	52	p	p	X
ajlm-2140	90	53	<	<	X
ajlm-2140	90	54	0.001	0.001	NUM
ajlm-2140	90	55	)	)	PUNCT
ajlm-2140	90	56	.	.	PUNCT
ajlm-2140	91	1	however	however	ADV
ajlm-2140	91	2	,	,	PUNCT
ajlm-2140	91	3	there	there	PRON
ajlm-2140	91	4	was	be	VERB
ajlm-2140	91	5	no	no	DET
ajlm-2140	91	6	agreement	agreement	NOUN
ajlm-2140	91	7	between	between	ADP
ajlm-2140	91	8	the	the	DET
ajlm-2140	91	9	sysmex	sysmex	NOUN
ajlm-2140	91	10	xn-3000	xn-3000	PROPN
ajlm-2140	91	11	analyser	analyser	PROPN
ajlm-2140	91	12	and	and	CCONJ
ajlm-2140	91	13	pbs	pbs	PROPN
ajlm-2140	91	14	microscopy	microscopy	NOUN
ajlm-2140	91	15	for	for	ADP
ajlm-2140	91	16	the	the	DET
ajlm-2140	91	17	differential	differential	ADJ
ajlm-2140	91	18	count	count	NOUN
ajlm-2140	91	19	of	of	ADP
ajlm-2140	91	20	basophils	basophils	PROPN
ajlm-2140	91	21	.	.	PUNCT
ajlm-2140	92	1	the	the	DET
ajlm-2140	92	2	automated	automate	VERB
ajlm-2140	92	3	analyser	analyser	NOUN
ajlm-2140	92	4	does	do	AUX
ajlm-2140	92	5	not	not	PART
ajlm-2140	92	6	quantify	quantify	VERB
ajlm-2140	92	7	the	the	DET
ajlm-2140	92	8	presence	presence	NOUN
ajlm-2140	92	9	of	of	ADP
ajlm-2140	92	10	blasts	blast	NOUN
ajlm-2140	92	11	and	and	CCONJ
ajlm-2140	92	12	abnormal	abnormal	ADJ
ajlm-2140	92	13	or	or	CCONJ
ajlm-2140	92	14	atypical	atypical	ADJ
ajlm-2140	92	15	lymphocytes	lymphocyte	NOUN
ajlm-2140	92	16	;	;	PUNCT
ajlm-2140	92	17	it	it	PRON
ajlm-2140	92	18	only	only	ADV
ajlm-2140	92	19	provides	provide	VERB
ajlm-2140	92	20	a	a	DET
ajlm-2140	92	21	qualitative	qualitative	ADJ
ajlm-2140	92	22	assessment	assessment	NOUN
ajlm-2140	92	23	through	through	ADP
ajlm-2140	92	24	the	the	DET
ajlm-2140	92	25	presence	presence	NOUN
ajlm-2140	92	26	of	of	ADP
ajlm-2140	92	27	flags	flag	NOUN
ajlm-2140	92	28	.	.	PUNCT
ajlm-2140	93	1	therefore	therefore	ADV
ajlm-2140	93	2	,	,	PUNCT
ajlm-2140	93	3	a	a	DET
ajlm-2140	93	4	quantitative	quantitative	ADJ
ajlm-2140	93	5	agreement	agreement	NOUN
ajlm-2140	93	6	between	between	ADP
ajlm-2140	93	7	microscopy	microscopy	NOUN
ajlm-2140	93	8	and	and	CCONJ
ajlm-2140	93	9	the	the	DET
ajlm-2140	93	10	analyser	analyser	NOUN
ajlm-2140	93	11	could	could	AUX
ajlm-2140	93	12	not	not	PART
ajlm-2140	93	13	be	be	AUX
ajlm-2140	93	14	determined	determine	VERB
ajlm-2140	93	15	.	.	PUNCT
ajlm-2140	94	1	the	the	DET
ajlm-2140	94	2	‘	'	PUNCT
ajlm-2140	94	3	blast	blast	NOUN
ajlm-2140	94	4	’	'	PUNCT
ajlm-2140	94	5	flag	flag	NOUN
ajlm-2140	94	6	indicates	indicate	VERB
ajlm-2140	94	7	the	the	DET
ajlm-2140	94	8	suspected	suspect	VERB
ajlm-2140	94	9	presence	presence	NOUN
ajlm-2140	94	10	of	of	ADP
ajlm-2140	94	11	malignancy	malignancy	NOUN
ajlm-2140	94	12	(	(	PUNCT
ajlm-2140	94	13	myeloid	myeloid	NOUN
ajlm-2140	94	14	or	or	CCONJ
ajlm-2140	94	15	lymphoid).13	lymphoid).13	AUX
ajlm-2140	94	16	although	although	SCONJ
ajlm-2140	94	17	the	the	DET
ajlm-2140	94	18	wpc	wpc	NOUN
ajlm-2140	94	19	,	,	PUNCT
ajlm-2140	94	20	employed	employ	VERB
ajlm-2140	94	21	by	by	ADP
ajlm-2140	94	22	the	the	DET
ajlm-2140	94	23	xn	xn	PROPN
ajlm-2140	94	24	-	-	PUNCT
ajlm-2140	94	25	series	series	NOUN
ajlm-2140	94	26	,	,	PUNCT
ajlm-2140	94	27	has	have	AUX
ajlm-2140	94	28	improved	improve	VERB
ajlm-2140	94	29	the	the	DET
ajlm-2140	94	30	detection	detection	NOUN
ajlm-2140	94	31	of	of	ADP
ajlm-2140	94	32	blasts	blast	NOUN
ajlm-2140	94	33	,	,	PUNCT
ajlm-2140	94	34	the	the	DET
ajlm-2140	94	35	literature	literature	NOUN
ajlm-2140	94	36	demonstrates	demonstrate	VERB
ajlm-2140	94	37	a	a	DET
ajlm-2140	94	38	low	low	ADJ
ajlm-2140	94	39	specificity	specificity	NOUN
ajlm-2140	94	40	and	and	CCONJ
ajlm-2140	94	41	variable	variable	ADJ
ajlm-2140	94	42	sensitivity	sensitivity	NOUN
ajlm-2140	94	43	(	(	PUNCT
ajlm-2140	94	44	60	60	NUM
ajlm-2140	94	45	%	%	NOUN
ajlm-2140	94	46	–	–	PUNCT
ajlm-2140	94	47	100%).4	100%).4	PROPN
ajlm-2140	94	48	a	a	DET
ajlm-2140	94	49	study	study	NOUN
ajlm-2140	94	50	conducted	conduct	VERB
ajlm-2140	94	51	in	in	ADP
ajlm-2140	94	52	denmark	denmark	NOUN
ajlm-2140	94	53	in	in	ADP
ajlm-2140	94	54	2020	2020	NUM
ajlm-2140	94	55	revealed	reveal	VERB
ajlm-2140	94	56	that	that	SCONJ
ajlm-2140	94	57	the	the	DET
ajlm-2140	94	58	wpc	wpc	NOUN
ajlm-2140	94	59	produced	produce	VERB
ajlm-2140	94	60	a	a	DET
ajlm-2140	94	61	high	high	ADJ
ajlm-2140	94	62	number	number	NOUN
ajlm-2140	94	63	of	of	ADP
ajlm-2140	94	64	fp	fp	PROPN
ajlm-2140	94	65	(	(	PUNCT
ajlm-2140	94	66	14.5	14.5	NUM
ajlm-2140	94	67	%	%	NOUN
ajlm-2140	94	68	)	)	PUNCT
ajlm-2140	94	69	and	and	CCONJ
ajlm-2140	94	70	fn	fn	INTJ
ajlm-2140	94	71	(	(	PUNCT
ajlm-2140	94	72	12.8	12.8	NUM
ajlm-2140	94	73	%	%	NOUN
ajlm-2140	94	74	)	)	PUNCT
ajlm-2140	94	75	results	result	NOUN
ajlm-2140	94	76	when	when	SCONJ
ajlm-2140	94	77	detecting	detect	VERB
ajlm-2140	94	78	blasts	blast	NOUN
ajlm-2140	94	79	,	,	PUNCT
ajlm-2140	94	80	possibly	possibly	ADV
ajlm-2140	94	81	due	due	ADP
ajlm-2140	94	82	to	to	ADP
ajlm-2140	94	83	leucopenia	leucopenia	NOUN
ajlm-2140	94	84	and	and	CCONJ
ajlm-2140	94	85	a	a	DET
ajlm-2140	94	86	low	low	ADJ
ajlm-2140	94	87	number	number	NOUN
ajlm-2140	94	88	of	of	ADP
ajlm-2140	94	89	circulating	circulate	VERB
ajlm-2140	94	90	blast	blast	NOUN
ajlm-2140	94	91	cells.4	cells.4	PROPN
ajlm-2140	94	92	our	our	PRON
ajlm-2140	94	93	study	study	NOUN
ajlm-2140	94	94	demonstrated	demonstrate	VERB
ajlm-2140	94	95	a	a	DET
ajlm-2140	94	96	sensitivity	sensitivity	NOUN
ajlm-2140	94	97	of	of	ADP
ajlm-2140	94	98	96.3	96.3	NUM
ajlm-2140	94	99	%	%	NOUN
ajlm-2140	94	100	and	and	CCONJ
ajlm-2140	94	101	a	a	DET
ajlm-2140	94	102	specificity	specificity	NOUN
ajlm-2140	94	103	of	of	ADP
ajlm-2140	94	104	84.9	84.9	NUM
ajlm-2140	94	105	%	%	NOUN
ajlm-2140	94	106	for	for	ADP
ajlm-2140	94	107	the	the	DET
ajlm-2140	94	108	blast	blast	NOUN
ajlm-2140	94	109	flag	flag	NOUN
ajlm-2140	94	110	,	,	PUNCT
ajlm-2140	94	111	and	and	CCONJ
ajlm-2140	94	112	the	the	DET
ajlm-2140	94	113	blast	blast	NOUN
ajlm-2140	94	114	count	count	NOUN
ajlm-2140	94	115	ranged	range	VERB
ajlm-2140	94	116	from	from	ADP
ajlm-2140	94	117	0	0	NUM
ajlm-2140	94	118	%	%	NOUN
ajlm-2140	94	119	to	to	PART
ajlm-2140	94	120	78	78	NUM
ajlm-2140	94	121	%	%	NOUN
ajlm-2140	94	122	.	.	PUNCT
ajlm-2140	95	1	the	the	DET
ajlm-2140	95	2	sensitivity	sensitivity	NOUN
ajlm-2140	95	3	and	and	CCONJ
ajlm-2140	95	4	specificity	specificity	NOUN
ajlm-2140	95	5	of	of	ADP
ajlm-2140	95	6	the	the	DET
ajlm-2140	95	7	blast	blast	NOUN
ajlm-2140	95	8	wbc	wbc	ADJ
ajlm-2140	95	9	flag	flag	NOUN
ajlm-2140	95	10	were	be	AUX
ajlm-2140	95	11	determined	determine	VERB
ajlm-2140	95	12	to	to	PART
ajlm-2140	95	13	be	be	AUX
ajlm-2140	95	14	influenced	influence	VERB
ajlm-2140	95	15	by	by	ADP
ajlm-2140	95	16	leucopenia	leucopenia	PROPN
ajlm-2140	95	17	(	(	PUNCT
ajlm-2140	95	18	wcc	wcc	NOUN
ajlm-2140	95	19	of	of	ADP
ajlm-2140	95	20	≤	≤	NUM
ajlm-2140	95	21	1.5	1.5	NUM
ajlm-2140	95	22	×	×	NOUN
ajlm-2140	95	23	109	109	NUM
ajlm-2140	95	24	/	/	SYM
ajlm-2140	95	25	l	l	NOUN
ajlm-2140	95	26	)	)	PUNCT
ajlm-2140	95	27	.	.	PUNCT
ajlm-2140	96	1	the	the	PRON
ajlm-2140	96	2	lower	low	ADJ
ajlm-2140	96	3	the	the	DET
ajlm-2140	96	4	wcc	wcc	PROPN
ajlm-2140	96	5	,	,	PUNCT
ajlm-2140	96	6	the	the	PRON
ajlm-2140	96	7	higher	high	ADJ
ajlm-2140	96	8	the	the	DET
ajlm-2140	96	9	likelihood	likelihood	NOUN
ajlm-2140	96	10	of	of	ADP
ajlm-2140	96	11	erroneous	erroneous	ADJ
ajlm-2140	96	12	blast	blast	NOUN
ajlm-2140	96	13	detection	detection	NOUN
ajlm-2140	96	14	by	by	ADP
ajlm-2140	96	15	the	the	DET
ajlm-2140	96	16	analyser	analyser	NOUN
ajlm-2140	96	17	.	.	PUNCT
ajlm-2140	97	1	this	this	PRON
ajlm-2140	97	2	is	be	AUX
ajlm-2140	97	3	similar	similar	ADJ
ajlm-2140	97	4	to	to	ADP
ajlm-2140	97	5	a	a	DET
ajlm-2140	97	6	previous	previous	ADJ
ajlm-2140	97	7	report	report	NOUN
ajlm-2140	97	8	in	in	ADP
ajlm-2140	97	9	korea	korea	PROPN
ajlm-2140	97	10	in	in	ADP
ajlm-2140	97	11	2021	2021	NUM
ajlm-2140	97	12	where	where	SCONJ
ajlm-2140	97	13	the	the	DET
ajlm-2140	97	14	sensitivity	sensitivity	NOUN
ajlm-2140	97	15	increased	increase	VERB
ajlm-2140	97	16	as	as	SCONJ
ajlm-2140	97	17	the	the	DET
ajlm-2140	97	18	wbc	wbc	NOUN
ajlm-2140	97	19	rose	rise	VERB
ajlm-2140	97	20	to	to	ADP
ajlm-2140	97	21	>	>	X
ajlm-2140	97	22	6	6	NUM
ajlm-2140	97	23	×	×	NOUN
ajlm-2140	97	24	109	109	NUM
ajlm-2140	97	25	/	/	SYM
ajlm-2140	97	26	l.2	l.2	VERB
ajlm-2140	97	27	although	although	SCONJ
ajlm-2140	97	28	in	in	ADP
ajlm-2140	97	29	our	our	PRON
ajlm-2140	97	30	study	study	NOUN
ajlm-2140	97	31	,	,	PUNCT
ajlm-2140	97	32	the	the	DET
ajlm-2140	97	33	automated	automate	VERB
ajlm-2140	97	34	analyser	analyser	NOUN
ajlm-2140	97	35	did	do	AUX
ajlm-2140	97	36	not	not	PART
ajlm-2140	97	37	detect	detect	VERB
ajlm-2140	97	38	the	the	DET
ajlm-2140	97	39	presence	presence	NOUN
ajlm-2140	97	40	of	of	ADP
ajlm-2140	97	41	blasts	blast	NOUN
ajlm-2140	97	42	in	in	ADP
ajlm-2140	97	43	one	one	NUM
ajlm-2140	97	44	sample	sample	NOUN
ajlm-2140	97	45	(	(	PUNCT
ajlm-2140	97	46	0.4	0.4	NUM
ajlm-2140	97	47	%	%	NOUN
ajlm-2140	97	48	)	)	PUNCT
ajlm-2140	97	49	from	from	ADP
ajlm-2140	97	50	a	a	DET
ajlm-2140	97	51	patient	patient	NOUN
ajlm-2140	97	52	with	with	ADP
ajlm-2140	97	53	leucopenia	leucopenia	PROPN
ajlm-2140	97	54	(	(	PUNCT
ajlm-2140	97	55	wcc	wcc	PROPN
ajlm-2140	97	56	:	:	PUNCT
ajlm-2140	97	57	<	<	X
ajlm-2140	97	58	1.5	1.5	NUM
ajlm-2140	97	59	×	×	NOUN
ajlm-2140	97	60	109	109	NUM
ajlm-2140	97	61	/	/	SYM
ajlm-2140	97	62	l	l	NOUN
ajlm-2140	97	63	)	)	PUNCT
ajlm-2140	97	64	,	,	PUNCT
ajlm-2140	97	65	malignancy	malignancy	NOUN
ajlm-2140	97	66	and	and	CCONJ
ajlm-2140	97	67	current	current	ADJ
ajlm-2140	97	68	chemotherapy	chemotherapy	NOUN
ajlm-2140	97	69	exposure	exposure	NOUN
ajlm-2140	97	70	,	,	PUNCT
ajlm-2140	97	71	21	21	NUM
ajlm-2140	97	72	%	%	NOUN
ajlm-2140	97	73	blasts	blast	NOUN
ajlm-2140	97	74	were	be	AUX
ajlm-2140	97	75	detected	detect	VERB
ajlm-2140	97	76	by	by	ADP
ajlm-2140	97	77	microscopy	microscopy	NOUN
ajlm-2140	97	78	in	in	ADP
ajlm-2140	97	79	that	that	DET
ajlm-2140	97	80	sample	sample	NOUN
ajlm-2140	97	81	.	.	PUNCT
ajlm-2140	98	1	in	in	ADP
ajlm-2140	98	2	the	the	DET
ajlm-2140	98	3	korean	korean	ADJ
ajlm-2140	98	4	study	study	NOUN
ajlm-2140	98	5	,	,	PUNCT
ajlm-2140	98	6	the	the	DET
ajlm-2140	98	7	sensitivity	sensitivity	NOUN
ajlm-2140	98	8	of	of	ADP
ajlm-2140	98	9	the	the	DET
ajlm-2140	98	10	wpc	wpc	NOUN
ajlm-2140	98	11	in	in	ADP
ajlm-2140	98	12	detecting	detect	VERB
ajlm-2140	98	13	blasts	blast	NOUN
ajlm-2140	98	14	in	in	ADP
ajlm-2140	98	15	leucopenic	leucopenic	ADJ
ajlm-2140	98	16	samples	sample	NOUN
ajlm-2140	98	17	(	(	PUNCT
ajlm-2140	98	18	<	<	X
ajlm-2140	98	19	1.5	1.5	NUM
ajlm-2140	98	20	×	×	NOUN
ajlm-2140	98	21	109	109	NUM
ajlm-2140	98	22	/	/	SYM
ajlm-2140	98	23	l	l	NOUN
ajlm-2140	98	24	)	)	PUNCT
ajlm-2140	98	25	was	be	AUX
ajlm-2140	98	26	56%.2	56%.2	NUM
ajlm-2140	98	27	this	this	PRON
ajlm-2140	98	28	may	may	AUX
ajlm-2140	98	29	be	be	AUX
ajlm-2140	98	30	explained	explain	VERB
ajlm-2140	98	31	by	by	ADP
ajlm-2140	98	32	patients	patient	NOUN
ajlm-2140	98	33	receiving	receive	VERB
ajlm-2140	98	34	chemotherapy	chemotherapy	NOUN
ajlm-2140	98	35	or	or	CCONJ
ajlm-2140	98	36	transplantation	transplantation	NOUN
ajlm-2140	98	37	,	,	PUNCT
ajlm-2140	98	38	which	which	PRON
ajlm-2140	98	39	may	may	AUX
ajlm-2140	98	40	alter	alter	VERB
ajlm-2140	98	41	the	the	DET
ajlm-2140	98	42	side	side	NOUN
ajlm-2140	98	43	-	-	PUNCT
ajlm-2140	98	44	fluorescent	fluorescent	NOUN
ajlm-2140	98	45	light.2	light.2	NOUN
ajlm-2140	98	46	in	in	ADP
ajlm-2140	98	47	the	the	DET
ajlm-2140	98	48	case	case	NOUN
ajlm-2140	98	49	of	of	ADP
ajlm-2140	98	50	leucopenia	leucopenia	NOUN
ajlm-2140	98	51	,	,	PUNCT
ajlm-2140	98	52	blasts	blast	NOUN
ajlm-2140	98	53	may	may	AUX
ajlm-2140	98	54	be	be	AUX
ajlm-2140	98	55	further	far	ADV
ajlm-2140	98	56	missed	miss	VERB
ajlm-2140	98	57	due	due	ADP
ajlm-2140	98	58	to	to	PART
ajlm-2140	98	59	infrequency.4	infrequency.4	VERB
ajlm-2140	98	60	our	our	PRON
ajlm-2140	98	61	study	study	NOUN
ajlm-2140	98	62	demonstrated	demonstrate	VERB
ajlm-2140	98	63	that	that	SCONJ
ajlm-2140	98	64	microscopy	microscopy	NOUN
ajlm-2140	98	65	remains	remain	VERB
ajlm-2140	98	66	the	the	DET
ajlm-2140	98	67	gold	gold	ADJ
ajlm-2140	98	68	standard	standard	NOUN
ajlm-2140	98	69	in	in	ADP
ajlm-2140	98	70	the	the	DET
ajlm-2140	98	71	detection	detection	NOUN
ajlm-2140	98	72	of	of	ADP
ajlm-2140	98	73	blasts	blast	NOUN
ajlm-2140	98	74	in	in	ADP
ajlm-2140	98	75	patients	patient	NOUN
ajlm-2140	98	76	with	with	ADP
ajlm-2140	98	77	a	a	DET
ajlm-2140	98	78	low	low	ADJ
ajlm-2140	98	79	wcc	wcc	NOUN
ajlm-2140	98	80	,	,	PUNCT
ajlm-2140	98	81	patients	patient	NOUN
ajlm-2140	98	82	with	with	ADP
ajlm-2140	98	83	a	a	DET
ajlm-2140	98	84	malignancy	malignancy	NOUN
ajlm-2140	98	85	,	,	PUNCT
ajlm-2140	98	86	and	and	CCONJ
ajlm-2140	98	87	patients	patient	NOUN
ajlm-2140	98	88	receiving	receive	VERB
ajlm-2140	98	89	chemotherapy	chemotherapy	NOUN
ajlm-2140	98	90	.	.	PUNCT
ajlm-2140	99	1	the	the	DET
ajlm-2140	99	2	‘	'	PUNCT
ajlm-2140	99	3	atypical	atypical	ADJ
ajlm-2140	99	4	lymphocyte	lymphocyte	NOUN
ajlm-2140	99	5	’	'	PUNCT
ajlm-2140	99	6	flag	flag	NOUN
ajlm-2140	99	7	indicates	indicate	VERB
ajlm-2140	99	8	reactive	reactive	ADJ
ajlm-2140	99	9	disorders	disorder	NOUN
ajlm-2140	99	10	(	(	PUNCT
ajlm-2140	99	11	infections	infection	NOUN
ajlm-2140	99	12	or	or	CCONJ
ajlm-2140	99	13	inflammatory	inflammatory	ADJ
ajlm-2140	99	14	states).14	states).14	NOUN
ajlm-2140	99	15	the	the	DET
ajlm-2140	99	16	morphology	morphology	NOUN
ajlm-2140	99	17	may	may	AUX
ajlm-2140	99	18	be	be	AUX
ajlm-2140	99	19	heterogenous	heterogenous	ADJ
ajlm-2140	99	20	,	,	PUNCT
ajlm-2140	99	21	including	include	VERB
ajlm-2140	99	22	larger	large	ADJ
ajlm-2140	99	23	size	size	NOUN
ajlm-2140	99	24	,	,	PUNCT
ajlm-2140	99	25	round	round	ADJ
ajlm-2140	99	26	nucleus	nucleus	NOUN
ajlm-2140	99	27	,	,	PUNCT
ajlm-2140	99	28	larger	large	ADJ
ajlm-2140	99	29	nucleolus	nucleolus	NOUN
ajlm-2140	99	30	,	,	PUNCT
ajlm-2140	99	31	abundant	abundant	ADJ
ajlm-2140	99	32	deep	deep	ADJ
ajlm-2140	99	33	basophilic	basophilic	ADJ
ajlm-2140	99	34	cytoplasm	cytoplasm	NOUN
ajlm-2140	99	35	with	with	ADP
ajlm-2140	99	36	tenting	tenting	NOUN
ajlm-2140	99	37	,	,	PUNCT
ajlm-2140	99	38	or	or	CCONJ
ajlm-2140	99	39	the	the	DET
ajlm-2140	99	40	presence	presence	NOUN
ajlm-2140	99	41	of	of	ADP
ajlm-2140	99	42	intracytoplasmic	intracytoplasmic	ADJ
ajlm-2140	99	43	granules.15	granules.15	NOUN
ajlm-2140	99	44	according	accord	VERB
ajlm-2140	99	45	to	to	ADP
ajlm-2140	99	46	a	a	DET
ajlm-2140	99	47	local	local	ADJ
ajlm-2140	99	48	study	study	NOUN
ajlm-2140	99	49	conducted	conduct	VERB
ajlm-2140	99	50	at	at	ADP
ajlm-2140	99	51	charlotte	charlotte	PROPN
ajlm-2140	99	52	maxeke	maxeke	PROPN
ajlm-2140	99	53	johannesburg	johannesburg	PROPN
ajlm-2140	99	54	academic	academic	ADJ
ajlm-2140	99	55	hospital	hospital	PROPN
ajlm-2140	99	56	,	,	PUNCT
ajlm-2140	99	57	south	south	PROPN
ajlm-2140	99	58	africa	africa	PROPN
ajlm-2140	99	59	,	,	PUNCT
ajlm-2140	99	60	in	in	ADP
ajlm-2140	99	61	2018	2018	NUM
ajlm-2140	99	62	,	,	PUNCT
ajlm-2140	99	63	the	the	DET
ajlm-2140	99	64	‘	'	PUNCT
ajlm-2140	99	65	atypical	atypical	ADJ
ajlm-2140	99	66	lymphocyte	lymphocyte	NOUN
ajlm-2140	99	67	’	'	PUNCT
ajlm-2140	99	68	flag	flag	NOUN
ajlm-2140	99	69	was	be	AUX
ajlm-2140	99	70	associated	associate	VERB
ajlm-2140	99	71	with	with	ADP
ajlm-2140	99	72	a	a	DET
ajlm-2140	99	73	high	high	ADJ
ajlm-2140	99	74	fp	fp	NOUN
ajlm-2140	99	75	rate	rate	NOUN
ajlm-2140	99	76	of	of	ADP
ajlm-2140	99	77	41.74%.7	41.74%.7	NUM
ajlm-2140	99	78	inflammatory	inflammatory	ADJ
ajlm-2140	99	79	states	state	NOUN
ajlm-2140	99	80	such	such	ADJ
ajlm-2140	99	81	as	as	ADP
ajlm-2140	99	82	hiv	hiv	PROPN
ajlm-2140	99	83	may	may	AUX
ajlm-2140	99	84	affect	affect	VERB
ajlm-2140	99	85	the	the	DET
ajlm-2140	99	86	sensitivity	sensitivity	NOUN
ajlm-2140	99	87	of	of	ADP
ajlm-2140	99	88	the	the	DET
ajlm-2140	99	89	atypical	atypical	ADJ
ajlm-2140	99	90	lymphocyte	lymphocyte	NOUN
ajlm-2140	99	91	and	and	CCONJ
ajlm-2140	99	92	abnormal	abnormal	ADJ
ajlm-2140	99	93	lymphocyte	lymphocyte	ADJ
ajlm-2140	99	94	channel	channel	NOUN
ajlm-2140	99	95	of	of	ADP
ajlm-2140	99	96	the	the	DET
ajlm-2140	99	97	automated	automate	VERB
ajlm-2140	99	98	analyser.7	analyser.7	PROPN
ajlm-2140	99	99	this	this	PRON
ajlm-2140	99	100	,	,	PUNCT
ajlm-2140	99	101	however	however	ADV
ajlm-2140	99	102	,	,	PUNCT
ajlm-2140	99	103	was	be	AUX
ajlm-2140	99	104	not	not	PART
ajlm-2140	99	105	proven	prove	VERB
ajlm-2140	99	106	in	in	ADP
ajlm-2140	99	107	our	our	PRON
ajlm-2140	99	108	study	study	NOUN
ajlm-2140	99	109	possibly	possibly	ADV
ajlm-2140	99	110	due	due	ADP
ajlm-2140	99	111	to	to	ADP
ajlm-2140	99	112	the	the	DET
ajlm-2140	99	113	low	low	ADJ
ajlm-2140	99	114	number	number	NOUN
ajlm-2140	99	115	of	of	ADP
ajlm-2140	99	116	hiv	hiv	PROPN
ajlm-2140	99	117	-	-	PUNCT
ajlm-2140	99	118	positive	positive	ADJ
ajlm-2140	99	119	patients	patient	NOUN
ajlm-2140	99	120	in	in	ADP
ajlm-2140	99	121	the	the	DET
ajlm-2140	99	122	study	study	NOUN
ajlm-2140	99	123	(	(	PUNCT
ajlm-2140	99	124	11.2	11.2	NUM
ajlm-2140	99	125	%	%	NOUN
ajlm-2140	99	126	)	)	PUNCT
ajlm-2140	99	127	,	,	PUNCT
ajlm-2140	99	128	which	which	PRON
ajlm-2140	99	129	is	be	AUX
ajlm-2140	99	130	lower	low	ADJ
ajlm-2140	99	131	than	than	ADP
ajlm-2140	99	132	the	the	DET
ajlm-2140	99	133	27	27	NUM
ajlm-2140	99	134	%	%	NOUN
ajlm-2140	99	135	prevalence	prevalence	NOUN
ajlm-2140	99	136	of	of	ADP
ajlm-2140	99	137	hiv	hiv	PROPN
ajlm-2140	99	138	in	in	ADP
ajlm-2140	99	139	kwazulu	kwazulu	PROPN
ajlm-2140	99	140	-	-	PUNCT
ajlm-2140	99	141	natal.16	natal.16	PROPN
ajlm-2140	99	142	schapkaitz	schapkaitz	PROPN
ajlm-2140	99	143	and	and	CCONJ
ajlm-2140	99	144	khoza	khoza	PROPN
ajlm-2140	99	145	previously	previously	ADV
ajlm-2140	99	146	demonstrated	demonstrate	VERB
ajlm-2140	99	147	the	the	DET
ajlm-2140	99	148	sensitivity	sensitivity	NOUN
ajlm-2140	99	149	and	and	CCONJ
ajlm-2140	99	150	specificity	specificity	NOUN
ajlm-2140	99	151	of	of	ADP
ajlm-2140	99	152	the	the	DET
ajlm-2140	99	153	‘	'	PUNCT
ajlm-2140	99	154	atypical	atypical	ADJ
ajlm-2140	99	155	lymphocyte	lymphocyte	NOUN
ajlm-2140	99	156	’	'	PUNCT
ajlm-2140	99	157	flag	flag	NOUN
ajlm-2140	99	158	in	in	ADP
ajlm-2140	99	159	patients	patient	NOUN
ajlm-2140	99	160	with	with	ADP
ajlm-2140	99	161	hiv	hiv	PROPN
ajlm-2140	99	162	in	in	ADP
ajlm-2140	99	163	the	the	DET
ajlm-2140	99	164	south	south	ADJ
ajlm-2140	99	165	african	african	ADJ
ajlm-2140	99	166	setting	set	VERB
ajlm-2140	99	167	to	to	PART
ajlm-2140	99	168	be	be	AUX
ajlm-2140	99	169	100	100	NUM
ajlm-2140	99	170	%	%	NOUN
ajlm-2140	99	171	and	and	CCONJ
ajlm-2140	99	172	74.67%.7	74.67%.7	PRON
ajlm-2140	99	173	our	our	PRON
ajlm-2140	99	174	study	study	NOUN
ajlm-2140	99	175	revealed	reveal	VERB
ajlm-2140	99	176	the	the	DET
ajlm-2140	99	177	reverse	reverse	NOUN
ajlm-2140	99	178	:	:	PUNCT
ajlm-2140	99	179	a	a	DET
ajlm-2140	99	180	sensitivity	sensitivity	NOUN
ajlm-2140	99	181	of	of	ADP
ajlm-2140	99	182	26.1	26.1	NUM
ajlm-2140	99	183	%	%	NOUN
ajlm-2140	99	184	and	and	CCONJ
ajlm-2140	99	185	a	a	DET
ajlm-2140	99	186	specificity	specificity	NOUN
ajlm-2140	99	187	of	of	ADP
ajlm-2140	99	188	99.5	99.5	NUM
ajlm-2140	99	189	%	%	NOUN
ajlm-2140	99	190	.	.	PUNCT
ajlm-2140	100	1	our	our	PRON
ajlm-2140	100	2	study	study	NOUN
ajlm-2140	100	3	also	also	ADV
ajlm-2140	100	4	demonstrated	demonstrate	VERB
ajlm-2140	100	5	that	that	SCONJ
ajlm-2140	100	6	the	the	DET
ajlm-2140	100	7	accuracy	accuracy	NOUN
ajlm-2140	100	8	of	of	ADP
ajlm-2140	100	9	the	the	DET
ajlm-2140	100	10	atypical	atypical	ADJ
ajlm-2140	100	11	lymphocyte	lymphocyte	ADJ
ajlm-2140	100	12	flag	flag	NOUN
ajlm-2140	100	13	was	be	AUX
ajlm-2140	100	14	not	not	PART
ajlm-2140	100	15	significantly	significantly	ADV
ajlm-2140	100	16	influenced	influence	VERB
ajlm-2140	100	17	by	by	ADP
ajlm-2140	100	18	the	the	DET
ajlm-2140	100	19	clinical	clinical	ADJ
ajlm-2140	100	20	parameters	parameter	NOUN
ajlm-2140	100	21	.	.	PUNCT
ajlm-2140	101	1	‘	'	PUNCT
ajlm-2140	101	2	abnormal	abnormal	ADJ
ajlm-2140	101	3	lymphocytes	lymphocyte	NOUN
ajlm-2140	101	4	’	'	PUNCT
ajlm-2140	101	5	indicates	indicate	VERB
ajlm-2140	101	6	a	a	DET
ajlm-2140	101	7	malignant	malignant	ADJ
ajlm-2140	101	8	lymphoid	lymphoid	NOUN
ajlm-2140	101	9	process	process	NOUN
ajlm-2140	101	10	which	which	PRON
ajlm-2140	101	11	could	could	AUX
ajlm-2140	101	12	be	be	AUX
ajlm-2140	101	13	acute	acute	ADJ
ajlm-2140	101	14	,	,	PUNCT
ajlm-2140	101	15	chronic	chronic	ADJ
ajlm-2140	101	16	,	,	PUNCT
ajlm-2140	101	17	indolent	indolent	ADJ
ajlm-2140	101	18	,	,	PUNCT
ajlm-2140	101	19	or	or	CCONJ
ajlm-2140	101	20	high	high	ADJ
ajlm-2140	101	21	grade.17	grade.17	ADJ
ajlm-2140	101	22	distinguishing	distinguish	VERB
ajlm-2140	101	23	reactive	reactive	NOUN
ajlm-2140	101	24	lymphocytes	lymphocyte	VERB
ajlm-2140	101	25	secondary	secondary	ADJ
ajlm-2140	101	26	to	to	ADP
ajlm-2140	101	27	a	a	DET
ajlm-2140	101	28	viral	viral	ADJ
ajlm-2140	101	29	aetiology	aetiology	NOUN
ajlm-2140	101	30	from	from	ADP
ajlm-2140	101	31	those	those	PRON
ajlm-2140	101	32	arising	arise	VERB
ajlm-2140	101	33	from	from	ADP
ajlm-2140	101	34	a	a	DET
ajlm-2140	101	35	lymphoproliferative	lymphoproliferative	ADJ
ajlm-2140	101	36	disorder	disorder	NOUN
ajlm-2140	101	37	is	be	AUX
ajlm-2140	101	38	challenging	challenge	VERB
ajlm-2140	101	39	due	due	ADJ
ajlm-2140	101	40	to	to	ADP
ajlm-2140	101	41	morphological	morphological	ADJ
ajlm-2140	101	42	heterogeneity.7	heterogeneity.7	NOUN
ajlm-2140	101	43	according	accord	VERB
ajlm-2140	101	44	to	to	ADP
ajlm-2140	101	45	a	a	DET
ajlm-2140	101	46	local	local	ADJ
ajlm-2140	101	47	study	study	NOUN
ajlm-2140	101	48	conducted	conduct	VERB
ajlm-2140	101	49	in	in	ADP
ajlm-2140	101	50	charlotte	charlotte	PROPN
ajlm-2140	101	51	maxeke	maxeke	PROPN
ajlm-2140	101	52	johannesburg	johannesburg	PROPN
ajlm-2140	101	53	academic	academic	ADJ
ajlm-2140	101	54	hospital	hospital	PROPN
ajlm-2140	101	55	,	,	PUNCT
ajlm-2140	101	56	south	south	PROPN
ajlm-2140	101	57	africa	africa	PROPN
ajlm-2140	101	58	,	,	PUNCT
ajlm-2140	101	59	in	in	ADP
ajlm-2140	101	60	2018	2018	NUM
ajlm-2140	101	61	,	,	PUNCT
ajlm-2140	101	62	the	the	DET
ajlm-2140	101	63	fp	fp	ADJ
ajlm-2140	101	64	rate	rate	NOUN
ajlm-2140	101	65	for	for	ADP
ajlm-2140	101	66	abnormal	abnormal	ADJ
ajlm-2140	101	67	lymphocyte	lymphocyte	ADJ
ajlm-2140	101	68	flags	flag	NOUN
ajlm-2140	101	69	using	use	VERB
ajlm-2140	101	70	the	the	DET
ajlm-2140	101	71	sysmex	sysmex	NOUN
ajlm-2140	101	72	xn-9000	xn-9000	PROPN
ajlm-2140	101	73	was	be	AUX
ajlm-2140	101	74	55.56	55.56	NUM
ajlm-2140	101	75	%	%	NOUN
ajlm-2140	101	76	due	due	ADP
ajlm-2140	101	77	to	to	ADP
ajlm-2140	101	78	the	the	DET
ajlm-2140	101	79	presence	presence	NOUN
ajlm-2140	101	80	of	of	ADP
ajlm-2140	101	81	hiv	hiv	PROPN
ajlm-2140	101	82	,	,	PUNCT
ajlm-2140	101	83	opportunistic	opportunistic	ADJ
ajlm-2140	101	84	infections	infection	NOUN
ajlm-2140	101	85	,	,	PUNCT
ajlm-2140	101	86	and	and	CCONJ
ajlm-2140	101	87	lymphopenia.7	lymphopenia.7	NOUN
ajlm-2140	101	88	the	the	DET
ajlm-2140	101	89	study	study	NOUN
ajlm-2140	101	90	also	also	ADV
ajlm-2140	101	91	demonstrated	demonstrate	VERB
ajlm-2140	101	92	a	a	DET
ajlm-2140	101	93	sensitivity	sensitivity	NOUN
ajlm-2140	101	94	of	of	ADP
ajlm-2140	101	95	88.46	88.46	NUM
ajlm-2140	101	96	%	%	NOUN
ajlm-2140	101	97	and	and	CCONJ
ajlm-2140	101	98	a	a	DET
ajlm-2140	101	99	specificity	specificity	NOUN
ajlm-2140	101	100	of	of	ADP
ajlm-2140	101	101	74.6	74.6	NUM
ajlm-2140	101	102	%	%	NOUN
ajlm-2140	101	103	for	for	ADP
ajlm-2140	101	104	the	the	DET
ajlm-2140	101	105	‘	'	PUNCT
ajlm-2140	101	106	abnormal	abnormal	ADJ
ajlm-2140	101	107	lymphocyte	lymphocyte	ADJ
ajlm-2140	101	108	’	'	PUNCT
ajlm-2140	101	109	flag	flag	NOUN
ajlm-2140	101	110	.	.	PUNCT
ajlm-2140	102	1	in	in	ADP
ajlm-2140	102	2	our	our	PRON
ajlm-2140	102	3	study	study	NOUN
ajlm-2140	102	4	,	,	PUNCT
ajlm-2140	102	5	the	the	DET
ajlm-2140	102	6	fp	fp	PROPN
ajlm-2140	102	7	rate	rate	NOUN
ajlm-2140	102	8	was	be	AUX
ajlm-2140	102	9	3.2	3.2	NUM
ajlm-2140	102	10	%	%	NOUN
ajlm-2140	102	11	,	,	PUNCT
ajlm-2140	102	12	and	and	CCONJ
ajlm-2140	102	13	we	we	PRON
ajlm-2140	102	14	observed	observe	VERB
ajlm-2140	102	15	a	a	DET
ajlm-2140	102	16	higher	high	ADJ
ajlm-2140	102	17	sensitivity	sensitivity	NOUN
ajlm-2140	102	18	(	(	PUNCT
ajlm-2140	102	19	90	90	NUM
ajlm-2140	102	20	%	%	NOUN
ajlm-2140	102	21	)	)	PUNCT
ajlm-2140	102	22	and	and	CCONJ
ajlm-2140	102	23	specificity	specificity	NOUN
ajlm-2140	102	24	(	(	PUNCT
ajlm-2140	102	25	96.2	96.2	NUM
ajlm-2140	102	26	%	%	NOUN
ajlm-2140	102	27	)	)	PUNCT
ajlm-2140	102	28	.	.	PUNCT
ajlm-2140	103	1	in	in	ADP
ajlm-2140	103	2	our	our	PRON
ajlm-2140	103	3	study	study	NOUN
ajlm-2140	103	4	,	,	PUNCT
ajlm-2140	103	5	four	four	NUM
ajlm-2140	103	6	(	(	PUNCT
ajlm-2140	103	7	1.6	1.6	NUM
ajlm-2140	103	8	%	%	NOUN
ajlm-2140	103	9	)	)	PUNCT
ajlm-2140	103	10	samples	sample	NOUN
ajlm-2140	103	11	confirmed	confirm	VERB
ajlm-2140	103	12	to	to	PART
ajlm-2140	103	13	be	be	AUX
ajlm-2140	103	14	positive	positive	ADJ
ajlm-2140	103	15	for	for	ADP
ajlm-2140	103	16	abnormal	abnormal	ADJ
ajlm-2140	103	17	lymphocytes	lymphocyte	NOUN
ajlm-2140	103	18	using	use	VERB
ajlm-2140	103	19	pbs	pbs	PROPN
ajlm-2140	103	20	microscopy	microscopy	NOUN
ajlm-2140	103	21	were	be	AUX
ajlm-2140	103	22	fn	fn	ADJ
ajlm-2140	103	23	for	for	ADP
ajlm-2140	103	24	‘	'	PUNCT
ajlm-2140	103	25	abnormal	abnormal	ADJ
ajlm-2140	103	26	lymphocytes	lymphocyte	NOUN
ajlm-2140	103	27	’	'	PUNCT
ajlm-2140	103	28	on	on	ADP
ajlm-2140	103	29	the	the	DET
ajlm-2140	103	30	analyser	analyser	NOUN
ajlm-2140	103	31	.	.	PUNCT
ajlm-2140	104	1	the	the	DET
ajlm-2140	104	2	clinical	clinical	ADJ
ajlm-2140	104	3	parameters	parameter	NOUN
ajlm-2140	104	4	in	in	ADP
ajlm-2140	104	5	those	those	DET
ajlm-2140	104	6	samples	sample	NOUN
ajlm-2140	104	7	included	include	VERB
ajlm-2140	104	8	recent	recent	ADJ
ajlm-2140	104	9	chemotherapy	chemotherapy	NOUN
ajlm-2140	104	10	exposure	exposure	NOUN
ajlm-2140	104	11	,	,	PUNCT
ajlm-2140	104	12	malignancy	malignancy	NOUN
ajlm-2140	104	13	,	,	PUNCT
ajlm-2140	104	14	and	and	CCONJ
ajlm-2140	104	15	infection	infection	NOUN
ajlm-2140	104	16	;	;	PUNCT
ajlm-2140	104	17	two	two	NUM
ajlm-2140	104	18	samples	sample	NOUN
ajlm-2140	104	19	were	be	AUX
ajlm-2140	104	20	unexplained	unexplained	ADJ
ajlm-2140	104	21	.	.	PUNCT
ajlm-2140	105	1	our	our	PRON
ajlm-2140	105	2	study	study	NOUN
ajlm-2140	105	3	also	also	ADV
ajlm-2140	105	4	demonstrated	demonstrate	VERB
ajlm-2140	105	5	reduced	reduced	ADJ
ajlm-2140	105	6	reliability	reliability	NOUN
ajlm-2140	105	7	of	of	ADP
ajlm-2140	105	8	the	the	DET
ajlm-2140	105	9	‘	'	PUNCT
ajlm-2140	105	10	abnormal	abnormal	ADJ
ajlm-2140	105	11	lymphocyte	lymphocyte	ADJ
ajlm-2140	105	12	’	'	PUNCT
ajlm-2140	105	13	flag	flag	NOUN
ajlm-2140	105	14	in	in	ADP
ajlm-2140	105	15	the	the	DET
ajlm-2140	105	16	presence	presence	NOUN
ajlm-2140	105	17	of	of	ADP
ajlm-2140	105	18	chemotherapy	chemotherapy	NOUN
ajlm-2140	105	19	.	.	PUNCT
ajlm-2140	106	1	in	in	ADP
ajlm-2140	106	2	centres	centre	NOUN
ajlm-2140	106	3	treating	treat	VERB
ajlm-2140	106	4	and	and	CCONJ
ajlm-2140	106	5	monitoring	monitor	VERB
ajlm-2140	106	6	haematological	haematological	ADJ
ajlm-2140	106	7	disorders	disorder	NOUN
ajlm-2140	106	8	,	,	PUNCT
ajlm-2140	106	9	a	a	DET
ajlm-2140	106	10	high	high	ADJ
ajlm-2140	106	11	sensitivity	sensitivity	NOUN
ajlm-2140	106	12	for	for	ADP
ajlm-2140	106	13	‘	'	PUNCT
ajlm-2140	106	14	abnormal	abnormal	ADJ
ajlm-2140	106	15	lymphocytes	lymphocyte	NOUN
ajlm-2140	106	16	’	'	PUNCT
ajlm-2140	106	17	is	be	AUX
ajlm-2140	106	18	required	require	VERB
ajlm-2140	106	19	.	.	PUNCT
ajlm-2140	107	1	thus	thus	ADV
ajlm-2140	107	2	,	,	PUNCT
ajlm-2140	107	3	in	in	ADP
ajlm-2140	107	4	these	these	DET
ajlm-2140	107	5	instances	instance	NOUN
ajlm-2140	107	6	,	,	PUNCT
ajlm-2140	107	7	laboratories	laboratory	NOUN
ajlm-2140	107	8	should	should	AUX
ajlm-2140	107	9	rely	rely	VERB
ajlm-2140	107	10	on	on	ADP
ajlm-2140	107	11	the	the	DET
ajlm-2140	107	12	microscopic	microscopic	ADJ
ajlm-2140	107	13	review	review	NOUN
ajlm-2140	107	14	as	as	ADP
ajlm-2140	107	15	the	the	DET
ajlm-2140	107	16	gold	gold	NOUN
ajlm-2140	107	17	standard	standard	NOUN
ajlm-2140	107	18	.	.	PUNCT
ajlm-2140	108	1	the	the	DET
ajlm-2140	108	2	common	common	ADJ
ajlm-2140	108	3	reactive	reactive	ADJ
ajlm-2140	108	4	causes	cause	NOUN
ajlm-2140	108	5	of	of	ADP
ajlm-2140	108	6	monocytosis	monocytosis	NOUN
ajlm-2140	108	7	are	be	AUX
ajlm-2140	108	8	chronic	chronic	ADJ
ajlm-2140	108	9	infections	infection	NOUN
ajlm-2140	108	10	such	such	ADJ
ajlm-2140	108	11	as	as	ADP
ajlm-2140	108	12	tuberculosis	tuberculosis	NOUN
ajlm-2140	108	13	,	,	PUNCT
ajlm-2140	108	14	inflammatory	inflammatory	ADJ
ajlm-2140	108	15	states	state	NOUN
ajlm-2140	108	16	,	,	PUNCT
ajlm-2140	108	17	autoimmune	autoimmune	ADJ
ajlm-2140	108	18	disorders	disorder	NOUN
ajlm-2140	108	19	,	,	PUNCT
ajlm-2140	108	20	and	and	CCONJ
ajlm-2140	108	21	regenerating	regenerate	VERB
ajlm-2140	108	22	bone	bone	NOUN
ajlm-2140	108	23	marrow	marrow	NOUN
ajlm-2140	108	24	post	post	ADJ
ajlm-2140	108	25	-	-	ADJ
ajlm-2140	108	26	insult.18	insult.18	ADJ
ajlm-2140	108	27	south	south	PROPN
ajlm-2140	108	28	africa	africa	PROPN
ajlm-2140	108	29	has	have	VERB
ajlm-2140	108	30	the	the	DET
ajlm-2140	108	31	highest	high	ADJ
ajlm-2140	108	32	incidence	incidence	NOUN
ajlm-2140	108	33	of	of	ADP
ajlm-2140	108	34	tuberculosis	tuberculosis	NOUN
ajlm-2140	108	35	,	,	PUNCT
ajlm-2140	108	36	with	with	SCONJ
ajlm-2140	108	37	a	a	DET
ajlm-2140	108	38	prevalence	prevalence	NOUN
ajlm-2140	108	39	of	of	ADP
ajlm-2140	108	40	852	852	NUM
ajlm-2140	108	41	cases	case	NOUN
ajlm-2140	108	42	(	(	PUNCT
ajlm-2140	108	43	95	95	NUM
ajlm-2140	108	44	%	%	NOUN
ajlm-2140	108	45	ci	ci	NOUN
ajlm-2140	108	46	:	:	PUNCT
ajlm-2140	108	47	679–1026	679–1026	NUM
ajlm-2140	108	48	)	)	PUNCT
ajlm-2140	108	49	per	per	ADP
ajlm-2140	108	50	100	100	NUM
ajlm-2140	108	51	000	000	NUM
ajlm-2140	108	52	population.19	population.19	NOUN
ajlm-2140	108	53	three	three	NUM
ajlm-2140	108	54	(	(	PUNCT
ajlm-2140	108	55	1.2	1.2	NUM
ajlm-2140	108	56	%	%	NOUN
ajlm-2140	108	57	)	)	PUNCT
ajlm-2140	108	58	samples	sample	NOUN
ajlm-2140	108	59	flagged	flag	VERB
ajlm-2140	108	60	for	for	ADP
ajlm-2140	108	61	‘	'	PUNCT
ajlm-2140	108	62	monocytosis	monocytosis	NOUN
ajlm-2140	108	63	’	'	PUNCT
ajlm-2140	108	64	by	by	ADP
ajlm-2140	108	65	the	the	DET
ajlm-2140	108	66	analyser	analyser	NOUN
ajlm-2140	108	67	were	be	AUX
ajlm-2140	108	68	determined	determine	VERB
ajlm-2140	108	69	to	to	PART
ajlm-2140	108	70	be	be	AUX
ajlm-2140	108	71	fn	fn	ADJ
ajlm-2140	108	72	.	.	PUNCT
ajlm-2140	109	1	a	a	DET
ajlm-2140	109	2	microscopic	microscopic	ADJ
ajlm-2140	109	3	examination	examination	NOUN
ajlm-2140	109	4	of	of	ADP
ajlm-2140	109	5	the	the	DET
ajlm-2140	109	6	pbs	pbs	NOUN
ajlm-2140	109	7	in	in	ADP
ajlm-2140	109	8	these	these	DET
ajlm-2140	109	9	samples	sample	NOUN
ajlm-2140	109	10	,	,	PUNCT
ajlm-2140	109	11	however	however	ADV
ajlm-2140	109	12	,	,	PUNCT
ajlm-2140	109	13	revealed	reveal	VERB
ajlm-2140	109	14	>	>	X
ajlm-2140	109	15	20	20	NUM
ajlm-2140	109	16	%	%	NOUN
ajlm-2140	109	17	blasts	blast	VERB
ajlm-2140	109	18	in	in	ADP
ajlm-2140	109	19	these	these	DET
ajlm-2140	109	20	samples	sample	NOUN
ajlm-2140	109	21	.	.	PUNCT
ajlm-2140	110	1	this	this	PRON
ajlm-2140	110	2	is	be	AUX
ajlm-2140	110	3	clinically	clinically	ADV
ajlm-2140	110	4	relevant	relevant	ADJ
ajlm-2140	110	5	as	as	SCONJ
ajlm-2140	110	6	these	these	DET
ajlm-2140	110	7	samples	sample	NOUN
ajlm-2140	110	8	were	be	AUX
ajlm-2140	110	9	from	from	ADP
ajlm-2140	110	10	patients	patient	NOUN
ajlm-2140	110	11	with	with	ADP
ajlm-2140	110	12	malignancies	malignancy	NOUN
ajlm-2140	110	13	,	,	PUNCT
ajlm-2140	110	14	low	low	ADJ
ajlm-2140	110	15	wccs	wccs	NOUN
ajlm-2140	110	16	,	,	PUNCT
ajlm-2140	110	17	and	and	CCONJ
ajlm-2140	110	18	recent	recent	ADJ
ajlm-2140	110	19	chemotherapy	chemotherapy	NOUN
ajlm-2140	110	20	exposure	exposure	NOUN
ajlm-2140	110	21	.	.	PUNCT
ajlm-2140	111	1	adding	add	VERB
ajlm-2140	111	2	the	the	DET
ajlm-2140	111	3	‘	'	PUNCT
ajlm-2140	111	4	monocyte	monocyte	ADJ
ajlm-2140	111	5	workflow	workflow	NOUN
ajlm-2140	111	6	optimisation	optimisation	NOUN
ajlm-2140	111	7	’	'	PUNCT
ajlm-2140	111	8	rule	rule	NOUN
ajlm-2140	111	9	set	set	VERB
ajlm-2140	111	10	in	in	ADP
ajlm-2140	111	11	the	the	DET
ajlm-2140	111	12	extended	extended	ADJ
ajlm-2140	111	13	information	information	NOUN
ajlm-2140	111	14	processing	processing	NOUN
ajlm-2140	111	15	unit	unit	NOUN
ajlm-2140	111	16	of	of	ADP
ajlm-2140	111	17	the	the	DET
ajlm-2140	111	18	analyser	analyser	NOUN
ajlm-2140	111	19	adds	add	VERB
ajlm-2140	111	20	the	the	DET
ajlm-2140	111	21	function	function	NOUN
ajlm-2140	111	22	to	to	PART
ajlm-2140	111	23	distinguish	distinguish	VERB
ajlm-2140	111	24	reactive	reactive	ADJ
ajlm-2140	111	25	conditions	condition	NOUN
ajlm-2140	111	26	from	from	ADP
ajlm-2140	111	27	malignant	malignant	ADJ
ajlm-2140	111	28	monocytic	monocytic	ADJ
ajlm-2140	111	29	conditions	condition	NOUN
ajlm-2140	111	30	based	base	VERB
ajlm-2140	111	31	on	on	ADP
ajlm-2140	111	32	the	the	DET
ajlm-2140	111	33	presence	presence	NOUN
ajlm-2140	111	34	of	of	ADP
ajlm-2140	111	35	dysplasia	dysplasia	NOUN
ajlm-2140	111	36	and	and	CCONJ
ajlm-2140	111	37	persistent	persistent	ADJ
ajlm-2140	111	38	(	(	PUNCT
ajlm-2140	111	39	>	>	SYM
ajlm-2140	111	40	30	30	NUM
ajlm-2140	111	41	days	day	NOUN
ajlm-2140	111	42	)	)	PUNCT
ajlm-2140	111	43	monocytosis	monocytosis	NOUN
ajlm-2140	111	44	(	(	PUNCT
ajlm-2140	111	45	>	>	X
ajlm-2140	111	46	1.5	1.5	NUM
ajlm-2140	111	47	×	×	NOUN
ajlm-2140	111	48	109	109	NUM
ajlm-2140	111	49	/	/	SYM
ajlm-2140	111	50	l	l	NOUN
ajlm-2140	111	51	)	)	PUNCT
ajlm-2140	111	52	,	,	PUNCT
ajlm-2140	111	53	and	and	CCONJ
ajlm-2140	111	54	to	to	PART
ajlm-2140	111	55	recommend	recommend	VERB
ajlm-2140	111	56	a	a	DET
ajlm-2140	111	57	blood	blood	NOUN
ajlm-2140	111	58	smear	smear	NOUN
ajlm-2140	111	59	examination	examination	NOUN
ajlm-2140	111	60	in	in	ADP
ajlm-2140	111	61	only	only	ADJ
ajlm-2140	111	62	malignant	malignant	ADJ
ajlm-2140	111	63	monocytic	monocytic	ADJ
ajlm-2140	111	64	conditions.18	conditions.18	NOUN
ajlm-2140	111	65	furthermore	furthermore	ADV
ajlm-2140	111	66	,	,	PUNCT
ajlm-2140	111	67	the	the	DET
ajlm-2140	111	68	combination	combination	NOUN
ajlm-2140	111	69	of	of	ADP
ajlm-2140	111	70	a	a	DET
ajlm-2140	111	71	monocyte	monocyte	NOUN
ajlm-2140	111	72	count	count	NOUN
ajlm-2140	111	73	of	of	ADP
ajlm-2140	111	74	>	>	X
ajlm-2140	111	75	1.5	1.5	NUM
ajlm-2140	111	76	×	×	NOUN
ajlm-2140	111	77	109	109	NUM
ajlm-2140	111	78	/	/	SYM
ajlm-2140	111	79	l	l	NOUN
ajlm-2140	111	80	with	with	ADP
ajlm-2140	111	81	low	low	ADJ
ajlm-2140	111	82	haemoglobin	haemoglobin	NOUN
ajlm-2140	111	83	(	(	PUNCT
ajlm-2140	111	84	<	<	X
ajlm-2140	111	85	10	10	NUM
ajlm-2140	111	86	g	g	NOUN
ajlm-2140	111	87	/	/	SYM
ajlm-2140	111	88	dl	dl	NOUN
ajlm-2140	111	89	)	)	PUNCT
ajlm-2140	111	90	or	or	CCONJ
ajlm-2140	111	91	an	an	DET
ajlm-2140	111	92	abnormal	abnormal	ADJ
ajlm-2140	111	93	or	or	CCONJ
ajlm-2140	111	94	blast	blast	NOUN
ajlm-2140	111	95	flag	flag	NOUN
ajlm-2140	111	96	may	may	AUX
ajlm-2140	111	97	warrant	warrant	VERB
ajlm-2140	111	98	urgent	urgent	ADJ
ajlm-2140	111	99	pbs	pbs	PROPN
ajlm-2140	111	100	review	review	PROPN
ajlm-2140	111	101	to	to	PART
ajlm-2140	111	102	exclude	exclude	VERB
ajlm-2140	111	103	a	a	DET
ajlm-2140	111	104	malignant	malignant	ADJ
ajlm-2140	111	105	aetiology	aetiology	NOUN
ajlm-2140	111	106	.	.	PUNCT
ajlm-2140	112	1	a	a	DET
ajlm-2140	112	2	microscopic	microscopic	ADJ
ajlm-2140	112	3	review	review	NOUN
ajlm-2140	112	4	may	may	AUX
ajlm-2140	112	5	be	be	AUX
ajlm-2140	112	6	necessary	necessary	ADJ
ajlm-2140	112	7	in	in	ADP
ajlm-2140	112	8	the	the	DET
ajlm-2140	112	9	clinical	clinical	ADJ
ajlm-2140	112	10	context	context	NOUN
ajlm-2140	112	11	in	in	ADP
ajlm-2140	112	12	monocytosis	monocytosis	ADJ
ajlm-2140	112	13	cases	case	NOUN
ajlm-2140	112	14	with	with	ADP
ajlm-2140	112	15	a	a	DET
ajlm-2140	112	16	low	low	ADJ
ajlm-2140	112	17	wcc	wcc	NOUN
ajlm-2140	112	18	,	,	PUNCT
ajlm-2140	112	19	malignancy	malignancy	NOUN
ajlm-2140	112	20	,	,	PUNCT
ajlm-2140	112	21	and	and	CCONJ
ajlm-2140	112	22	chemotherapy	chemotherapy	NOUN
ajlm-2140	112	23	usage	usage	NOUN
ajlm-2140	112	24	to	to	PART
ajlm-2140	112	25	exclude	exclude	VERB
ajlm-2140	112	26	the	the	DET
ajlm-2140	112	27	presence	presence	NOUN
ajlm-2140	112	28	of	of	ADP
ajlm-2140	112	29	relapsed	relapse	VERB
ajlm-2140	112	30	or	or	CCONJ
ajlm-2140	112	31	residual	residual	ADJ
ajlm-2140	112	32	disease.18	disease.18	PROPN
ajlm-2140	112	33	overall	overall	ADJ
ajlm-2140	112	34	,	,	PUNCT
ajlm-2140	112	35	this	this	DET
ajlm-2140	112	36	study	study	NOUN
ajlm-2140	112	37	did	do	AUX
ajlm-2140	112	38	not	not	PART
ajlm-2140	112	39	show	show	VERB
ajlm-2140	112	40	a	a	DET
ajlm-2140	112	41	significant	significant	ADJ
ajlm-2140	112	42	influence	influence	NOUN
ajlm-2140	112	43	of	of	ADP
ajlm-2140	112	44	the	the	DET
ajlm-2140	112	45	presence	presence	NOUN
ajlm-2140	112	46	of	of	ADP
ajlm-2140	112	47	hiv	hiv	PROPN
ajlm-2140	112	48	,	,	PUNCT
ajlm-2140	112	49	previous	previous	ADJ
ajlm-2140	112	50	or	or	CCONJ
ajlm-2140	112	51	current	current	ADJ
ajlm-2140	112	52	coronavirus	coronavirus	NOUN
ajlm-2140	112	53	disease	disease	NOUN
ajlm-2140	112	54	2019	2019	NUM
ajlm-2140	112	55	infection	infection	NOUN
ajlm-2140	112	56	,	,	PUNCT
ajlm-2140	112	57	or	or	CCONJ
ajlm-2140	112	58	transplantation	transplantation	NOUN
ajlm-2140	112	59	(	(	PUNCT
ajlm-2140	112	60	solid	solid	ADJ
ajlm-2140	112	61	organ	organ	NOUN
ajlm-2140	112	62	or	or	CCONJ
ajlm-2140	112	63	haematopoietic	haematopoietic	ADJ
ajlm-2140	112	64	stem	stem	NOUN
ajlm-2140	112	65	cell	cell	NOUN
ajlm-2140	112	66	)	)	PUNCT
ajlm-2140	112	67	on	on	ADP
ajlm-2140	112	68	the	the	DET
ajlm-2140	112	69	sensitivity	sensitivity	NOUN
ajlm-2140	112	70	or	or	CCONJ
ajlm-2140	112	71	specificity	specificity	NOUN
ajlm-2140	112	72	of	of	ADP
ajlm-2140	112	73	the	the	DET
ajlm-2140	112	74	analyser	analyser	NOUN
ajlm-2140	112	75	,	,	PUNCT
ajlm-2140	112	76	probably	probably	ADV
ajlm-2140	112	77	due	due	ADP
ajlm-2140	112	78	to	to	ADP
ajlm-2140	112	79	the	the	DET
ajlm-2140	112	80	low	low	ADJ
ajlm-2140	112	81	study	study	NOUN
ajlm-2140	112	82	numbers	number	NOUN
ajlm-2140	112	83	.	.	PUNCT
ajlm-2140	113	1	limitations	limitation	NOUN
ajlm-2140	113	2	the	the	DET
ajlm-2140	113	3	study	study	NOUN
ajlm-2140	113	4	may	may	AUX
ajlm-2140	113	5	be	be	AUX
ajlm-2140	113	6	limited	limit	VERB
ajlm-2140	113	7	by	by	ADP
ajlm-2140	113	8	the	the	DET
ajlm-2140	113	9	subjectivity	subjectivity	NOUN
ajlm-2140	113	10	of	of	ADP
ajlm-2140	113	11	the	the	DET
ajlm-2140	113	12	primary	primary	ADJ
ajlm-2140	113	13	investigator	investigator	NOUN
ajlm-2140	113	14	.	.	PUNCT
ajlm-2140	114	1	this	this	DET
ajlm-2140	114	2	limitation	limitation	NOUN
ajlm-2140	114	3	was	be	AUX
ajlm-2140	114	4	improved	improve	VERB
ajlm-2140	114	5	by	by	ADP
ajlm-2140	114	6	adopting	adopt	VERB
ajlm-2140	114	7	the	the	DET
ajlm-2140	114	8	assessment	assessment	NOUN
ajlm-2140	114	9	of	of	ADP
ajlm-2140	114	10	a	a	DET
ajlm-2140	114	11	second	second	ADJ
ajlm-2140	114	12	observer	observer	NOUN
ajlm-2140	114	13	.	.	PUNCT
ajlm-2140	115	1	to	to	ADP
ajlm-2140	115	2	the	the	DET
ajlm-2140	115	3	best	good	ADJ
ajlm-2140	115	4	of	of	ADP
ajlm-2140	115	5	our	our	PRON
ajlm-2140	115	6	knowledge	knowledge	NOUN
ajlm-2140	115	7	,	,	PUNCT
ajlm-2140	115	8	this	this	PRON
ajlm-2140	115	9	is	be	AUX
ajlm-2140	115	10	the	the	DET
ajlm-2140	115	11	first	first	ADJ
ajlm-2140	115	12	prospective	prospective	ADJ
ajlm-2140	115	13	study	study	NOUN
ajlm-2140	115	14	of	of	ADP
ajlm-2140	115	15	this	this	DET
ajlm-2140	115	16	nature	nature	NOUN
ajlm-2140	115	17	in	in	ADP
ajlm-2140	115	18	the	the	DET
ajlm-2140	115	19	local	local	ADJ
ajlm-2140	115	20	population	population	NOUN
ajlm-2140	115	21	.	.	PUNCT
ajlm-2140	116	1	conclusion	conclusion	VERB
ajlm-2140	116	2	the	the	DET
ajlm-2140	116	3	sysmex	sysmex	NOUN
ajlm-2140	116	4	xn-3000	xn-3000	PROPN
ajlm-2140	116	5	automated	automated	PROPN
ajlm-2140	116	6	fbc	fbc	PROPN
ajlm-2140	116	7	analyser	analyser	NOUN
ajlm-2140	116	8	generates	generate	VERB
ajlm-2140	116	9	valuable	valuable	ADJ
ajlm-2140	116	10	numerical	numerical	ADJ
ajlm-2140	116	11	(	(	PUNCT
ajlm-2140	116	12	through	through	ADP
ajlm-2140	116	13	the	the	DET
ajlm-2140	116	14	white	white	ADJ
ajlm-2140	116	15	cell	cell	NOUN
ajlm-2140	116	16	differential	differential	NOUN
ajlm-2140	116	17	and	and	CCONJ
ajlm-2140	116	18	wpc	wpc	ADJ
ajlm-2140	116	19	channels	channel	NOUN
ajlm-2140	116	20	)	)	PUNCT
ajlm-2140	116	21	and	and	CCONJ
ajlm-2140	116	22	qualitative	qualitative	NOUN
ajlm-2140	116	23	(	(	PUNCT
ajlm-2140	116	24	through	through	ADP
ajlm-2140	116	25	internal	internal	ADJ
ajlm-2140	116	26	protocol	protocol	NOUN
ajlm-2140	116	27	messages	message	NOUN
ajlm-2140	116	28	or	or	CCONJ
ajlm-2140	116	29	flags	flag	NOUN
ajlm-2140	116	30	)	)	PUNCT
ajlm-2140	116	31	information	information	NOUN
ajlm-2140	116	32	that	that	PRON
ajlm-2140	116	33	may	may	AUX
ajlm-2140	116	34	assist	assist	VERB
ajlm-2140	116	35	laboratory	laboratory	NOUN
ajlm-2140	116	36	staff	staff	NOUN
ajlm-2140	116	37	in	in	ADP
ajlm-2140	116	38	accurately	accurately	ADV
ajlm-2140	116	39	assessing	assess	VERB
ajlm-2140	116	40	and	and	CCONJ
ajlm-2140	116	41	interpreting	interpret	VERB
ajlm-2140	116	42	pbs	pbs	PROPN
ajlm-2140	116	43	results	result	NOUN
ajlm-2140	116	44	and	and	CCONJ
ajlm-2140	116	45	help	help	VERB
ajlm-2140	116	46	pathologists	pathologist	NOUN
ajlm-2140	116	47	and	and	CCONJ
ajlm-2140	116	48	clinicians	clinician	NOUN
ajlm-2140	116	49	reach	reach	VERB
ajlm-2140	116	50	timeous	timeous	ADJ
ajlm-2140	116	51	and	and	CCONJ
ajlm-2140	116	52	correct	correct	VERB
ajlm-2140	116	53	diagnoses.15	diagnoses.15	NOUN
ajlm-2140	116	54	our	our	PRON
ajlm-2140	116	55	study	study	NOUN
ajlm-2140	116	56	confirmed	confirm	VERB
ajlm-2140	116	57	that	that	SCONJ
ajlm-2140	116	58	in	in	ADP
ajlm-2140	116	59	laboratories	laboratory	NOUN
ajlm-2140	116	60	focused	focus	VERB
ajlm-2140	116	61	on	on	ADP
ajlm-2140	116	62	patients	patient	NOUN
ajlm-2140	116	63	with	with	ADP
ajlm-2140	116	64	haematological	haematological	ADJ
ajlm-2140	116	65	conditions	condition	NOUN
ajlm-2140	116	66	,	,	PUNCT
ajlm-2140	116	67	low	low	ADJ
ajlm-2140	116	68	wcc	wcc	PROPN
ajlm-2140	116	69	(	(	PUNCT
ajlm-2140	116	70	<	<	X
ajlm-2140	116	71	1.5	1.5	NUM
ajlm-2140	116	72	×	×	NOUN
ajlm-2140	116	73	109	109	NUM
ajlm-2140	116	74	/	/	SYM
ajlm-2140	116	75	l	l	NOUN
ajlm-2140	116	76	)	)	PUNCT
ajlm-2140	116	77	and	and	CCONJ
ajlm-2140	116	78	undergoing	undergo	VERB
ajlm-2140	116	79	chemotherapy	chemotherapy	NOUN
ajlm-2140	116	80	or	or	CCONJ
ajlm-2140	116	81	haematopoietic	haematopoietic	ADJ
ajlm-2140	116	82	stem	stem	NOUN
ajlm-2140	116	83	cell	cell	NOUN
ajlm-2140	116	84	transplants	transplant	NOUN
ajlm-2140	116	85	,	,	PUNCT
ajlm-2140	116	86	microscopy	microscopy	NOUN
ajlm-2140	116	87	review	review	NOUN
ajlm-2140	116	88	remains	remain	VERB
ajlm-2140	116	89	the	the	DET
ajlm-2140	116	90	gold	gold	ADJ
ajlm-2140	116	91	standard	standard	NOUN
ajlm-2140	116	92	for	for	ADP
ajlm-2140	116	93	the	the	DET
ajlm-2140	116	94	detection	detection	NOUN
ajlm-2140	116	95	of	of	ADP
ajlm-2140	116	96	blasts	blast	NOUN
ajlm-2140	116	97	,	,	PUNCT
ajlm-2140	116	98	abnormal	abnormal	ADJ
ajlm-2140	116	99	lymphocytes	lymphocyte	NOUN
ajlm-2140	116	100	,	,	PUNCT
ajlm-2140	116	101	and	and	CCONJ
ajlm-2140	116	102	monocytosis	monocytosis	NOUN
ajlm-2140	116	103	.	.	PUNCT
ajlm-2140	117	1	acknowledgements	acknowledgement	VERB
ajlm-2140	117	2	the	the	DET
ajlm-2140	117	3	authors	author	NOUN
ajlm-2140	117	4	thank	thank	VERB
ajlm-2140	117	5	the	the	DET
ajlm-2140	117	6	management	management	NOUN
ajlm-2140	117	7	and	and	CCONJ
ajlm-2140	117	8	technologists	technologist	NOUN
ajlm-2140	117	9	of	of	ADP
ajlm-2140	117	10	the	the	DET
ajlm-2140	117	11	national	national	PROPN
ajlm-2140	117	12	health	health	PROPN
ajlm-2140	117	13	laboratory	laboratory	PROPN
ajlm-2140	117	14	services	service	NOUN
ajlm-2140	117	15	kwazulu	kwazulu	NOUN
ajlm-2140	117	16	-	-	NOUN
ajlm-2140	117	17	natal	natal	NOUN
ajlm-2140	117	18	as	as	ADV
ajlm-2140	117	19	well	well	ADV
ajlm-2140	117	20	as	as	ADP
ajlm-2140	117	21	the	the	DET
ajlm-2140	117	22	management	management	NOUN
ajlm-2140	117	23	of	of	ADP
ajlm-2140	117	24	inkosi	inkosi	PROPN
ajlm-2140	117	25	albert	albert	PROPN
ajlm-2140	117	26	luthuli	luthuli	PROPN
ajlm-2140	117	27	central	central	PROPN
ajlm-2140	117	28	hospital	hospital	PROPN
ajlm-2140	117	29	and	and	CCONJ
ajlm-2140	117	30	catherine	catherine	PROPN
ajlm-2140	117	31	connolly	connolly	PROPN
ajlm-2140	117	32	and	and	CCONJ
ajlm-2140	117	33	partson	partson	PROPN
ajlm-2140	117	34	tinarwo	tinarwo	PROPN
ajlm-2140	117	35	,	,	PUNCT
ajlm-2140	117	36	at	at	ADP
ajlm-2140	117	37	the	the	DET
ajlm-2140	117	38	university	university	NOUN
ajlm-2140	117	39	of	of	ADP
ajlm-2140	117	40	kwazulu	kwazulu	PROPN
ajlm-2140	117	41	-	-	PUNCT
ajlm-2140	117	42	natal	natal	ADJ
ajlm-2140	117	43	biostatistics	biostatistic	NOUN
ajlm-2140	117	44	department	department	NOUN
ajlm-2140	117	45	,	,	PUNCT
ajlm-2140	117	46	for	for	ADP
ajlm-2140	117	47	their	their	PRON
ajlm-2140	117	48	assistance	assistance	NOUN
ajlm-2140	117	49	with	with	ADP
ajlm-2140	117	50	the	the	DET
ajlm-2140	117	51	study	study	NOUN
ajlm-2140	117	52	.	.	PUNCT
ajlm-2140	118	1	competing	compete	VERB
ajlm-2140	118	2	interests	interest	NOUN
ajlm-2140	118	3	the	the	DET
ajlm-2140	118	4	authors	author	NOUN
ajlm-2140	118	5	wish	wish	VERB
ajlm-2140	118	6	to	to	PART
ajlm-2140	118	7	declare	declare	VERB
ajlm-2140	118	8	that	that	SCONJ
ajlm-2140	118	9	they	they	PRON
ajlm-2140	118	10	have	have	VERB
ajlm-2140	118	11	no	no	DET
ajlm-2140	118	12	personal	personal	ADJ
ajlm-2140	118	13	or	or	CCONJ
ajlm-2140	118	14	financial	financial	ADJ
ajlm-2140	118	15	interests	interest	NOUN
ajlm-2140	118	16	that	that	PRON
ajlm-2140	118	17	may	may	AUX
ajlm-2140	118	18	have	have	AUX
ajlm-2140	118	19	influenced	influence	VERB
ajlm-2140	118	20	the	the	DET
ajlm-2140	118	21	writing	writing	NOUN
ajlm-2140	118	22	of	of	ADP
ajlm-2140	118	23	this	this	DET
ajlm-2140	118	24	article	article	NOUN
ajlm-2140	118	25	.	.	PUNCT
ajlm-2140	119	1	authors	author	NOUN
ajlm-2140	119	2	’	'	PUNCT
ajlm-2140	119	3	contributions	contribution	NOUN
ajlm-2140	119	4	j.r	j.r	PROPN
ajlm-2140	119	5	.	.	PROPN
ajlm-2140	119	6	and	and	CCONJ
ajlm-2140	119	7	d.p	d.p	PROPN
ajlm-2140	119	8	.	.	PROPN
ajlm-2140	119	9	conceived	conceive	VERB
ajlm-2140	119	10	the	the	DET
ajlm-2140	119	11	research	research	NOUN
ajlm-2140	119	12	concepts	concept	NOUN
ajlm-2140	119	13	and	and	CCONJ
ajlm-2140	119	14	developed	develop	VERB
ajlm-2140	119	15	the	the	DET
ajlm-2140	119	16	theory	theory	NOUN
ajlm-2140	119	17	,	,	PUNCT
ajlm-2140	119	18	methodology	methodology	NOUN
ajlm-2140	119	19	,	,	PUNCT
ajlm-2140	119	20	and	and	CCONJ
ajlm-2140	119	21	protocol	protocol	NOUN
ajlm-2140	119	22	for	for	ADP
ajlm-2140	119	23	this	this	DET
ajlm-2140	119	24	study	study	NOUN
ajlm-2140	119	25	.	.	PUNCT
ajlm-2140	120	1	j.r	j.r	PROPN
ajlm-2140	120	2	.	.	PROPN
ajlm-2140	120	3	collected	collect	VERB
ajlm-2140	120	4	and	and	CCONJ
ajlm-2140	120	5	analysed	analyse	VERB
ajlm-2140	120	6	the	the	DET
ajlm-2140	120	7	data	datum	NOUN
ajlm-2140	120	8	.	.	PUNCT
ajlm-2140	121	1	n.r	n.r	PROPN
ajlm-2140	121	2	.	.	PROPN
ajlm-2140	121	3	reviewed	review	VERB
ajlm-2140	121	4	the	the	DET
ajlm-2140	121	5	work	work	NOUN
ajlm-2140	121	6	and	and	CCONJ
ajlm-2140	121	7	advised	advise	VERB
ajlm-2140	121	8	on	on	ADP
ajlm-2140	121	9	the	the	DET
ajlm-2140	121	10	study	study	NOUN
ajlm-2140	121	11	design	design	NOUN
ajlm-2140	121	12	and	and	CCONJ
ajlm-2140	121	13	implementation	implementation	NOUN
ajlm-2140	121	14	of	of	ADP
ajlm-2140	121	15	the	the	DET
ajlm-2140	121	16	research	research	NOUN
ajlm-2140	121	17	.	.	PUNCT
ajlm-2140	122	1	d.p	d.p	PROPN
ajlm-2140	122	2	.	.	PROPN
ajlm-2140	122	3	supervised	supervised	ADJ
ajlm-2140	122	4	and	and	CCONJ
ajlm-2140	122	5	n.r	n.r	PROPN
ajlm-2140	122	6	.	.	PROPN
ajlm-2140	122	7	co	co	VERB
ajlm-2140	122	8	-	-	VERB
ajlm-2140	122	9	supervised	supervise	VERB
ajlm-2140	122	10	the	the	DET
ajlm-2140	122	11	project	project	NOUN
ajlm-2140	122	12	.	.	PUNCT
ajlm-2140	123	1	all	all	DET
ajlm-2140	123	2	authors	author	NOUN
ajlm-2140	123	3	contributed	contribute	VERB
ajlm-2140	123	4	to	to	ADP
ajlm-2140	123	5	the	the	DET
ajlm-2140	123	6	analysis	analysis	NOUN
ajlm-2140	123	7	of	of	ADP
ajlm-2140	123	8	the	the	DET
ajlm-2140	123	9	results	result	NOUN
ajlm-2140	123	10	and	and	CCONJ
ajlm-2140	123	11	the	the	DET
ajlm-2140	123	12	writing	writing	NOUN
ajlm-2140	123	13	of	of	ADP
ajlm-2140	123	14	the	the	DET
ajlm-2140	123	15	final	final	ADJ
ajlm-2140	123	16	manuscript	manuscript	NOUN
ajlm-2140	123	17	.	.	PUNCT
ajlm-2140	124	1	sources	source	NOUN
ajlm-2140	124	2	of	of	ADP
ajlm-2140	124	3	support	support	NOUN
ajlm-2140	124	4	this	this	DET
ajlm-2140	124	5	research	research	NOUN
ajlm-2140	124	6	received	receive	VERB
ajlm-2140	124	7	no	no	DET
ajlm-2140	124	8	specific	specific	ADJ
ajlm-2140	124	9	grant	grant	NOUN
ajlm-2140	124	10	from	from	ADP
ajlm-2140	124	11	any	any	DET
ajlm-2140	124	12	funding	funding	NOUN
ajlm-2140	124	13	agency	agency	NOUN
ajlm-2140	124	14	in	in	ADP
ajlm-2140	124	15	the	the	DET
ajlm-2140	124	16	public	public	ADJ
ajlm-2140	124	17	,	,	PUNCT
ajlm-2140	124	18	commercial	commercial	ADJ
ajlm-2140	124	19	or	or	CCONJ
ajlm-2140	124	20	not	not	PART
ajlm-2140	124	21	-	-	PUNCT
ajlm-2140	124	22	for	for	ADP
ajlm-2140	124	23	-	-	PUNCT
ajlm-2140	124	24	profit	profit	NOUN
ajlm-2140	124	25	sectors	sector	NOUN
ajlm-2140	124	26	.	.	PUNCT
ajlm-2140	125	1	data	datum	NOUN
ajlm-2140	125	2	availability	availability	NOUN
ajlm-2140	125	3	data	datum	NOUN
ajlm-2140	125	4	supporting	support	VERB
ajlm-2140	125	5	this	this	DET
ajlm-2140	125	6	study	study	NOUN
ajlm-2140	125	7	is	be	AUX
ajlm-2140	125	8	available	available	ADJ
ajlm-2140	125	9	from	from	ADP
ajlm-2140	125	10	the	the	DET
ajlm-2140	125	11	corresponding	corresponding	ADJ
ajlm-2140	125	12	author	author	NOUN
ajlm-2140	125	13	,	,	PUNCT
ajlm-2140	125	14	j.r	j.r	PROPN
ajlm-2140	125	15	.	.	PROPN
ajlm-2140	125	16	,	,	PUNCT
ajlm-2140	125	17	on	on	ADP
ajlm-2140	125	18	request	request	NOUN
ajlm-2140	125	19	.	.	PUNCT
ajlm-2140	126	1	disclaimer	disclaimer	VERB
ajlm-2140	126	2	the	the	DET
ajlm-2140	126	3	views	view	NOUN
ajlm-2140	126	4	and	and	CCONJ
ajlm-2140	126	5	opinions	opinion	NOUN
ajlm-2140	126	6	expressed	express	VERB
ajlm-2140	126	7	in	in	ADP
ajlm-2140	126	8	this	this	DET
ajlm-2140	126	9	article	article	NOUN
ajlm-2140	126	10	are	be	AUX
ajlm-2140	126	11	those	those	PRON
ajlm-2140	126	12	of	of	ADP
ajlm-2140	126	13	the	the	DET
ajlm-2140	126	14	authors	author	NOUN
ajlm-2140	126	15	and	and	CCONJ
ajlm-2140	126	16	do	do	AUX
ajlm-2140	126	17	not	not	PART
ajlm-2140	126	18	necessarily	necessarily	ADV
ajlm-2140	126	19	reflect	reflect	VERB
ajlm-2140	126	20	the	the	DET
ajlm-2140	126	21	official	official	ADJ
ajlm-2140	126	22	policy	policy	NOUN
ajlm-2140	126	23	or	or	CCONJ
ajlm-2140	126	24	position	position	NOUN
ajlm-2140	126	25	of	of	ADP
ajlm-2140	126	26	any	any	DET
ajlm-2140	126	27	affiliated	affiliated	ADJ
ajlm-2140	126	28	agency	agency	NOUN
ajlm-2140	126	29	of	of	ADP
ajlm-2140	126	30	the	the	DET
ajlm-2140	126	31	authors	author	NOUN
ajlm-2140	126	32	.	.	PUNCT
ajlm-2140	127	1	references	reference	NOUN
ajlm-2140	127	2	joubert	joubert	PROPN
ajlm-2140	127	3	j	j	PROPN
ajlm-2140	127	4	,	,	PUNCT
ajlm-2140	127	5	weyers	weyer	NOUN
ajlm-2140	127	6	r	r	PROPN
ajlm-2140	127	7	,	,	PUNCT
ajlm-2140	127	8	raubenheimer	raubenheimer	PROPN
ajlm-2140	127	9	je	je	PROPN
ajlm-2140	127	10	.	.	PUNCT
ajlm-2140	128	1	reducing	reduce	VERB
ajlm-2140	128	2	unnecessary	unnecessary	ADJ
ajlm-2140	128	3	blood	blood	NOUN
ajlm-2140	128	4	smear	smear	NOUN
ajlm-2140	128	5	examinations	examination	NOUN
ajlm-2140	128	6	:	:	PUNCT
ajlm-2140	128	7	can	can	AUX
ajlm-2140	128	8	sysmex	sysmex	VERB
ajlm-2140	128	9	blood	blood	NOUN
ajlm-2140	128	10	cell	cell	NOUN
ajlm-2140	128	11	analysers	analyser	NOUN
ajlm-2140	128	12	help	help	VERB
ajlm-2140	128	13	?	?	PUNCT
ajlm-2140	129	1	med	med	ADJ
ajlm-2140	129	2	technol	technol	PROPN
ajlm-2140	129	3	sa	sa	PROPN
ajlm-2140	130	1	[	[	X
ajlm-2140	130	2	serial	serial	ADJ
ajlm-2140	130	3	online	online	NOUN
ajlm-2140	130	4	]	]	PUNCT
ajlm-2140	130	5	.	.	PUNCT
ajlm-2140	131	1	2014;28(1):6–12	2014;28(1):6–12	X
ajlm-2140	131	2	.	.	PUNCT
ajlm-2140	131	3	available	available	ADJ
ajlm-2140	131	4	from	from	ADP
ajlm-2140	131	5	:	:	PUNCT
ajlm-2140	131	6	https://hdl.handle.net/10520/ejc157717	https://hdl.handle.net/10520/ejc157717	PROPN
ajlm-2140	131	7	lee	lee	PROPN
ajlm-2140	131	8	n	n	PROPN
ajlm-2140	131	9	,	,	PUNCT
ajlm-2140	131	10	jun	jun	PROPN
ajlm-2140	131	11	j	j	PROPN
ajlm-2140	131	12	hyun	hyun	PROPN
ajlm-2140	131	13	,	,	PUNCT
ajlm-2140	131	14	lee	lee	PROPN
ajlm-2140	131	15	ds	ds	PROPN
ajlm-2140	131	16	.	.	PROPN
ajlm-2140	131	17	decreased	decrease	VERB
ajlm-2140	131	18	sensitivity	sensitivity	NOUN
ajlm-2140	131	19	of	of	ADP
ajlm-2140	131	20	the	the	DET
ajlm-2140	131	21	automatic	automatic	ADJ
ajlm-2140	131	22	white	white	ADJ
ajlm-2140	131	23	precursor	precursor	NOUN
ajlm-2140	131	24	cell	cell	NOUN
ajlm-2140	131	25	channel	channel	NOUN
ajlm-2140	131	26	(	(	PUNCT
ajlm-2140	131	27	wpc	wpc	NOUN
ajlm-2140	131	28	)	)	PUNCT
ajlm-2140	131	29	for	for	ADP
ajlm-2140	131	30	blast	blast	NOUN
ajlm-2140	131	31	flagging	flag	VERB
ajlm-2140	131	32	in	in	ADP
ajlm-2140	131	33	patients	patient	NOUN
ajlm-2140	131	34	with	with	ADP
ajlm-2140	131	35	leukopenia	leukopenia	PROPN
ajlm-2140	131	36	.	.	PUNCT
ajlm-2140	132	1	clin	clin	PROPN
ajlm-2140	132	2	biochem	biochem	PROPN
ajlm-2140	132	3	.	.	PUNCT
ajlm-2140	133	1	2016;49(9):675–681	2016;49(9):675–681	X
ajlm-2140	133	2	.	.	PUNCT
ajlm-2140	134	1	https://doi.org/10.1016/j.clinbiochem.2016.01.016	https://doi.org/10.1016/j.clinbiochem.2016.01.016	PROPN
ajlm-2140	134	2	briggs	briggs	PROPN
ajlm-2140	134	3	cj	cj	PROPN
ajlm-2140	134	4	,	,	PUNCT
ajlm-2140	134	5	linssen	linssen	PROPN
ajlm-2140	134	6	j	j	PROPN
ajlm-2140	134	7	,	,	PUNCT
ajlm-2140	134	8	longair	longair	PROPN
ajlm-2140	134	9	i	i	PRON
ajlm-2140	134	10	,	,	PUNCT
ajlm-2140	134	11	machin	machin	PROPN
ajlm-2140	134	12	sj	sj	PROPN
ajlm-2140	134	13	.	.	PROPN
ajlm-2140	134	14	improved	improve	VERB
ajlm-2140	134	15	flagging	flagging	ADJ
ajlm-2140	134	16	rates	rate	NOUN
ajlm-2140	134	17	on	on	ADP
ajlm-2140	134	18	the	the	DET
ajlm-2140	134	19	sysmex	sysmex	NOUN
ajlm-2140	134	20	xe-5000	xe-5000	NOUN
ajlm-2140	134	21	compared	compare	VERB
ajlm-2140	134	22	with	with	ADP
ajlm-2140	134	23	the	the	DET
ajlm-2140	134	24	xe-2100	xe-2100	PROPN
ajlm-2140	134	25	reduce	reduce	VERB
ajlm-2140	134	26	the	the	DET
ajlm-2140	134	27	number	number	NOUN
ajlm-2140	134	28	of	of	ADP
ajlm-2140	134	29	manual	manual	ADJ
ajlm-2140	134	30	film	film	NOUN
ajlm-2140	134	31	reviews	review	NOUN
ajlm-2140	134	32	and	and	CCONJ
ajlm-2140	134	33	increase	increase	VERB
ajlm-2140	134	34	laboratory	laboratory	NOUN
ajlm-2140	134	35	productivity	productivity	NOUN
ajlm-2140	134	36	.	.	PUNCT
ajlm-2140	135	1	am	be	AUX
ajlm-2140	135	2	j	j	PROPN
ajlm-2140	135	3	clin	clin	PROPN
ajlm-2140	135	4	pathol	pathol	NOUN
ajlm-2140	135	5	.	.	PUNCT
ajlm-2140	136	1	2011;136(2):309–316	2011;136(2):309–316	X
ajlm-2140	136	2	.	.	PUNCT
ajlm-2140	136	3	https://doi.org/10.1309/ajcpdlr4kgkafw4w	https://doi.org/10.1309/ajcpdlr4kgkafw4w	PROPN
ajlm-2140	136	4	sejrup	sejrup	PROPN
ajlm-2140	136	5	j	j	PROPN
ajlm-2140	136	6	,	,	PUNCT
ajlm-2140	136	7	pedersen	pedersen	PROPN
ajlm-2140	136	8	dm	dm	PROPN
ajlm-2140	136	9	,	,	PUNCT
ajlm-2140	136	10	phillipsen	phillipsen	PROPN
ajlm-2140	136	11	jp	jp	PROPN
ajlm-2140	136	12	,	,	PUNCT
ajlm-2140	136	13	et	et	PROPN
ajlm-2140	136	14	al	al	PROPN
ajlm-2140	136	15	.	.	PUNCT
ajlm-2140	136	16	performance	performance	NOUN
ajlm-2140	136	17	of	of	ADP
ajlm-2140	136	18	the	the	DET
ajlm-2140	136	19	sysmex	sysmex	NOUN
ajlm-2140	136	20	white	white	PROPN
ajlm-2140	136	21	precursor	precursor	PROPN
ajlm-2140	136	22	channel	channel	NOUN
ajlm-2140	136	23	to	to	PART
ajlm-2140	136	24	discover	discover	VERB
ajlm-2140	136	25	circulating	circulate	VERB
ajlm-2140	136	26	leukemic	leukemic	ADJ
ajlm-2140	136	27	blast	blast	NOUN
ajlm-2140	136	28	cells	cell	NOUN
ajlm-2140	136	29	.	.	PUNCT
ajlm-2140	137	1	int	int	NOUN
ajlm-2140	137	2	j	j	PROPN
ajlm-2140	137	3	lab	lab	NOUN
ajlm-2140	137	4	hematol	hematol	NOUN
ajlm-2140	137	5	.	.	PUNCT
ajlm-2140	138	1	2020;2020(1):1–10	2020;2020(1):1–10	NUM
ajlm-2140	138	2	.	.	PUNCT
ajlm-2140	139	1	https://doi.org/10.1111/ijlh.13274	https://doi.org/10.1111/ijlh.13274	NOUN
ajlm-2140	139	2	blomme	blomme	PROPN
ajlm-2140	139	3	s	s	PROPN
ajlm-2140	139	4	,	,	PUNCT
ajlm-2140	139	5	boeckx	boeckx	PROPN
ajlm-2140	139	6	n	n	CCONJ
ajlm-2140	139	7	,	,	PUNCT
ajlm-2140	139	8	brusselmans	brusselman	VERB
ajlm-2140	139	9	c	c	NOUN
ajlm-2140	139	10	,	,	PUNCT
ajlm-2140	139	11	claerhout	claerhout	NOUN
ajlm-2140	139	12	h	h	NOUN
ajlm-2140	139	13	,	,	PUNCT
ajlm-2140	139	14	van	van	PROPN
ajlm-2140	139	15	laer	laer	PROPN
ajlm-2140	139	16	c.	c.	PROPN
ajlm-2140	140	1	the	the	DET
ajlm-2140	140	2	integration	integration	NOUN
ajlm-2140	140	3	of	of	ADP
ajlm-2140	140	4	sysmex	sysmex	NOUN
ajlm-2140	140	5	xn-9100	xn-9100	NOUN
ajlm-2140	140	6	’	'	PUNCT
ajlm-2140	140	7	wpc	wpc	X
ajlm-2140	140	8	channel	channel	NOUN
ajlm-2140	140	9	reflex	reflex	NOUN
ajlm-2140	140	10	testing	testing	NOUN
ajlm-2140	140	11	in	in	ADP
ajlm-2140	140	12	the	the	DET
ajlm-2140	140	13	detection	detection	NOUN
ajlm-2140	140	14	of	of	ADP
ajlm-2140	140	15	reactive	reactive	ADJ
ajlm-2140	140	16	versus	versus	ADP
ajlm-2140	140	17	malignant	malignant	ADJ
ajlm-2140	140	18	blood	blood	NOUN
ajlm-2140	140	19	samples	sample	NOUN
ajlm-2140	140	20	.	.	PUNCT
ajlm-2140	141	1	int	int	NOUN
ajlm-2140	141	2	j	j	PROPN
ajlm-2140	141	3	lab	lab	PROPN
ajlm-2140	141	4	hematol	hematol	NOUN
ajlm-2140	141	5	2020;43(2):191–198	2020;43(2):191–198	NUM
ajlm-2140	141	6	.	.	PUNCT
ajlm-2140	142	1	https://doi.org/10.1111/ijlh.13352	https://doi.org/10.1111/ijlh.13352	NOUN
ajlm-2140	142	2	mbongwa	mbongwa	NOUN
ajlm-2140	142	3	,	,	PUNCT
ajlm-2140	142	4	nompumelelo	nompumelelo	ADV
ajlm-2140	142	5	dys	dys	NOUN
ajlm-2140	142	6	.	.	PUNCT
ajlm-2140	143	1	haematology	haematology	NOUN
ajlm-2140	143	2	sysmex	sysmex	NOUN
ajlm-2140	143	3	xn3000	xn3000	PROPN
ajlm-2140	143	4	analyzer	analyzer	PROPN
ajlm-2140	143	5	and	and	CCONJ
ajlm-2140	143	6	workflow	workflow	NOUN
ajlm-2140	143	7	(	(	PUNCT
ajlm-2140	143	8	hae1798	hae1798	NOUN
ajlm-2140	143	9	)	)	PUNCT
ajlm-2140	143	10	.	.	PUNCT
ajlm-2140	144	1	durban	durban	PROPN
ajlm-2140	144	2	:	:	PUNCT
ajlm-2140	144	3	nompumelelo	nompumelelo	NOUN
ajlm-2140	144	4	,	,	PUNCT
ajlm-2140	144	5	mbongwa	mbongwa	NOUN
ajlm-2140	144	6	;	;	PUNCT
ajlm-2140	144	7	2019	2019	NUM
ajlm-2140	144	8	.	.	PUNCT
ajlm-2140	145	1	schapkaitz	schapkaitz	PROPN
ajlm-2140	145	2	e	e	PROPN
ajlm-2140	145	3	,	,	PUNCT
ajlm-2140	145	4	khoza	khoza	PROPN
ajlm-2140	145	5	p.	p.	NOUN
ajlm-2140	145	6	performance	performance	NOUN
ajlm-2140	145	7	evaluation	evaluation	NOUN
ajlm-2140	145	8	of	of	ADP
ajlm-2140	145	9	the	the	DET
ajlm-2140	145	10	white	white	ADJ
ajlm-2140	145	11	cell	cell	NOUN
ajlm-2140	145	12	precursor	precursor	NOUN
ajlm-2140	145	13	channel	channel	NOUN
ajlm-2140	145	14	on	on	ADP
ajlm-2140	145	15	the	the	DET
ajlm-2140	145	16	sysmex	sysmex	NOUN
ajlm-2140	145	17	xn	xn	PROPN
ajlm-2140	145	18	hematology	hematology	NOUN
ajlm-2140	145	19	analyzer	analyzer	NOUN
ajlm-2140	145	20	in	in	ADP
ajlm-2140	145	21	hiv	hiv	PROPN
ajlm-2140	145	22	specimens	specimens	PROPN
ajlm-2140	145	23	.	.	PUNCT
ajlm-2140	146	1	j	j	PROPN
ajlm-2140	146	2	clin	clin	PROPN
ajlm-2140	146	3	lab	lab	PROPN
ajlm-2140	146	4	anal	anal	PROPN
ajlm-2140	146	5	.	.	PUNCT
ajlm-2140	147	1	2018;32(4):1–5	2018;32(4):1–5	PROPN
ajlm-2140	147	2	.	.	PUNCT
ajlm-2140	148	1	https://doi.org/10.1002/jcla.22335	https://doi.org/10.1002/jcla.22335	PROPN
ajlm-2140	149	1	kim	kim	PROPN
ajlm-2140	149	2	h	h	PROPN
ajlm-2140	149	3	,	,	PUNCT
ajlm-2140	149	4	hur	hur	PROPN
ajlm-2140	149	5	m	m	PROPN
ajlm-2140	149	6	,	,	PUNCT
ajlm-2140	149	7	choi	choi	PROPN
ajlm-2140	149	8	sg	sg	PROPN
ajlm-2140	149	9	,	,	PUNCT
ajlm-2140	149	10	oh	oh	INTJ
ajlm-2140	149	11	km	km	NOUN
ajlm-2140	149	12	,	,	PUNCT
ajlm-2140	149	13	moon	moon	PROPN
ajlm-2140	149	14	hw	hw	PROPN
ajlm-2140	149	15	,	,	PUNCT
ajlm-2140	149	16	yun	yun	PROPN
ajlm-2140	149	17	ym	ym	PROPN
ajlm-2140	149	18	.	.	PUNCT
ajlm-2140	150	1	comparison	comparison	NOUN
ajlm-2140	150	2	of	of	ADP
ajlm-2140	150	3	white	white	ADJ
ajlm-2140	150	4	blood	blood	NOUN
ajlm-2140	150	5	cell	cell	NOUN
ajlm-2140	150	6	counts	count	NOUN
ajlm-2140	150	7	by	by	ADP
ajlm-2140	150	8	wnr	wnr	PROPN
ajlm-2140	150	9	,	,	PUNCT
ajlm-2140	150	10	wdf	wdf	PROPN
ajlm-2140	150	11	,	,	PUNCT
ajlm-2140	150	12	and	and	CCONJ
ajlm-2140	150	13	wpc	wpc	ADJ
ajlm-2140	150	14	channels	channel	NOUN
ajlm-2140	150	15	in	in	ADP
ajlm-2140	150	16	sysmex	sysmex	NOUN
ajlm-2140	150	17	xn	xn	PROPN
ajlm-2140	150	18	hematology	hematology	PROPN
ajlm-2140	150	19	analyzer	analyzer	NOUN
ajlm-2140	150	20	.	.	PUNCT
ajlm-2140	151	1	int	int	PROPN
ajlm-2140	151	2	j	j	PROPN
ajlm-2140	151	3	lab	lab	NOUN
ajlm-2140	151	4	hematol	hematol	NOUN
ajlm-2140	151	5	.	.	PUNCT
ajlm-2140	152	1	2015;37(6):869–875	2015;37(6):869–875	NUM
ajlm-2140	152	2	.	.	PUNCT
ajlm-2140	152	3	https://doi.org/10.1111/ijlh.12421	https://doi.org/10.1111/ijlh.12421	VERB
ajlm-2140	152	4	clinical	clinical	ADJ
ajlm-2140	152	5	and	and	CCONJ
ajlm-2140	152	6	laboratory	laboratory	NOUN
ajlm-2140	152	7	standards	standard	NOUN
ajlm-2140	152	8	institute	institute	PROPN
ajlm-2140	152	9	(	(	PUNCT
ajlm-2140	152	10	clsi	clsi	PROPN
ajlm-2140	152	11	)	)	PUNCT
ajlm-2140	152	12	.	.	PUNCT
ajlm-2140	153	1	reference	reference	NOUN
ajlm-2140	153	2	leukocyte	leukocyte	NOUN
ajlm-2140	153	3	(	(	PUNCT
ajlm-2140	153	4	wbc	wbc	PROPN
ajlm-2140	153	5	)	)	PUNCT
ajlm-2140	153	6	differential	differential	NOUN
ajlm-2140	153	7	count	count	NOUN
ajlm-2140	153	8	(	(	PUNCT
ajlm-2140	153	9	proportional	proportional	ADJ
ajlm-2140	153	10	)	)	PUNCT
ajlm-2140	153	11	and	and	CCONJ
ajlm-2140	153	12	evaluation	evaluation	NOUN
ajlm-2140	153	13	of	of	ADP
ajlm-2140	153	14	instrmental	instrmental	ADJ
ajlm-2140	153	15	methods	method	NOUN
ajlm-2140	153	16	;	;	PUNCT
ajlm-2140	153	17	approved	approve	VERB
ajlm-2140	153	18	standard	standard	ADJ
ajlm-2140	153	19	-	-	PUNCT
ajlm-2140	153	20	second	second	NOUN
ajlm-2140	153	21	edition	edition	NOUN
ajlm-2140	154	1	[	[	X
ajlm-2140	154	2	homepage	homepage	NOUN
ajlm-2140	154	3	on	on	ADP
ajlm-2140	154	4	the	the	DET
ajlm-2140	154	5	internet	internet	NOUN
ajlm-2140	154	6	]	]	PUNCT
ajlm-2140	154	7	.	.	PUNCT
ajlm-2140	155	1	clsi	clsi	PROPN
ajlm-2140	155	2	document	document	NOUN
ajlm-2140	155	3	h20	h20	NOUN
ajlm-2140	155	4	-	-	PUNCT
ajlm-2140	155	5	a2	a2	PROPN
ajlm-2140	155	6	.	.	PUNCT
ajlm-2140	155	7	2007	2007	NUM
ajlm-2140	155	8	.	.	PUNCT
ajlm-2140	156	1	available	available	ADJ
ajlm-2140	156	2	from	from	ADP
ajlm-2140	156	3	:	:	PUNCT
ajlm-2140	156	4	https://clsi.org/media/1400/h20a2_sample.pdf	https://clsi.org/media/1400/h20a2_sample.pdf	PROPN
ajlm-2140	156	5	bennett	bennett	PROPN
ajlm-2140	156	6	je	je	PROPN
ajlm-2140	156	7	,	,	PUNCT
ajlm-2140	156	8	dolin	dolin	PROPN
ajlm-2140	156	9	r	r	PROPN
ajlm-2140	156	10	,	,	PUNCT
ajlm-2140	156	11	blaser	blaser	PROPN
ajlm-2140	156	12	mj	mj	PROPN
ajlm-2140	156	13	.	.	PUNCT
ajlm-2140	156	14	infectious	infectious	ADJ
ajlm-2140	156	15	disease	disease	NOUN
ajlm-2140	156	16	essentials	essential	NOUN
ajlm-2140	156	17	.	.	PUNCT
ajlm-2140	157	1	amsterdam	amsterdam	PROPN
ajlm-2140	157	2	:	:	PUNCT
ajlm-2140	157	3	elsevier	elsevier	NOUN
ajlm-2140	157	4	;	;	PUNCT
ajlm-2140	157	5	2015:138–149	2015:138–149	NUM
ajlm-2140	157	6	.	.	PUNCT
ajlm-2140	158	1	petrone	petrone	PROPN
ajlm-2140	158	2	j	j	PROPN
ajlm-2140	158	3	,	,	PUNCT
ajlm-2140	158	4	frater	frater	PROPN
ajlm-2140	158	5	j.	j.	PROPN
ajlm-2140	158	6	blast	blast	PROPN
ajlm-2140	158	7	flagging	flagging	NOUN
ajlm-2140	158	8	of	of	ADP
ajlm-2140	158	9	the	the	DET
ajlm-2140	158	10	sysmex	sysmex	NOUN
ajlm-2140	158	11	xn-10	xn-10	PRON
ajlm-2140	158	12	hematology	hematology	NOUN
ajlm-2140	158	13	analyzer	analyzer	NOUN
ajlm-2140	158	14	with	with	ADP
ajlm-2140	158	15	supervised	supervised	ADJ
ajlm-2140	158	16	cell	cell	NOUN
ajlm-2140	158	17	image	image	NOUN
ajlm-2140	158	18	analysis	analysis	NOUN
ajlm-2140	158	19	:	:	PUNCT
ajlm-2140	158	20	impact	impact	NOUN
ajlm-2140	158	21	on	on	ADP
ajlm-2140	158	22	quantity	quantity	NOUN
ajlm-2140	158	23	parameters	parameter	NOUN
ajlm-2140	158	24	.	.	PUNCT
ajlm-2140	159	1	int	int	NOUN
ajlm-2140	159	2	j	j	PROPN
ajlm-2140	159	3	lab	lab	NOUN
ajlm-2140	159	4	hematol	hematol	NOUN
ajlm-2140	159	5	.	.	PUNCT
ajlm-2140	160	1	2019;41(5):601–606	2019;41(5):601–606	NUM
ajlm-2140	160	2	.	.	PUNCT
ajlm-2140	160	3	https://doi.org/10.1111/ijlh.13069	https://doi.org/10.1111/ijlh.13069	ADP
ajlm-2140	160	4	white	white	ADJ
ajlm-2140	160	5	blood	blood	NOUN
ajlm-2140	160	6	cell	cell	NOUN
ajlm-2140	160	7	functionality	functionality	NOUN
ajlm-2140	161	1	[	[	X
ajlm-2140	161	2	homepage	homepage	NOUN
ajlm-2140	161	3	on	on	ADP
ajlm-2140	161	4	the	the	DET
ajlm-2140	161	5	internet	internet	NOUN
ajlm-2140	161	6	]	]	PUNCT
ajlm-2140	161	7	.	.	PUNCT
ajlm-2140	162	1	whitepaper	whitepaper	NOUN
ajlm-2140	162	2	.	.	PUNCT
ajlm-2140	163	1	2017	2017	NUM
ajlm-2140	163	2	.	.	PUNCT
ajlm-2140	164	1	pp	pp	ADV
ajlm-2140	164	2	.	.	PUNCT
ajlm-2140	165	1	1–7	1–7	X
ajlm-2140	165	2	.	.	PUNCT
ajlm-2140	165	3	available	available	ADJ
ajlm-2140	165	4	from	from	ADP
ajlm-2140	165	5	:	:	PUNCT
ajlm-2140	165	6	www.sysmex-europe.com/whitepapers	www.sysmex-europe.com/whitepapers	PROPN
ajlm-2140	165	7	sukhacheva	sukhacheva	VERB
ajlm-2140	165	8	e.	e.	PROPN
ajlm-2140	165	9	comments	comments	PROPN
ajlm-2140	165	10	re	re	ADP
ajlm-2140	165	11	article	article	NOUN
ajlm-2140	165	12	on	on	ADP
ajlm-2140	165	13	comparison	comparison	NOUN
ajlm-2140	165	14	of	of	ADP
ajlm-2140	165	15	performance	performance	NOUN
ajlm-2140	165	16	and	and	CCONJ
ajlm-2140	165	17	abnormal	abnormal	ADJ
ajlm-2140	165	18	cell	cell	NOUN
ajlm-2140	165	19	flagging	flagging	NOUN
ajlm-2140	165	20	of	of	ADP
ajlm-2140	165	21	two	two	NUM
ajlm-2140	165	22	automated	automate	VERB
ajlm-2140	165	23	hematology	hematology	NOUN
ajlm-2140	165	24	analyzers	analyzer	NOUN
ajlm-2140	165	25	:	:	PUNCT
ajlm-2140	165	26	sysmex	sysmex	NOUN
ajlm-2140	165	27	xn	xn	PROPN
ajlm-2140	165	28	3000	3000	NUM
ajlm-2140	165	29	and	and	CCONJ
ajlm-2140	165	30	beckman	beckman	PROPN
ajlm-2140	165	31	coulter	coulter	PROPN
ajlm-2140	165	32	dxh	dxh	VERB
ajlm-2140	165	33	800	800	NUM
ajlm-2140	165	34	.	.	PUNCT
ajlm-2140	166	1	int	int	PROPN
ajlm-2140	166	2	j	j	PROPN
ajlm-2140	166	3	lab	lab	NOUN
ajlm-2140	166	4	hematol	hematol	NOUN
ajlm-2140	166	5	.	.	PUNCT
ajlm-2140	167	1	2020;42(3):e96	2020;42(3):e96	NUM
ajlm-2140	167	2	–	–	PUNCT
ajlm-2140	167	3	e97	e97	NUM
ajlm-2140	167	4	.	.	PUNCT
ajlm-2140	168	1	https://doi.org/10.1111/ijlh.13132	https://doi.org/10.1111/ijlh.13132	PROPN
ajlm-2140	168	2	weinberg	weinberg	PROPN
ajlm-2140	168	3	se	se	PROPN
ajlm-2140	168	4	,	,	PUNCT
ajlm-2140	168	5	behdad	behdad	PROPN
ajlm-2140	168	6	a	a	DET
ajlm-2140	168	7	,	,	PUNCT
ajlm-2140	168	8	ji	ji	PROPN
ajlm-2140	168	9	p.	p.	NOUN
ajlm-2140	168	10	atypical	atypical	ADJ
ajlm-2140	168	11	lymphocytes	lymphocyte	NOUN
ajlm-2140	168	12	in	in	ADP
ajlm-2140	168	13	peripheral	peripheral	ADJ
ajlm-2140	168	14	blood	blood	NOUN
ajlm-2140	168	15	of	of	ADP
ajlm-2140	168	16	patients	patient	NOUN
ajlm-2140	168	17	with	with	ADP
ajlm-2140	168	18	covid-19	covid-19	PROPN
ajlm-2140	168	19	.	.	PUNCT
ajlm-2140	169	1	br	br	PROPN
ajlm-2140	169	2	j	j	PROPN
ajlm-2140	169	3	haematol	haematol	NOUN
ajlm-2140	169	4	.	.	PUNCT
ajlm-2140	170	1	2020;190(1):36–39	2020;190(1):36–39	X
ajlm-2140	170	2	.	.	PUNCT
ajlm-2140	171	1	https://doi.org/10.1111/bjh.16848	https://doi.org/10.1111/bjh.16848	NOUN
ajlm-2140	171	2	enhancement	enhancement	NOUN
ajlm-2140	171	3	se	se	X
ajlm-2140	171	4	.	.	PUNCT
ajlm-2140	171	5	seed	seed	NOUN
ajlm-2140	171	6	haematology	haematology	NOUN
ajlm-2140	171	7	.	.	PUNCT
ajlm-2140	172	1	syxmex	syxmex	NOUN
ajlm-2140	172	2	.	.	PUNCT
ajlm-2140	173	1	2012;(march):3–6	2012;(march):3–6	NOUN
ajlm-2140	173	2	.	.	PUNCT
ajlm-2140	174	1	vandormael	vandormael	PROPN
ajlm-2140	174	2	a	a	PROPN
ajlm-2140	174	3	,	,	PUNCT
ajlm-2140	174	4	cuadros	cuadros	PROPN
ajlm-2140	174	5	d	d	PROPN
ajlm-2140	174	6	,	,	PUNCT
ajlm-2140	174	7	kim	kim	PROPN
ajlm-2140	174	8	hy	hy	PROPN
ajlm-2140	174	9	,	,	PUNCT
ajlm-2140	174	10	bärnighausen	bärnighausen	PROPN
ajlm-2140	174	11	t	t	PROPN
ajlm-2140	174	12	,	,	PUNCT
ajlm-2140	174	13	tanser	tanser	NOUN
ajlm-2140	174	14	f.	f.	PROPN
ajlm-2140	175	1	the	the	DET
ajlm-2140	175	2	state	state	NOUN
ajlm-2140	175	3	of	of	ADP
ajlm-2140	175	4	the	the	DET
ajlm-2140	175	5	hiv	hiv	PROPN
ajlm-2140	175	6	epidemic	epidemic	NOUN
ajlm-2140	175	7	in	in	ADP
ajlm-2140	175	8	rural	rural	ADJ
ajlm-2140	175	9	kwazulu	kwazulu	NOUN
ajlm-2140	175	10	-	-	PUNCT
ajlm-2140	175	11	natal	natal	ADJ
ajlm-2140	175	12	,	,	PUNCT
ajlm-2140	175	13	south	south	PROPN
ajlm-2140	175	14	africa	africa	PROPN
ajlm-2140	175	15	:	:	PUNCT
ajlm-2140	175	16	a	a	DET
ajlm-2140	175	17	novel	novel	ADJ
ajlm-2140	175	18	application	application	NOUN
ajlm-2140	175	19	of	of	ADP
ajlm-2140	175	20	disease	disease	NOUN
ajlm-2140	175	21	metrics	metric	NOUN
ajlm-2140	175	22	to	to	PART
ajlm-2140	175	23	assess	assess	VERB
ajlm-2140	175	24	trajectories	trajectory	NOUN
ajlm-2140	175	25	and	and	CCONJ
ajlm-2140	175	26	highlight	highlight	VERB
ajlm-2140	175	27	areas	area	NOUN
ajlm-2140	175	28	for	for	ADP
ajlm-2140	175	29	intervention	intervention	NOUN
ajlm-2140	175	30	.	.	PUNCT
ajlm-2140	176	1	int	int	PROPN
ajlm-2140	176	2	j	j	PROPN
ajlm-2140	176	3	epidemiol	epidemiol	PROPN
ajlm-2140	176	4	.	.	PUNCT
ajlm-2140	177	1	2021;49(2):666–675	2021;49(2):666–675	X
ajlm-2140	177	2	.	.	PUNCT
ajlm-2140	178	1	https://doi.org/10.1093/ije/dyz269	https://doi.org/10.1093/ije/dyz269	PROPN
ajlm-2140	178	2	refaat	refaat	PROPN
ajlm-2140	178	3	l	l	PROPN
ajlm-2140	178	4	,	,	PUNCT
ajlm-2140	178	5	abdellateif	abdellateif	PROPN
ajlm-2140	178	6	ms	ms	PROPN
ajlm-2140	178	7	,	,	PUNCT
ajlm-2140	178	8	bayoumi	bayoumi	NOUN
ajlm-2140	178	9	a	a	DET
ajlm-2140	178	10	,	,	PUNCT
ajlm-2140	178	11	khafagy	khafagy	PROPN
ajlm-2140	178	12	m	m	PROPN
ajlm-2140	178	13	,	,	PUNCT
ajlm-2140	178	14	kandeel	kandeel	PROPN
ajlm-2140	178	15	ez	ez	PROPN
ajlm-2140	178	16	,	,	PUNCT
ajlm-2140	178	17	nooh	nooh	ADJ
ajlm-2140	178	18	ha	ha	INTJ
ajlm-2140	178	19	.	.	PROPN
ajlm-2140	178	20	detection	detection	NOUN
ajlm-2140	178	21	of	of	ADP
ajlm-2140	178	22	abnormal	abnormal	ADJ
ajlm-2140	178	23	lymphocytes	lymphocyte	NOUN
ajlm-2140	178	24	in	in	ADP
ajlm-2140	178	25	the	the	DET
ajlm-2140	178	26	peripheral	peripheral	ADJ
ajlm-2140	178	27	blood	blood	NOUN
ajlm-2140	178	28	of	of	ADP
ajlm-2140	178	29	covid-19	covid-19	PROPN
ajlm-2140	178	30	cancer	cancer	NOUN
ajlm-2140	178	31	patients	patient	NOUN
ajlm-2140	178	32	:	:	PUNCT
ajlm-2140	178	33	diagnostic	diagnostic	ADJ
ajlm-2140	178	34	and	and	CCONJ
ajlm-2140	178	35	prognostic	prognostic	ADJ
ajlm-2140	178	36	possibility	possibility	NOUN
ajlm-2140	178	37	.	.	PUNCT
ajlm-2140	179	1	hematol	hematol	NOUN
ajlm-2140	179	2	(	(	PUNCT
ajlm-2140	179	3	united	united	ADJ
ajlm-2140	179	4	kingdom	kingdom	PROPN
ajlm-2140	179	5	)	)	PUNCT
ajlm-2140	179	6	.	.	PUNCT
ajlm-2140	180	1	2022;27(1):745–756	2022;27(1):745–756	X
ajlm-2140	180	2	.	.	PUNCT
ajlm-2140	181	1	https://doi.org/10.1080/16078454.2022.2089830	https://doi.org/10.1080/16078454.2022.2089830	NOUN
ajlm-2140	181	2	kocaturk	kocaturk	NOUN
ajlm-2140	181	3	e	e	NOUN
ajlm-2140	181	4	,	,	PUNCT
ajlm-2140	181	5	kusku	kusku	PROPN
ajlm-2140	181	6	kiraz	kiraz	PROPN
ajlm-2140	181	7	z	z	PROPN
ajlm-2140	181	8	,	,	PUNCT
ajlm-2140	181	9	uskudar	uskudar	PROPN
ajlm-2140	181	10	teke	teke	PROPN
ajlm-2140	181	11	h	h	PROPN
ajlm-2140	181	12	,	,	PUNCT
ajlm-2140	181	13	demir	demir	PROPN
ajlm-2140	181	14	ss	ss	PROPN
ajlm-2140	181	15	,	,	PUNCT
ajlm-2140	181	16	alatas	alata	NOUN
ajlm-2140	181	17	io	io	PROPN
ajlm-2140	181	18	.	.	PUNCT
ajlm-2140	181	19	a	a	DET
ajlm-2140	181	20	new	new	ADJ
ajlm-2140	181	21	approach	approach	NOUN
ajlm-2140	181	22	for	for	ADP
ajlm-2140	181	23	diagnosing	diagnose	VERB
ajlm-2140	181	24	hematological	hematological	ADJ
ajlm-2140	181	25	malignancies	malignancy	NOUN
ajlm-2140	181	26	using	use	VERB
ajlm-2140	181	27	monocytosis	monocytosis	ADJ
ajlm-2140	181	28	workflow	workflow	NOUN
ajlm-2140	181	29	optimization	optimization	NOUN
ajlm-2140	181	30	and	and	CCONJ
ajlm-2140	181	31	abnormal	abnormal	ADJ
ajlm-2140	181	32	lymphocyte	lymphocyte	NOUN
ajlm-2140	181	33	/	/	PUNCT
ajlm-2140	181	34	blast	blast	NOUN
ajlm-2140	181	35	flag	flag	NOUN
ajlm-2140	181	36	of	of	ADP
ajlm-2140	181	37	sysmex	sysmex	NOUN
ajlm-2140	181	38	xn	xn	PROPN
ajlm-2140	181	39	series	series	PROPN
ajlm-2140	181	40	of	of	ADP
ajlm-2140	181	41	blood	blood	NOUN
ajlm-2140	181	42	count	count	NOUN
ajlm-2140	181	43	analyzers	analyzer	NOUN
ajlm-2140	181	44	.	.	PUNCT
ajlm-2140	182	1	int	int	NOUN
ajlm-2140	182	2	j	j	PROPN
ajlm-2140	182	3	lab	lab	NOUN
ajlm-2140	182	4	hematol	hematol	NOUN
ajlm-2140	182	5	.	.	PUNCT
ajlm-2140	183	1	2020;(june):1–6	2020;(june):1–6	NUM
ajlm-2140	183	2	.	.	PUNCT
ajlm-2140	183	3	https://doi.org/10.1111/ijlh.13281	https://doi.org/10.1111/ijlh.13281	PROPN
ajlm-2140	183	4	ayles	ayle	VERB
ajlm-2140	183	5	h	h	NOUN
ajlm-2140	183	6	,	,	PUNCT
ajlm-2140	183	7	mureithi	mureithi	PROPN
ajlm-2140	183	8	l	l	NOUN
ajlm-2140	183	9	,	,	PUNCT
ajlm-2140	183	10	simwinga	simwinga	ADJ
ajlm-2140	183	11	m.	m.	NOUN
ajlm-2140	183	12	the	the	DET
ajlm-2140	183	13	state	state	NOUN
ajlm-2140	183	14	of	of	ADP
ajlm-2140	183	15	tuberculosis	tuberculosis	NOUN
ajlm-2140	183	16	in	in	ADP
ajlm-2140	183	17	south	south	PROPN
ajlm-2140	183	18	africa	africa	PROPN
ajlm-2140	183	19	:	:	PUNCT
ajlm-2140	183	20	what	what	PRON
ajlm-2140	183	21	does	do	AUX
ajlm-2140	183	22	the	the	DET
ajlm-2140	183	23	first	first	ADJ
ajlm-2140	183	24	national	national	ADJ
ajlm-2140	183	25	tuberculosis	tuberculosis	NOUN
ajlm-2140	183	26	prevalence	prevalence	NOUN
ajlm-2140	183	27	survey	survey	NOUN
ajlm-2140	183	28	teach	teach	VERB
ajlm-2140	183	29	us	we	PRON
ajlm-2140	183	30	?	?	PUNCT
ajlm-2140	184	1	lancet	lancet	PROPN
ajlm-2140	184	2	infect	infect	PROPN
ajlm-2140	184	3	dis	dis	PROPN
ajlm-2140	184	4	.	.	PUNCT
ajlm-2140	185	1	2022;22(8):1094–1096	2022;22(8):1094–1096	NUM
ajlm-2140	185	2	.	.	PUNCT
ajlm-2140	186	1	https://doi.org/10.1016/s1473-3099(22)00286-9	https://doi.org/10.1016/s1473-3099(22)00286-9	NOUN